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TRANSMISSION NETWORKS INFERRED FROM HIV SEQUENCE DATA 
Insert the lay summary text here - the space will expand as you type.  
HIV can be transmitted through sexual contact (heterosexual or homosexual), through sharing needles and 
during childbirth. 100,000 people are infected in the UK and around 45% of these are men who have sex with 
men (MSM), 45% are heterosexuals and ~5-10% are people who inject drugs. 
HIV displays huge genetic diversity: numerous subtypes exist and the virus is distinct in between even 
transmission-recipient pairs. If viruses sampled from different individuals are highly genetically similar, those 
individuals may have infected each other or be associated with the same transmission chain. In the UK, many 
HIV genetic sequences are available because these are generated as standard practice during medical 
treatment. The relationships between all UK viruses can be reconstructed in the form of large trees of l ife, or 
phylogenies, to assess the probability of transmission events at the national level. These trees contain 
thousands of sequences, but within them, “clusters”, or groups of related sequences, are of particular interest 
because they contain sequences associated with the same transmission chain. 
In Chapter 3, I develop software tools that identify clusters within large phylogenies automatically and describe 
them in terms of risk group. In Chapter 4, the tools are used to analyse and compare the UK and Swiss HIV 
epidemics. Switzerland generates HIV sequences from Swiss patients in the same way as is done in the UK 
and the two countries have the two largest HIV sequence databases in the world. I found clustering patterns in 
the two countries to be broadly similar, although the UK epidemic comprised more men who self-identified as 
heterosexuals yet clustered with MSM, suggesting that they are more likely to have been infected through sex 
with men. 
In Chapter 4, I analysed the transmission patterns of HIV subtypes that have entered the UK only recently. 
Subtype B predominated until the 1990s, but non-B subtypes now circulate and account for 60% of new 
diagnoses each year. In contrast in the rest of Europe, subtype B still represents >80% of infections. These 
non-B subtypes infect mostly heterosexuals. I found that these clusters were more likely to be smaller than 
subtype B clusters among MSM; and between 2007 and 2010, the non-B clusters were less likely to grow. 
However, a small proportion of non-B clusters comprised MSM and these clusters were more likely to grow. It 
thus appears that crossover of non-B subtypes into MSM has caused expansion of those subtypes within the 
UK. 
In Chapter 5, I use simulations of HIV epidemics to evaluate how well identified clusters match true transmission 
chains. 
Together with other evidence, this thesis demonstrates that the UK HIV epidemic continues to be driven by 
transmission among MSM. New subtypes historically associated with heterosexual transmission now circulate 
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ABSTRACT  
HIV in the UK in the 1980s was concentrated within men who have sex with men 
(MSM) and people who inject drugs (PWID) but heterosexual sex is now the most 
frequently reported risk behaviour. As these risk groups are associated with different 
virus populations, this is reflected in the subtype diversification of the UK epidemic, 
which was historically dominated by subtype B. 
I have made use of a national database of HIV sequences collected during routine 
clinical care, which also contains data on age, sex, route of exposure & ethnicity. The 
2014 release of the UK HIV Drug Resistance Database contained data from over 
60,000 patients. 
In this thesis, I first describe the development of novel tools that rapidly and 
automatically identify HIV clusters within phylogenetic trees containing tens of 
thousands of sequences because they represent transmission chains within the larger 
infected population.  
I use these tools to compare the HIV subtype B epidemics in the UK and Switzerland, 
which had both been described separately but using different approaches. Working 
with Swiss colleagues, I was able to analyse the epidemics in exactly the same way 
without having to share sensitive data. I found clustering in the UK to be much higher 
at relaxed thresholds than in Switzerland (34% vs 16%) indicating that the UK 
database is more likely to capture transmission chains. Down sampling revealed that 
this pattern is driven by the larger size of the UK epidemic. At tighter cluster 
thresholds, the epidemics were very similar. 
I next use these tools to analyse the spread of emerging subtypes A1, C, D and G in 
the UK. I found both risk group and cluster size to be predictive of cluster growth, 
which I tested using simulations and a GLM. Growth of MSM and crossover clusters 
was significantly higher than expected for subtypes A1 and C, indicating that crossover 
from heterosexuals to MSM has contributed to their expansion within the UK. 
 
vi 
Numbers were small for subtypes D and G but the proportion of new diagnoses linking 
to MSM and crossover clusters was similar to A1 and C, suggesting that the same 
pattern may be emerging for D and G. 
I conclude by evaluating the accuracy of a method previously described by our group 
to generate transmission networks from HIV sequences. The interpretation of 
clustering patterns from phylogenetic trees is difficult because of the absence of a 
standardised statistical framework. In contrast, a body of work exists that relates 
disease transmission to networks. Using large simulated datasets, I developed 
algorithms which eliminate improbable links. I then reconstructed improved UK 
transmission networks for subtypes A1, B and C and compare network metrics (such 
as the degree distribution) between risk groups. 
Together with other evidence, this thesis demonstrates that the UK HIV epidemic 
continues to be driven by transmission among MSM. The UK epidemic is no longer 
compartmentalised and the crossing over of subtypes across risk groups has been 
facilitated by MSM also having sex with women.  
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1 TRANSMISSION AND 
EVOLUTION OF HIV 
1.1 The HIV Epidemic 
1.1.1 Global distribution of HIV  
The Human Immunodeficiency Virus (HIV) is the causative agent of Acquired 
Immunodeficiency Syndrome (AIDS). AIDS was first recognized in 1981, when 
previously healthy young men were diagnosed with unusual infections that suggested 
their immune systems were malfunctioning [1]. The AIDS-causing virus was isolated 
first in France in 1983 [2] then later that year in the United States of America (USA) 
[3], establishing a definite link between the virus and AIDS. The appellation “HIV” 
was internationally adopted in 1986 [4]. 
The immune system of people living with HIV progressively fails until they are no 
longer able to fight off other infections and die from AIDS. The number of people 
living with HIV continues to rise. In 2013, 35 million people were infected, 2.1 million 
people became newly infected and 1.5 million died from AIDS [5]. The World Health 
Organization (WHO) considers HIV a global pandemic but infections are unequally 
Transmission networks inferred from HIV sequence data 
 
24  Manon Ragonnet-Cronin - October 2015 
 
distributed across the globe. Sub-Saharan Africa is the most severely affected region, 
with 67% of infections, or 24.7 million people living with HIV. HIV is a leading cause 
of death in a number of countries, leaving millions of children orphaned. AIDS patients 
are unable to work and require significant medical care. As such HIV is a major social 
and economic burden. In addition, HIV is a highly stigmatised condition due to its 
associations with homosexuality, drug use and race. Thirty years into the epidemic, 
HIV has no cure or vaccine and continues to be a major global heath priority.  
1.1.2 HIV in the UK 
In the UK in 2013, an estimated 107,000 people were living with HIV, a quarter of 
whom were unaware of their infection [6]. At the beginning of the HIV epidemic in 
the 1980s, HIV was concentrated within men who have sex with men (MSM) and 
people who inject drugs (PWID). Harm reduction and needle exchange programs have 
decreased HIV incidence in PWID substantially since then. Since 1999, heterosexual 
sex has become increasingly frequently reported as the risk behaviour for HIV 
acquisition. Currently, MSM and heterosexuals account for around 45% each of 
prevalent cases and PWIDs for 5% [6]. 
1.1.3 Origin of HIV 
HIV arose by zoonotic transfer of simian immunodeficiency virus (SIV) from non-
human primates. A number of cross-species transmission events have led to HIV’s 
current genetic diversity [7, 8]. HIV-1, discovered first, is closely related to SIV in 
chimpanzees (SIVcpz) [9]. HIV-2 was isolated from West African patients with AIDS 
in 1986. HIV-2 is related to HIV-1 but has distinct antigenic components and evolved 
from SIV in sooty mangabeys (SIVsm) [9] (Figure 1.1). HIV has been classified 
according to genetic similarities: HIV-1 contains four groups, M, N, O and P, while 
HIV-2 separates into eight, A to H [10]. HIV-1 group M is the pandemic-causing 
strain, and it comprises a further 11 major subtypes (A1, A2, B, C, D, F1, F2, G, H, J, 
K) as well as an increasing number of circulating and unique recombinant forms (CRF, 
URF) [11]. The HIV-1 groups M, N, O and P are each individually closer to SIV 
Chapter 1: Transmission and evolution of HIV 
 
Manon Ragonnet-Cronin - October 2015   25 
 
isolates than they are to each other and so appear to have originated from distinct cross-
species events [8] (Figure 1.1).  
 
Figure 1.1: Primate lentivirus phylogenetic relationships based on the pol region. 
Scale in nucleotide substitutions per site. By Thomas Splettstoesser and based on 
Kuiken et al. [12], via Wikimedia Commons.  
Thirty nine species of non-human primates possess a strain of SIV [13]; however the 
virus does not normally cause serious illness in its natural host (for exceptions, see [14, 
15]). This resistance to disease has been shown to arise in part due to a down-regulation 
of immune activation in naturally SIV-infected cercopithecoid monkeys [16] and 
points to a long-term adaptive co-evolution, in contrast to the recent emergence and 
high pathogenicity of HIV in humans and rhesus macaques. Modern methods of 
analysing ancient samples support the hypothesis that HIV-1 group M was introduced 
into human populations around 1900 [17] in Kinshasa in the Democratic Republic of 
Congo [18, 19], the country displaying the highest genetic diversity of HIV. It is likely 
that transmission occurred through the practice of primate bushmeat hunting, through 
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exposure to infected blood due to animal bites or during butchering [8]. The oral polio 
vaccine theory suggested that HIV was the result of vaccination trials conducted in the 
Belgian Congo in the late 1950s; but this theory has been discredited. No HIV virus 
nor chimpanzee DNA were found in remnant batches of the vaccine [20], and 
molecular clock analyses (see section 2.2.2.2) place the common ancestor to 
circulating HIV strains before the 1950s [21, 22]. 
1.2 Molecular virology of HIV 
1.2.1 HIV life cycle and disease progression 
Two aspects of HIV biology make it a particularly challenging disease. Firstly, HIV 
directly attacks the host’s immune system. HIV infects CD4+ T cells responsible for 
regulating immune responses, progressively compromising the host’s ability to fight 
off infection. Secondly, infected hosts do not show any symptoms for 8 to 12 years 
without treatment but are still able to transmit the virus during this period of clinical 
latency.  
HIV is classified as a member of the lentiviral genus in the Retroviridae family. 
Lentiviruses contain single-stranded positive-sense RNA genomes. The HIV particle 
is spherical and 120nm in diameter and each particle contains two copies of its full 
genome. The genome is ~10,000bp and consists of three main genes, gag, pol, and env 
and six accessory genes: tat, rev, nef, vif, vpr and vpu, encoding a total of 19 proteins. 
The major target cells of HIV are CD4+ T cells vital to the human immune system, 
but macrophages and dendritic cells can also be infected. Entry into the cell is 
dependent on binding to the CD4+ receptor and a co-receptor (one of the chemokine 
receptors CCR5 or CXCR4). After the viral capsid has entered the cell, the viral 
enzyme reverse transcriptase (RT) converts viral RNA in to double-stranded DNA 
(dsDNA). The viral protein integrase then integrates the dsDNA into the host cellular 
DNA, often within active transcription units [23]. Viral genes become highly 
expressed and infected cells produce and release numerous viral particles, triggering 
cytotoxic defences. Alternatively, the integrated virus can enter viral latency and lie 
dormant within the host DNA, expressed at low levels or not at all. Latent virus can 
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persist indefinitely in memory T-cells and this latent reservoir is a major barrier to 
curing HIV [24].  
 
 
Figure 1.2: HIV course of infection. CD4+ counts and HIV copies in an untreated 
patient. By Jurema Oliveira, and based on Figure 1 in Pantaleo et al. [25]. Via 
Wikimedia Commons, GNU Free Documentation License.  
HIV disease progression to AIDS is divided into three stages (Figure 1.2). During the 
first 2-4 weeks (acute infection) the virus replicates rapidly, occasionally causing 
generic symptoms of immune activation such as a fever, headache and sore throat. 
Extremely high viral loads (107 viral RNA copies/mL blood) are associated with high 
infectiousness during this stage of infection [26]. CD4+ counts falls and are never 
recovered. Initiation of host adaptive immune responses causes patients to enter the 
latent period of HIV infection. During the next 8-12 years the patient does not show 
any overt symptoms. At the start of latency the infection is controlled by the host 
immune system, but immunity fails over time in the absence of treatment. Viral loads 
increase gradually, correlating with the decline of CD4+ T cells in the peripheral blood 
and a progressive failure of the immune system. When CD4+ cell counts drop below 
a critical level, around 200 cells/mm3, cell-mediated immune responses cannot 
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function. The AIDS stage has been reached and patients are no longer able to fight off 
opportunistic infections. Patients usually die within a year of developing AIDS [27]. 
Antiretroviral therapy (ART) prevents the virus from multiplying and destroying the 
host’s immune system so that patients never progress to AIDS (see section 1.2.3). 
1.2.2 Viral replication and molecular evolution  
Many mutations happen during reverse transcription. The enzyme that synthesises 
complementary DNA from viral RNA, RT, is extremely error-prone and has no 
proofreading ability. One error is made every 1,000-10,000 bases causing 5 to 10 
nucleotide substitutions per new HIV genome synthesized [28]. In addition HIV has 
an extremely high replication rate: in the absence of treatment 1010 virions are 
produced daily by infected individuals [29]. On top of this, two genomic copies are 
packaged into HIV virions and these can produce recombinants. During reverse 
transcription, both copies are used to produce double stranded DNA through a process 
of template switching [30]. Recombination occurs at a minimum rate of 2.8 crossovers 
per genome per cycle [31]. Occasionally, virions become coinfected with divergent 
strains leading to intra and inter-subtype (section 1.4.2) recombinant viruses [32, 33]. 
HIV thus displays high genetic variability both within a host and at the level of the 
population. High within-host variation allows selection of HIV variants able to evade 
human immune responses and resist HIV drugs. The extreme genetic diversity of 
circulating isolates contributes to the difficulties in producing a vaccine.  
HIV undergoes a major bottleneck at transmission; in 60-80% of infections, a single 
founder virus is transmitted [18, 34-36]. Intra-patient genetic diversity then increases 
over the course of infection [37] as a consequence of both genetic drift and immune 
selection. Selection acts on the genetically diverse quasispecies as whole, allowing the 
viral population to rapidly adapt to its host. Viral escape mutants that reduce 
recognition and destruction by the immune system are strongly selected [38-40]. 
Neutralising antibodies drive the diversification of HIV envelope in early infection 
[41]. The most important genetic determinant of disease progression identified so far 
is the Human Leukocyte Antigen (HLA) [42, 43]. Some HLA alleles that confer a 
Chapter 1: Transmission and evolution of HIV 
 
Manon Ragonnet-Cronin - October 2015   29 
 
notable protective effect against HIV disease, such as B57, are called ‘super-
controller’ alleles [44]. Additionally, non-immune related selection is driven by ART 
which results in drug-resistant viruses (see section 1.2.4). 
1.2.3 HIV treatment 
Azidothymidine (AZT) was the first HIV drug approved by the US government in 
1987. Since then, around 30 more drugs have been approved. Many stages of the viral 
life cycle cannot be targeted because they utilise host machinery and drugs targeting 
host machinery are harmful to the host. Existing drugs each target different aspects of 
the viral life cycle and are sorted into five classes based on their target. Nucleotide 
Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleotide Reverse Transcriptase 
Inhibitors (NNRTIs) both block the viral RT (see section 1.2.2). Protease Inhibitors 
(PIs) prevent the protease enzyme from cleaving newly synthesised proteins to make 
them functional. Integrase inhibitors block double-stranded viral DNA from 
integrating into the host genome. Fusion inhibitors prevent the virus from docking and 
entering into new cells. All drugs are used in combinations of 3 drugs from 2 or more 
classes and can fully suppress replication of wild type virus below detectable levels. 
Prescribing drugs in combination (Highly Active Anti-Retroviral Treatment or 
HAART) has changed HIV to a chronic disease: viral loads are lowered, optimally to 
undetectable levels, and CD4+ cell count increases. It has been shown that with 
optimal therapy the life expectancy of an infected individual lies within the normal 
range [45]. At present, these drugs prevent disease but do not cure HIV as they are not 
able to remove integrated latent provirus (section 1.2.1). 
1.2.4 Drug Resistance 
Incompletely suppressed virus can lead to mutations arising in targeted enzymes that 
allow the virus to develop resistance to treatment. The opportunity to develop 
resistance is reduced as HIV replication is more efficiently blocked and as HAART 
significantly decreases replication, drug resistant mutations (DRM) are far less likely 
to emerge and be selected for. However, viral rebound, for example as a consequence 
of incomplete adherence to drug regimens, can favour the emergence of DRM.  
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Widespread use of ART has led to the development of DRM in circulating strains. 
Drug resistant strains can be transmitted (transmitted drug resistance or TDR) and can 
considerably reduce the efficacy of first line therapies. Resistance exists to all available 
classes of drugs but mutations are most common in the pol region of HIV because 
drugs that have been available the longest target protease (PR) and RT. Because of 
increasing prevalence of TDR [46, 47], genotyping (sequencing of the pol region) is 
recommended for all newly diagnosed individuals and is routinely performed in a 
number of countries [48-50]. The identification of specific DRM allows for tailoring 
of drug regimens. In the UK the virus is genotyped to detect drug resistance mutations 
before the initiation of therapy and in the case of immune failure, so that drug regimens 
can be tailored (see section 2.1.2). 
1.3 HIV transmission and prevention 
HIV is transmitted mainly through sexual intercourse. HIV can also be transmitted 
through contact with infected blood and from mother to child (MTCT). In sub-Saharan 
Africa, heterosexual sex is the dominant route of transmission while in Europe it is sex 
between men. In Asia, the use of contaminated needles has emerged as a driver of the 
epidemic. In the USA, both sex between men and needle sharing are major risk factors. 
Accurate estimates of per act transmission are essential for designing HIV 
interventions and for mathematically modelling the HIV epidemic (see section 1.5).  
1.3.1 Sexual transmission of HIV 
During intercourse, the receptive partner is at higher risk for HIV than the insertive 
partner. The risk per (unprotected) sexual act in developed countries has been 
calculated in meta-analyses as highest for receptive anal intercourse: 1.38% (95 CI 
1.02-1.86%), 0.11% for insertive anal intercourse, 0.08% for receptive vaginal 
intercourse and 0.04% for insertive vaginal intercourse [51]. 
Original estimates for transmission were derived from longitudinal analyses of 
heterosexual sero-discordant couples in Uganda [52] and extrapolated to MSM and 
high resources settings. Since then a number of studies have been conducted in 
heterosexuals and MSM in the developed world (reviewed in [51]) and in low resource 
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settings (reviewed in [53]), in the pre and post-HAART eras. In low resource settings, 
calculated estimates 2-8 times higher [53]. 
MSM have a higher risk of contracting HIV than heterosexuals because of increased 
risk during anal intercourse, the higher prevalence of HIV among MSM, sexual role 
versatility and possibly increased risk-taking behaviour in this group [54]. 
Condoms prevent sexual HIV transmission [55] and have been available since the 
beginning of the epidemic but lack of compliance have limited their ability to curb the 
epidemic. The risk of sexual transmission of HIV is increased in the presence of other 
sexually transmitted infections (STI) [56]. Genital ulcer disease, for example, 
increases HIV transmission risk fivefold [53]. Thus, STI treatment is an effective 
prevention strategy [56]. Additionally, circumcision reduces the risk of heterosexual 
HIV acquisition in men [26] and voluntary medical male circumcision programmes 
have been initiated in 14 eastern and southern African countries. 
HIV transmission risk is highly dependent on viral load [57]. In turn, viral load is 
dependent on a number of factors, including infection stage (see section 1.2.1) [58]. 
High viral loads during the first few weeks of infection may lead to a large proportion 
of transmissions originating from recently infected patients [26]. ART (see section 
1.2.3) suppresses viral loads and thus decreases HIV transmission [59, 60]. Treatment 
and viral load monitoring are thus key prevention strategies, coining the expression 
“treatment as prevention”. Moreover, clinical trials have demonstrated that HIV 
acquisition can be decreased by the prophylactic use of antiretrovirals [27]. The use of 
pre-exposure prophylaxis (PrEP) is currently supported by guidelines in the USA but 
not in the UK. HIV testing is considered an important component of HIV prevention, 
particularly in the context of such high numbers of undiagnosed cases. It is possible 
that increased transmission from patients with recent infections is in part due to 
transmitters not being aware of their HIV positive status. HIV testing enables patients 
to make informed decisions about safer sex and HIV treatment, thus reducing their 
likelihood of transmitting the virus. 
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1.3.2 Transmission of HIV through needle sharing 
Exchange of blood through sharing needles among PWID is a major route of HIV 
transmission. Globally, 10% of new infections occur through PWID, although if sub-
Saharan Africa is excluded, this surges to 30% [61]. PWID, their partners and children 
account for one third of AIDS cases in the USA [62]. Infectivity per act for needle 
sharing is 0.63% (95% CI 0.41%-0.92%) [51], and with PWID engaging in hundreds 
of injections every year, lifetime risk is very high. The estimate was calculated for 
subtype B among PWID cohort in Thailand and is considered to the most relevant to 
the current US epidemic.  
The transmission of HIV through injection drug use can be completely prevented by 
the provision of clean needles. The size of the HIV epidemic among PWID in different 
countries is a direct consequence of that country’s policy towards harm reduction and 
legislation surrounding drug use. Needle exchange programmes have drastically 
reduced the incidence of HIV in countries where they exist, including the UK.  
1.3.3 Iatrogenic transmission of HIV 
Iatrogenic transmission is the transmission of infectious agents in a medical setting. 
The estimated risk of HIV transmission is highest for blood transfusions; in a 
retrospective analysis, 90% of HIV+ blood recipients became infected [51]. Early in 
the epidemic, 14,000 people became HIV positive through infected blood in Europe 
and the USA [63], primarily haemophiliacs [64]. Testing of donor blood has practically 
eliminated this route of infection in countries where it is implemented. In Africa 6% 
of infections are estimated to be the result of blood transfusions [65]. 
The re-use of injection equipment in hospitals is estimated by the WHO to contribute 
1.6% of new infections in Africa [65] but this number is disputed, with one research 
group claiming that up to half of infections are linked to medical exposure [66]. Risk 
per exposure is estimated at 0.23% (95% CI 0-0.46%) [51]. 
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1.3.4 Mother to child transmission (MTCT) of HIV  
MTCT can occur at three stages: during pregnancy, during delivery or through 
breastfeeding. In the absence of treatment, the total risk across these stages ranges from 
15% to 45% and has been estimated at 22.6% in developed country settings [67]. In 
1996, a placebo-controlled trial with AZT reduced MTCT to 7.6 % [67]. Access to 
antenatal combination ART reduced MTCT to 0.46% in the UK in 2010-2011 [68]. 
MTCT approached 0 when the mother’s viral loads were controlled. This year, Cuba 
became to first country to have eliminated MTCT of HIV. Globally, only 57% of 
pregnant women living with HIV received ART in 2011 and MTCT accounts for 10% 
of new infections annually (http://apps.who.int/gho/data/node.main.627). 
1.4 Phylogenetic analysis of HIV 
1.4.1 Rationale 
The accumulation of HIV mutations occurs on a time scale similar to that of the 
ecological processes to which it is subject, for example spatial dynamics, changes in 
virus population size (due to epidemic spread and transmission bottlenecks) and host 
immune pressure. HIV phylogenies reconstructed from viruses sampled over time can 
be used to infer the evolutionary and transmission history of the pathogen [69-71]. 
HIV phylogenetics was initially used to confirm transmission pairs in contact 
investigations, the first of which established the transmission of HIV from a dentist in 
Florida to a number of his patients in 1992 [72]. More recently, viral linkage has been 
used in clinical trials that evaluate whether treating the infected partner decreases their 
risk of transmitting HIV to their HIV-negative partner [73]. In the event of the partner 
of a treated patient becoming infected, phylogenetic analysis is used to test whether 
the infection may have come from outside the partnership. Erroneously attributing the 
transmission to the treated partner would underestimate the efficacy of the 
intervention.  
In addition to phylogenies informing us on the relationships between samples, methods 
have been developed that incorporate sample dates to estimate the timing of events in 
the tree (the molecular clock, see Methods) [74]. The purpose of the molecular clock 
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is to correlate genetic distance with calendar time. Demographic reconstructions can 
also be enhanced by the inclusion of geographic parameters into analyses [75]. 
Therefore sequentially sampled viral isolates can reveal past population dynamics, 
such as dates of introduction of the virus into different populations, population size 
(incidence) through time and space, dispersal and epidemic growth rate and doubling 
time [76]. Together, phylogenetic and phylogeographic analyses have been used to 
elucidate the origin of HIV, reconstruct its spread around the world and to resolve 
ongoing transmission patterns within countries and smaller areas. 
1.4.2 Subtype diversification and global spread 
Subtypes are defined based on the high genetic distances found between them: 25-
35%, as compared to 5-20% found within a subtype [77]. Diversification into subtypes 
is the result of a number of random founder effects of HIV-1 group M outwards from 
Kinshasa [19, 22, 78]. The present HIV subtype distribution is geographically 
heterogeneous. Globally, subtype C is most prevalent and accounts for nearly 50% of 
infections [11]. In Southern Africa and in India, >90% of infections are subtype C [11]. 
Phylogenetic and phylogeographic analyses place the origin of subtype C around 1960 
in the Democratic Republic of Congo [79] and then indicate spread eastwards and 
southwards in Africa. Subtype C was introduced into India around 1971 [80] and, as 
in sub-Saharan Africa, is transmitted mainly heterosexually.  
B is the most dispersed subtype and was the first discovered. B predominates in Europe 
and North America but is responsible for only 12% of infections globally [11]. 
Bayesian phylogenetic analysis testing strongly supports that subtype B was exported 
from Africa to Haiti around 1966 and then to USA around 1969 [81]. Before the end 
of the 1960s, subtype B was also circulating in South America [82], but was not 
introduced into Eastern Europe until the 1980s [83]. Comparative demographic 
analyses of subtypes B and C suggest the B epidemic initially exploded in the West 
among PWID and MSM (growing twice as fast as it had in Africa) but then stabilised 
in the 1990s, whereas the subtype C epidemic in sub-Saharan Africa still appears to be 
growing exponentially [84]. In Eastern Europe, where a high proportion of HIV 
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transmission is through PWID [61], the subtype B epidemic also seems to be growing 
exponentially [83]. 
Subtype A accounts for another 12% of infections [11] and is most common in East 
Africa (where it co-circulates with subtype D) and in Eastern Europe where over 70% 
of infections are subtype A [83]. The subtype A epidemic in Eastern Europe began in 
Ukraine in the mid-1990s among PWID and rapidly spread to other Eastern European 
countries and Russia [85]. The absence of a selection during blood to blood infection 
(due to the absence of a mucosal immune barrier), combined with the rapidity of the 
spread through the region, led to subtype A displaying particularly low genetic 
diversity.  Subtype AE, the first recombinant discovered in Thailand in the 1980s [86], 
dominates the southeast Asian epidemic [11]. 
The dates of viral introductions based on sequence analysis into different parts of the 
worlds are consistent with our overall understanding of HIV spread across the world. 
HIV epidemic growth patterns arise as a consequence of the underlying characteristics 
of the transmission networks. The most notable difference is that in sub-Saharan 
Africa, a large proportion of HIV transmission occurs through heterosexual sex and 
from mother to child, while in the rest of the world MSM and PWID are most affected. 
Within smaller populations and geographical areas other epidemiological factors are 
likely to affect the rate of spread, including times of introduction into different risk 
populations, sexual and drug behaviours, as well as laws, health policies and education 
relating to HIV. Only rarely have subtype-specific patterns that could play a role in the 
dynamics of these distinct epidemics (such as the increased transmissibility [87] and 
disease progression [88] of subtype D) been observed. 
HIV was introduced into the UK MSM population around 1980 [89], probably from 
the USA [90], and separately into UK PWID around 1983 [91, 92] Until the early 
1990s the UK epidemic was dominated by the transmission of subtype B among MSM 
and PWID. In the 1990s, cases among heterosexuals became more common [93] and 
these were often linked to immigration [90]. The prevalence of non-B subtypes has 
increased over time (Figure 1.3). 48% of HIV diagnoses between 2002 and 2010 were 
among heterosexuals [93]. The predominant viral subtype was B (39.9%), followed by 
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C (34.3%), A (5%), recombinants (12%), D (2.4%), G (2.7%) and AE (2%). The 
genetic diversity of the UK epidemic is a reflection of immigration in to the UK: 
subtype C comes from sub-Saharan Africa and India and subtype A comes from East 
Africa and Eastern Europe. However, non-B subtypes are increasingly being acquired 
within the UK [94, 95] (Chapter 5). For some time the UK epidemic was 
compartmentalised by subtype and risk group, with B predominantly circulating 
among MSM and non-B virus among heterosexuals. Yet recently a small but 
significant proportion of non-B infections are being acquired through sex between men 
[93] (Chapter 5). 
1.4.3 Findings from local epidemics 
 
 
Figure 1.3: HIV diagnoses by subtype and by year in the UK HIV Drug 
Resistance Database. Generated from the database.  
Local and national epidemics can be monitored through phylogenetic analysis to help 
guide intervention strategies and make predictions about the future of the epidemic 
[96]. In addition, molecular epidemiology has been applauded for providing an 
alternative source of information on epidemics in parallel to that revealed through 
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For example, phylogenetic analyses can reveal whether imported strains are spreading 
locally [97] (in which case local and foreign sequences are intermingled in the tree). 
Linkages between national epidemics have been established within Europe [98] and 
globally [99]. Within Switzerland, phylogenetic analysis established that only 25% of 
non-B infections were found to arise within Swiss-specific subtrees, indicating a 
growing role for immigration in the Swiss HIV epidemic [97]. In France, a 
phylogenetic analysis of sequences sampled from recently acquired infections 
concluded that at least 20% of non-B subtype infections had been acquired in France 
[100]. In Chapter 5, I investigate the spread of non-B subtypes within the UK using 
phylogenetic analysis. 
Another question that has been addressed using phylogenetics is the contribution of 
recent infections towards onward transmission. Because recently infected patients 
have high viral loads and often do not know their status, it has been suggested that they 
are responsible for a disproportionate number of onward transmissions. Accordingly, 
their viruses have shown a stronger tendency to cluster in phylogenies than those from 
chronic infections [101, 102], meaning that they are found close together in trees, 
separated by small genetic distances. (Cluster definitions and methods are explained 
in detail in section 3.2.) However, clustering of recent infections does not necessarily 
mean that onward transmission occurred during early infection [103]. In fact a large 
proportion of clustered recent infections will be recipients sampled soon after they 
themselves became infected [104]. Clustering of recent infections will also be more 
likely because sequences will not yet have diverged [104]. 
The extent of overlap between risk groups and the role of bridging populations in 
driving the epidemic remains an open question. In Switzerland, phylogenetic analysis 
has demonstrated a lack of overlap between MSM and heterosexual/PWID HIV 
epidemics. The heterosexual subtype B epidemic appears to have been continually 
reseeded by PWID and not to be self-sustaining [105]. In the UK, between 1 and 11% 
of self-identified heterosexual men appear to have become infected with subtype B 
through sex with men [106], providing a potential bridge between the MSM and 
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heterosexual subtype B epidemics. In Chapter 5, we examine the extent of non-B 
subtype bridging in the other direction, form heterosexuals to MSM.  
The higher the sample fraction, the more detailed analyses can be. In the UK, tens of 
thousands of sequences are available through the UK HIV RDB: sample coverage 
approaches 60%. Phylogenetic analysis has revealed six large transmission chains 
among MSM, reflecting independent introductions into the UK. The epidemic 
displayed exponential growth in the 1980s, then stabilised in the 1990s but continues 
to be highly clustered [107]. Within large MSM clusters, the internal architecture has 
been further resolved indicating that the epidemic has unfolded in bursts with 25% of 
transmissions occurring within 6 months of infection [108]. Heterosexuals in the UK 
displayed far less clustering and much slower epidemic dynamics: only 2% of 
transmissions occurred within 6 months of infection [109].  
The Swiss HIV Cohort Study similarly contains HIV sequences from >60% of the 
HIV-infected population. The UK and Switzerland have led the way in the field of 
molecular epidemiology and phylodynamics. The two countries’ epidemics are 
compared in Chapter 4. 
1.4.4 From phylogeny to transmission network 
Recently, there has been huge interest in using HIV phylogenies to gain information 
about the HIV transmission network and sexual contact network. Networks have been 
developed extensively in mathematical models to study the spread of infectious 
diseases and benefit from a rigorous statistical framework (see section 1.5). 
Meanwhile, sequences provide what mathematical models are often lacking: data. 
1.5 Network modeling of epidemics 
1.5.1 Classical modeling approaches 
Mathematical models can be used to understand and predict the spread of diseases 
using sets of equations relating the variables in the system. Models are intended to be 
a simplification of the real world, but capture the essential features of the system, for 
example the number of infected individuals over time. Additionally, models offer a 
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setting in which to test the effect of interventions, for example they can be used to 
estimate the reduction in the total number of infected individuals expected by using a 
vaccine with a particular efficacy. 
Classical epidemiological models divide the population into classes (or 
compartments), such as “susceptible” and “infected” and represent the flow of 
individuals between compartments using equations. One of the simplest models, the 





Where S represents the proportion of susceptible individuals at time t, I the proportion 
of infected individuals and R the proportion of recovered (or removed) individuals. 
Individuals move from compartment S to compartment I according to the transmission 
rate of the disease and the contact rate between infecteds and susceptibles 
(amalgamated into β) and the relative numbers of susceptibles and infecteds. 
Individuals then recover at a rate γ. Thus:  
 𝑑𝑆
𝑑𝑡 








=  𝛾𝐼  
(3) 
An example of the movement of a population through the compartments for set rates 
of β and γ is shown in Figure 1.4.  
From looking at equation (2), it is clear that if people are infected slowly and recover 
rapidly (𝛽𝑆𝐼 < 𝛾𝐼), there will not be anyone in the infected compartment and the 
disease will never take off. The relative rate of exit from the infected compartment as 
S I R
γ β 
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compared to that of entry into the compartment (the relative recovery rate or γ/β) must 
be small enough for the disease to spread. The inverse of the relative recovery rate is 







R0 is defined as the number of secondary cases arising from an infection in a 




Figure 1.4: Infection dynamics of an SIR model. This figure was plotted assuming 
β=1 and γ=0.25 for a population of 100 with a single individual initially infected.  
Compartmental models often assume random mixing, which means that all susceptible 
individuals are equally likely to come in contact with infected individuals. As random 
mixing is a poor assumption in the case of sexually transmitted infections such as HIV 
[110], some models incorporate high and low risk groups which interact more or less. 
Compartmental models in fact be extended to include numerous compartments, for 
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example disease stages (acute, chromic, AIDS) or age group, so this allows for some 
differences in transmissibility and behaviour between groups. However, the higher the 
number of compartments the more parameters are required. The error in each 
introduces uncertainty into the model. 
The first mathematical models of HIV were used to predict the number of future HIV 
and AIDS cases. Blower et al. conducted an analysis of the HIV epidemic in New 
York City [111]. In order to make their model realistic, they included three risk groups 
(MSM, PWID and heterosexuals) and two sexes, with interaction terms within and 
between each risk group. However, the model contained over 30 parameters, and due 
to the uncertainty in the parameters the predicted number of infections over time had 
very wide confidence intervals. Williams and Anderson also tried to predict HIV cases 
for England and Wales [112]. As well as risk group, they included categories for levels 
of sexual and drug-related activity. Again, so many parameter combinations fit past 
trends that they could not make reliable predictions, although they emphasised the 
importance of bridging populations to future trends.  
Compartmental models are used extensively, and usefully, to test and predict the 
impact of different intervention strategies. However, they suffer from three major 
limitations. Firstly, as mentioned above, they assume random mixing despite the pool 
of partners realistically being much smaller than the population as a whole. Secondly, 
compartmental models cannot take into account differences at the individual level, 
despite heterogeneity in number of partners being central to the spread of STIs such as 
HIV (see section 1.5.5). While additional compartments can be added, the large 
number of parameters required introduce uncertainty. Thirdly, the simplest 
compartmental models are deterministic so that the output of the model is fully 
determined based on the initial conditions and the parameter values. A deterministic 
model does not take into account randomness and will produce the same output if it is 
run with the same starting parameters.  
These limitations can be addressed by models which make explicit the contact 
structure in a population by using a network and model the spread of disease on that 
network. 
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1.5.2 Contact network models 
Contact network models capture the diversity in host behaviours and interactions by 
modeling each individual in the population as a discrete object with its own 
parameters. As well as variation in the number of partners, other features of the 
network, for example assortativity (the tendency of individuals sharing characteristics 
to partner) or heterogeneity in transmission rates can easily be incorporated. Network 
models usually still have an underlying SIR model, but progress through disease stages 
for each individual can be determined by that individual’s characteristics. Whilst 
transmission and contact rates in compartmental models were amalgamated into one 
parameter β, they can now be decoupled. In some networks (heterosexual networks 
where partnerships are assumed to form randomly given the heterogeneity in contact 







Where 𝜏̅ is the average likelihood of transmission and 𝜏𝑐 is the inverse of the contact 
rate or level of connectivity of the network. The higher the contact rate, the lower the 
transmission probability required in order for an infection to take off. Hence we refer 
to 𝜏𝑐 as the epidemic threshold (see section 1.5.5). 
Incorporating stochasticity is more straightforward in network models as these contain 
inherent randomness. As such, models with the same starting parameters can have 
different outcomes. Finally, network models do not require large population sizes. 
Recently developed dynamic network models even allow for the structure of the 
contact network to change over time. 
One remaining problem however, is how to specify the underlying contact network of 
a population.  
1.5.3 Network theory 
In a network, each individual is represented by a node, and if they are linked, they 
share an “edge” that connects them. For some diseases, the definition of a contact is 
ambiguous; however for STIs, an edge indicates partnership, with sexual contacts 
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occurring as events along that edge. Edges can be directed (for example, showing the 
transmission of an infection from one individual to the next) or undirected (showing 
that the two individuals interact with each other). In a directed network, edges might 
be represented by arrows while, in an undirected network, nodes would be linked by a 
symmetrical line. Importantly, in the context of epidemiology, an infection can only 
be transmitted between an infected and a susceptible node that are linked on the 
network. 
Network theory has been developed independently in two fields: social sciences and 
physics, yielding a wealth of metrics which can be used to describe network structure 
and be useful for modeling disease transmission. Some metrics are measured at the 
network level. The number of edges connected to each node is referred to as its degree. 
If the degree of every node in a network is estimated, the degree distribution of the 
network as a whole can be plotted, showing the frequency of nodes with each number 
of connections. For example in Figure 1.5, node 2 has degree 3 and all other nodes 
have degree 1. The degree distribution is an important characteristic of a network 
because it provides information of the process that has led to the formation of the 
network. The distance between nodes is the number of edges between them on the 
shortest path, and the diameter of the network is the longest of all its pairwise distances. 
The diameter of the network in Figure 1.5 is 3. The clustering coefficient measures the 
tendency of nodes in a graph to cluster together, and can be estimated for a single node 
(local clustering) or for the network as a whole (global clustering). 
On one hand, data has been collected to construct real networks. However, determining 
the mixing behaviours between every individual in a population is time consuming and 
expensive and impossible for large populations. In the case of an STI like HIV, 
information on sexual contacts may not be readily volunteered (particularly in view of 
the criminalisation of HIV transmission), and there may be issues of recall. In parallel, 
algorithms have been developed to simulate networks. The simplest network that can 
be generated is random. In a random network such as those generated by the Erdõs-
Rényi model (Figure 1.6A), the probability of any node being connected to another is 
constant and independent [114]. In a network of n nodes, with a probability p for each 
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edge, the expected degree of each node will be (𝑛 − 1)𝑝 and the degree distribution 
of the network will be binomial. The diameter in a random network is proportional to 
the number of nodes, and clustering is low. 
 
 
1.5.4 Small world networks 
Empirical observations suggested early on that many real networks, such as social 
networks, were not random. In a random network your friends would be no more likely 
to know each other than two individuals taken from the population at random. The 
small-world phenomenon was first illustrated by Stanley Milgram’s experiment, in 
which he gave people packages which had to end up with a target final recipient [115]. 
The average number of steps between the initial recipient and the final recipient was 
much smaller than expected: around 6, hence the phrase “six degrees of separation”. 
In social networks, the distance between two nodes is shorter than expected in a 
random network, degree is highly variable and clustering is high [116]. Watts and 
Strogatz developed the first small world network model by rewiring a lattice at random 
[116]. Networks generated through the Watts-Strogatz model have shorter path lengths 
and exhibit higher clustering than random networks (Figure 1.6B.). They demonstrated 
that their model was a good fit to the neural network of C.elegans, the power grid of 
the western USA, and collaborations between film actors, the latter being a proxy for 
social networks. Similar patterns have been observed in many other types of self-
organising systems such as protein interaction networks and the World Wide Web.  
1 2 5 
3 
4 
Figure 1.5: Example of an undirected 
sexual contact network. 
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In small world networks, instead of the distance between nodes growing proportionally 
to the number of nodes in the network, it grows proportionally to the logarithm of the 
number of nodes. Empirical analyses have demonstrated that the nodes in real 
networks frequently follow a power law distribution [117]. The probability 𝑃(𝑘) of a 
node having k connections can be expressed as: 
 𝑷(𝑘) ~ 𝑘−𝛼 (6) 
The scaling exponent α is a measure of the variance of the network and is the slope of 
the line when the distribution is plotted on a log log scale. If the degree distribution of 
a network follows a power law, the network is called scale-free.  
1.5.5 Network Modeling of Epidemics 
Disease spreads more easily on small world networks than on random networks. The 
behavioural heterogeneity underlying the power law distribution in sexual contact 
networks is thought to be central to the spread of STIs and may indeed be the reason 
STIs persist. In parallel, however, heterogeneity in sexual activity decreases the 
magnitude of the HIV epidemic so that some people are very unlikely to ever become 
infected [118]. 
Small-world networks offer obvious possibilities in terms of interventions. They are 
resilient to random failure but vulnerable if hubs are destroyed [119, 120]. Random 
interventions may have no impact as they are more likely to hit nodes that are not 
highly connected. In contrast, removal of hubs will disconnect parts of network and 
disassemble its structure. The power law exponent indicates to what extent targeted 
interventions are necessary.  
As the variance of the degree distribution increases, the inverse of the contact rate from 
𝜏𝑐 from Equation (5) decreases [121] and 𝑅0 increases. If the exponent of the power 
law distribution lies in the range 2 < α < 3, the variance of the network degree 
distribution is theoretically infinite [113]. The level of connectivity τc from equation 
(5) tends towards 0 and there is theoretically no epidemic threshold [110, 122]. Even 
a pathogen with very low transmissibility will persist. In this case, only if highly 
connected nodes are targeted will it be possible to halt the epidemic [120]. 
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Figure 1.6: Networks generated under Erdõs-Rényi (A) and Watts-Strogatz (B) 
models (downloaded from Wikipedia under the creative commons licence).  
While all studies of sexual contact networks agree that networks are highly 
heterogeneous in terms of number of contacts [118, 123-129], it is disputed whether 
variance is infinite. Liljeros et al. searched for the best fit distribution to sexual 
partnerships based on a Swedish survey of sexual behaviour [128]. They fitted a linear 
curve to the tail of the double-logged plot of the distribution. The exponent of the 
power law can be extracted from the slope of the line, and they found it to be between 
2 and 3 for men and women. They concluded that the observed pattern is symptomatic 
of a preferential attachment scenario in which the most highly connected nodes tend 
to accumulate contacts over time (“the rich get richer”). Schneeberger et al. fitted 
power laws using maximum likelihood to the tail of the cumulative degree plots of 
British, USA and Zimbabwean sexual surveys [129]. In all cases they found the power 
law to be a good fit and the exponents to be between 2 and 3 in most cases. They note 
the particularly wide variance in the degree distribution of British MSM. 
However, these papers have been criticised for their statistical methods [123, 124, 
126]. The methods focus on the tail of the distribution to produce an estimate, but there 
is little information in the tail (because there are few data points) so fitting can be 
unreliable. In addition, uncertainty increases with increasing degree (18 is more likely 
to be rounded than a smaller number) which biases estimates of the exponent. Both 
A B 
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Handcock and Jones [124, 126] and Hamilton et al. [123] insist that fitting degree 
distributions without an underlying model for the formation of partnerships is 
insufficient.  
For example, if all individuals in a population acquire partners at a fixed, homogeneous 
rate, the degree distribution is expected to follow a Poisson distribution. If the 
homogeneity assumption is relaxed, but people still acquire partners at a constant rate, 
this will overdisperse the data and the degree distribution will follow a Poisson 
lognormal or a Negative Binomial distribution. Importantly, both these distributions 
always have finite variance, although they do allow for long tails. The Yule [130] and 
Waring [131] distributions both result from preferential attachment models. They 
incorporate a probability proportional to k that a new link is made to a person of degree 
k, as well as a constant probability that a new link is made to a person of degree 0 
(previously sexually inactive). In addition, the Waring incorporates a rate for non-
preferential attachments, so that a partnership may form at random between two 
people, regardless of degree [124, 131]. The Yule and the Waring are power-laws that 
have infinite variance for 2 < α < 3. 
Handcock and Jones fitted the Swedish data and sexual networks from Uganda and the 
USA to the distributions listed above through maximum likelihood [124-126]. They 
found that the Negative Binomial offered the best fit to most networks [124]. When 
they fitted a Yule distribution to the data (which still provides a better fit than the 
power law fitted by Liljeros et al.) the exponents were always >3, indicating the 
existence of an epidemic threshold.  
Beyond fitting models, Hamilton et al. note that the degree distribution exponents of 
five USA sexual contact networks do not predict the epidemic behaviour that is 
observed [123]. They found only very small differences in fits between the models 
tests, underlining our inability to differentiate between them. They suggest that a single 
stochastic process is insufficient to explain the degree distributions or that the degree 
distribution is inadequate in representing the behaviour of the network.  
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1.5.6 Calibrating models 
These studies underline the need for a better understanding of both the contact network 
and the disease transmission network. Creating a network representing a population 
requires knowledge of all the individuals in the population and their interactions. This 
is time-consuming and expensive, if not impossible, for anything but a small 
population [132]. At least, in the case of sexual networks, defining what constitutes a 
contact is straightforward, whereas this is much more difficult in the case of networks 
for modelling the transmission of airborne diseases [133].  
Numbers of sexual partnerships are collected through surveys, for example the 
National Survey of Sexual Attitudes and Lifestyles in the UK (NATSAL) [134], and 
these can be used to estimate degree distributions (see section 1.5.5). One limitation 
of studies of sexual behaviours is that participants may be unwilling to share 
information. Collecting social network information rather than sexual contact network 
may yield better responses, for example through rapid questionnaires [135], or venue-
based data collection [136]. Although ego-centrically collected, these data can be used 
to inform network models [137]. 
Any kind of random data collection, however, risks missing high degree nodes which 
are so central to capturing the variation in sexual contacts across the population. One 
solution to increase their likelihood of being sampled is to sample people with STIs 
[129]. Contact tracing, the act of obtaining a list of sexual contacts from patients 
diagnosed with an STI, has long been carried out both for testing and treatment. If any 
of those traced are infected, their contacts can also be identified. Contact tracing yields 
data on infected and uninfected partners which can be used to create contact 
transmission networks embedded within contact networks [138]. However, in the case 
of HIV, because of the delay between infection and diagnosis, people frequently 
incorrectly identify who infected them [139]. Instead, sequence data collected may 
provide additional insights into transmission network structure [140] and contact 
network structure [141] (Chapter 1). 
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2 MATERIALS AND METHODS 
2.1 Data 
2.1.1 Availability of HIV sequences 
ART targets the protease and reverse transcriptase of HIV, selecting for drug resistant 
mutations (DRM) within the pol region that encodes them. HIV treatment is 
compromised by the presence of DRM (see section 1.2.4).  
This has led to the accumulation of HIV pol sequences in databases. Early 
phylogenetic studies used gag and env sequences [72, 142, 143] while HIV pol was 
criticised for being too genetically conserved to accurately reconstruct HIV 
transmission. Hue et al. confirmed in 2004 that pol contains sufficient genetic diversity 
for the phylogenetic reconstruction of transmission events [144]. This region of the 
HIV genome is now extensively used in phylogenetic studies to address questions 
regarding HIV transmission dynamics. The pol region can also be used to classify the 
subtype of the infection. 
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2.1.2 The UK HIV Drug Resistance Database (UK HIV RDB) 
Following recommendations from the British HIV Association [49], clinics sequence 
the HIV pol region of patients before they begin therapy and in the event of virologic 
failure (viral loads >1000 copies/ml). Since 2001, pol sequences generated for clinical 
purposes in the UK have been deposited in a centralised database: the UK HIV Drug 
Resistance Database (http://www.hivrdb.org). The purpose of the UK HIV RDB is to 
monitor the spread of drug resistance and serve as a research resource.  
The UK epidemic is one of the most densely sampled HIV epidemics and the UK HIV 
RDB is the largest such database in the world. In 2011, the UK HIV DRB was 
estimated to contain sequences for approximately two-thirds of the subtype B MSM 
patients who were treated for HIV in the UK [140], and this proportion has increased 
since then. Sequences are available for around 50% of the infected population and 
>80% of patients diagnosed since 2005 (David Dunn, personal communication). 
Data are provided by clinics to the UK HIV RDB in a pseudo-anonymised form with 
a phonetic version of the patient’s name (soundex code), date of birth, date of 
diagnosis, sex and genetic sequence. Epidemiological data contributed by Public 
Health England included year of birth, age, gender, self-identified ethnicity (White, 
Black-African, Black-Caribbean, Black-other, Indian/ Pakistani/ Bangladeshi, other 
Asian/ Oriental, other-mixed, unknown), country of birth and self-reported most likely 
route of infection (PWID, heterosexual sex (HET), MSM, mother to child, blood 
product, or unknown). The epidemiological and subtype breakdown of the latest 
release is shown in Table 2.1. 
Although the collection and management of data by the UK HIV RDB are rigorous, 
there is always a risk that data collected are incorrect. Epidemiological data collected 
are self-reported. It is also possible that a single patient moving between clinics could 
be recorded as two separate patients. In order to avoid duplication of records, if the 
soundex code and date of birth of multiple patients match, genetic distances between 
sequences are calculated. Where the distance falls below 3.5%, database entries are 
examined further. If soundex codes and dates of birth match, dates of diagnosis are 
within a month of each other and genetic distance is <3.5%, the sequences are assumed 
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to be from the same patient and are linked with the same patient identifier in the 
database. 
Table 2.1 Epidemiological characteristics of 63163 unique patients in 2014 the 
UK HIV RDB.  
   A1 B C Other Total 
 MSM 170 22296 662 2364 25492 
Risk group HET 1721 3421 11930 7912 24984 
 IDU 92 879 128 303 1402 
 Other/unknown 529 5053 3144 2559 11285 
 Male 883 25842 4995 5832 37192 
Sex Female 1195 2051 8215 5183 16644 
 NA 434 4115 2654 2123 9327 
 White 495 22868 1729 3539 28631 
 Black-African 1354 561 10221 5831 17967 
Ethnicity Black-Caribbean 49 1222 273 282 1826 
 Indian/Pakistani/ 
Bangladeshi 
44 350 235 130 759 
 Other/unknown 570 6648 3406 3356 13980 
Total  2512 31649 15864 13138 63163 
Notes: The three major subtypes in the UK, and those that will be analysed in this 
thesis, are A1, B and C. Risk groups are men who have sex with men (MSM), 
heterosexuals (HET) and people who inject drugs (PWID). 
Data are then fully anonymised and delinked so that results from analysing the 
database cannot be used to identify source partners, mainly because of the 
criminalisation of HIV transmission [145]. In order to further decrease the possibility 
of including multiple sequences from a single patient, identical sequences are 
discarded prior to analysis.  
Deductive disclosure is the inference of an individual’s identity based on a set of 
anonymised characteristics that together make that individual the only one to fit the 
description. For example there may only be one female of black Caribbean ethnicity 
in Dunfermline, born in May 1972, diagnosed with HIV in 2010. Data in the UK HIV 
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RDB are amalgamated to prevent deductive disclosure. The UK is divided into only 
14 identified regions and data are aggregated from all centres within each region.  
Originally, sequencing was performed before the initiation of ART, and many 
sequences in the database originated from patients in chronic infection who had been 
infected for a long time. Sequencing is increasingly performed at diagnosis for better 
estimation of TDR rates. As we will see in Chapter 1, the timing of sampling and 
sequencing will influence the likelihood of a sequence clustering (see section 3.2). 
Samples sequenced closer in time to each other are more likely to cluster, as are and 
samples sequenced closer to infection. 
Three different versions of the UK HIV RDB were used in this thesis, as described in 
Table 2.2. For patients with more than one sequence in the database the earliest 
sequence was used, usually obtained before the initiation of ART. 











2009 2007 34469 26356 3 
2012 2010 43002 55556 5 
2014 2012 63163 106402 4, 6 
2.1.3 The LANL database 
HIV is the most widely sequenced organism. In addition to Genbank, HIV sequences 
made publicly available are curated by the Los Alamos National Laboratory in the 
LANL database. The LANL database (accessed 02/06/2015) contains 198428 pol 
sequences (minimum length 500bp) from 154 countries. The use of background 
sequences improves the reliability of inferences made through phylogenetic analysis. 
Because of the huge number of sequences in the UK HIV RDB and in LANL, we did 
not use all LANL sequences available. Instead, we downloaded all pol sequences 
(HXB2 nucleotide positions 2253-3459) available for subtypes A1, B, C, D and G 
(analysed in this thesis), of minimum length 500 bp. and excluding UK sequences, to 
create custom background sequence libraries. We then use the blast algorithm (Basic 
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Local Alignment Search Tool), as implemented in Viroblast [146] and Geneious [147], 
to return the ten closest LANL matches to each UK HIV RDB sequence. In many 
cases, the ten sequences returned for multiple UK sequences will be identical, thus the 
overall number of LANL matches included in the trees is far smaller than the overall 
number of LANL sequences available. While it would be possible to select the ten next 
sequences in cases where the first ten matches have already been included, this is not 
done because sequences more distantly related are unlikely to fall within clusters, and 
it is preferable not to increase the size of datasets for tree reconstruction any further.  
2.1.4 The Swiss HIV Cohort Study (SHCS) 
Switzerland is the only other country with an equivalent database and such high 
coverage of their epidemic (http://www.shcs.ch/). The SHCS was established in 1988 
as a prospective observational study. Socio-demographic and behavioural data (year 
of birth, sex, last negative HIV test, most likely transmission route, confections) of 
new patients are collected. Patient data are updated with CD4+ counts, treatment and 
viral failure events. Since 2002, genotypic drug resistance test have been linked to the 
database, with many stored samples sequences retrospectively. Currently the database 
contains over >12000 sequences [148]. 
In Chapter 4, I performed a comparison of the Swiss and UK epidemics. I did not 
directly access the Swiss data, but rather developed a pipeline which we both submitted 
our data to. 
2.2 Methods 
2.2.1 Sequence manipulations 
2.2.1.1 Sequencing and alignment 
Sequencing for the UK HIV RDB is performed by 19 laboratories across the UK (see 
Appendix 1) using different sequencing algorithms. The majority of sequences (>90%) 
cover the entire protease gene and up to 900 bases of reverse transcriptase. Sequences 
generated using the Trugene assay [149] are missing the first 9 bases of PR, the last 
3 bases of PR and the first 120 bases of RT. 
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Sequences submitted to the UK HIV RDB are aligned using the Stanford HIVdb 
program [150], with manual checks for poor quality, and are released as alignments.  
2.2.1.2 Subtype assignment 
Aligned sequences were submitted to Subtype Classification Using Evolutionary 
Algorithms (SCUEAL) locally for subtyping [151]. SCUEAL uses a model-based 
phylogenetic method to assign viral subtype and leaves smaller numbers of sequences 
unclassified than other subtyping programs [151]. The UK HIV RDB subtypes 
sequences in parallel using REGA [152]. For pure subtypes (including all those 
analysed in the present thesis), subtype assignments across methods vary very little. 
SCUEAL-assigned subtypes were used in this thesis.   
2.2.1.3 Sequence formats and editing 
For each UK HIV RDB release analysed, a fasta file of aligned sequences and a csv 
file (containing epidemiological data) were provided to me by the UK HIV RDB. 
Alignments were checked manually in BioEdit [153] and Geneious. The fasta file and 
csv were processed in R [154], for example to edit sequence names, or select sets of 
sequences based on subtype or date of diagnosis. R was used to discard sequences 
which were missing either the entire PR or the entire RT. 
Because drug selective pressure can cause convergent evolution in unrelated viruses, 
drug resistant sites are removed before phylogenetic analysis. The list of DRM has 
been standardised by the WHO [155] to facilitate comparisons between regional, 
national and international statistics and adjust for non-drug related polymorphic DRM 
[156, 157]. The 2011 updated drug resistance list [158] was used throughout this thesis, 
and sites were removed in R (Appendix 3). 
2.2.2 Phylogenetic analysis 
Phylogenetic trees are reconstructed based on the differences found between 
sequences. However, the number of possible trees increases super-exponentially with 
the number of sequences, rendering an exhaustive search impossible for large number 
of sequences. The most statistically robust methods, and those employed in this thesis, 
are maximum likelihood (ML) and Bayesian inference. 
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2.2.2.1 Maximum likelihood 
The ML method is based on a model of evolution. The ML method is character-based, 
using all the information contained in the sequences, and is statistically robust and 
well-founded [159]. The approach calculates the probability of the observed data (the 
sequence alignment), given the proposed model (tree topology, branch lengths and the 
parameters of the evolutionary model). For each site in the alignment, the probability 
of the observed nucleotides is calculated as the sum of probabilities of every possible 
reconstruction of ancestral states, given the substitution model. As sites in the sequence 
alignment are considered to evolve independently, the probability of the observed 
sequences is the product of the probabilities for each site. Under ML, the best tree is 
the one with maximizes the likelihood, or the probability of observing the data. 
Overall, this method produces accurate results [160] but can be computationally 
intensive. Uncertainty is not incorporated into the final tree, but support values can be 
assigned to nodes in ML trees through bootstrapping (see section 2.2.5.1) and the fit 
of alternative trees can be compared based on their likelihoods [161]. 
Two phylogenetic tree reconstruction programs are used in this thesis: RaxML [162] 
and FastTree [163]. RaxML conducts a more thorough heuristic search for the best 
tree, but FastTree is faster. FastTree is used in Chapter 3 as part of the pipeline that 
was applied to the UK and Swiss datasets. They perform similarly in terms of HIV 
cluster reconstruction (see Appendix 2). 
Both programs produce phylogenetic trees in Newick format. Newick tree format is a 
way of representing phylogenetic structure, branch lengths and bootstrap support 
values using parentheses and commas. Newick format is the minimal definition for a 
tree and branch lengths and bootstrap support values are optional. Other formats, 
Nexus being the most common, can store blocks of additional information associated 
with branches, nodes and tips, for example clock rates (see below) or colours for 
visualisation.  
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2.2.2.2 The molecular clock 
2.2.2.2.1 The strict molecular clock 
The molecular clock is a technique used in molecular evolution to date events on 
phylogenetic trees. Emil Zuckerkandl observed in 1962 that the number of differences 
in haemoglobin amino acid sequences sampled across species was proportional to the 
duration of time since the species diverged [164]. The suggestion that mutations 







In the case of species divergence, the clock is calibrated using fossil records to infer 
rate of evolution. In the case of viruses, which evolve much faster, sequentially 
sampled isolates have been used to calculate evolutionary rate [74]. Application of the 
molecular clock uses time-stamped sequences to date events in the evolutionary 
history of the virus which can be very useful to test different hypotheses, for example 
those concerning the origin of HIV [21]. While the strict molecular clock is 
consistently rejected for HIV sequences [83, 84, 165-169], dating is possible 
nonetheless using relaxed clock models [170]. 
2.2.2.2.2 The relaxed molecular clock 
According to the strict molecular clock, the rate of molecular evolution is constant and 
branch lengths are directly proportional to time. The relaxed clock models rates of 
evolution on one hand and the speciation process on the other so that the molecular 
clock can vary across the phylogenetic tree [171]. Earlier relaxed clock models were 
based on autocorrelated models of rate change, so that the rate of evolution of each 
branch was assumed to be inherited from the rate of the parental branch. Uncorrelated 
clocks depend only upon the mean clock rate associated with the whole tree and vary 
according to an underlying distribution, for example lognormal or exponential [172]. 
2.2.2.2.3 Least squares dating 
Large phylogenetic trees (containing thousands of sequences) can be time-resolved 
using least-squares dating (LSD). LSD simultaneously estimates the substitution rate 
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and dates of ancestral nodes in phylogenies with dated tips using least squares data 
fitting approaches [173]. LSD is significantly faster than BEAST (see below), running 
in linear time for rooted trees, and (nearly) quadratic time when the root must be 
estimated. LSD requires a topology and dates of tips as input. The topology of the tree 
is not changed (other than re-rooting if requested by the user). 
2.2.2.3 Bayesian evolutionary analysis by sampling trees (BEAST) 
The Bayesian approach searches for the distribution of trees that is most probable 
given the sequence alignment under a particular model of evolution. The Bayesian 
approach makes use of likelihood and incorporates prior knowledge which enables the 
user to convey any expectations or uncertainty about some of the model parameters 
before looking at the data. Most importantly, Bayesian analysis generates multiple 
trees, consistent with our uncertainty about the final tree topology. The most popular 
program for Bayesian phylodynamic analysis is BEAST [76]. 
BEAST incorporates relaxed molecular clock models which model rates of evolution 
and time in parallel based on prior distributions [171]. Use of a clock allows for events 
on the phylogenetic tree to be dated. The posterior distribution of parameters is 
sampled through Bayesian Markov chain Monte Carlo (MCMC) chains. 
2.2.2.4 Cluster identification 
The rationale behind different cluster identification methods is explained in section 
3.2. In Chapter 3, I discuss the Cluster Picker, developed by Samantha Lycett, which 
takes as input a phylogeny and a set of sequences and picks clusters based on user-
selected genetic distance and bootstrap cut-offs. We compare the Cluster Picker to 
PhyloPart, which identifies clusters in large trees if the median of their genetic 
distances is below a user-input t-percentile threshold of the whole-tree distance 
distribution [174]. 
The Cluster Picker is used throughout the thesis using genetic distance cut-offs of 1.5% 
and 4.5% an bootstrap cut-offs from 70% to 99%. The Cluster Picker code was 
modified for Chapter 4 to recognise ambiguous nucleotide bases as matches as 
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determined by the International Union of Pure and Applied Chemistry (IUPAC) 
notation. 
2.2.3 Epidemic simulation 
2.2.3.1 The Discrete Spatial PhyloSimulator (DSPS) 
The DSPS is a JAVA-encoded individual based model that runs in continuous time 
developed by Samantha Lycett [175]. The purpose of the DSPS is to simulate realistic 
epidemics along complex and variable contact networks. The program takes as input 
the parameters of the model (including network structure) and outputs a list of timed 
transmission events (transmitter/ recipient). 
Within the DSPS, separate demes contain hosts that share the same parameters. Demes 
are connected to each other to form contact networks. The DSPS allows three different 
disease progression models: SI, SIR and SEIR (where are exposed but not infectious 
for a duration of time).  
Throughout the simulation, a series of events (infection, recovery, migration) is created 
by assessing the current state of the population (for example the number of susceptible 
and infected individuals) and generating a weighted distribution of the likelihood of 
each type of event within each deme. The next event is chosen based on its probability 
and a random number to introduce stochasticity into the simulation.  
The DSPS outputs a population log containing the state (S, E, I or R) of each individual 
in the population at each time point, an event log showing infections and death events, 
a transmission tree and a pruned transmission tree containing only sampled 
individuals. 
2.2.3.2 HIV-specific DSPS (DSPS-HIV) 
To make the DSPS appropriate for the simulation of HIV epidemics, a number of 
modifications have been made to the base code by Emma Hodcroft [176]. 
Because of the long term duration of HIV epidemics, demographic parameters (birth 
and death) have been added. Options exist for the population size to increase through 
time (growth) or to stay stable. The network structure of the full network (including 
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all nodes that will die and be born) is set out before the start of the simulation in this 
case, rather than the network structure being updated, but links are inactivated unless 
hosts are alive. In the simulations used in this thesis, demes were set to represent 
households, each containing one male and one female.  
The DSPS-HIV has been developed to attach gender and orientation to each individual 
which determine the possible connections within the network. In this thesis, the 
networks were fully heterosexual with heterosexual couples existing together within 
households and a single deme containing female sex workers. 
Transmission probability is high during acute stage and drops thereafter. 
2.2.3.3 Sampling and sequence simulation 
Realistic sampling schemes were executed in R by Emma Hodcroft. For any specified 
time period, hosts that are both alive and infected were sampled randomly with the 
desired sample proportion. 
Matthew Hall’s “Virus Tree Simulator” was then used by Emma Hodcroft to simulate 
viral phylogenies based on the infection and sample times of individuals, taking into 
account within host viral evolution. Sequences were simulated along the resulting 
phylogenies using piBUSS [177] according to an HKY substitution model with 
different parameters allowed for the 1st/2nd and 3rd codon positions. Ancestral 
sequences for use in piBUSS were generated in BEAST from a collection of full-length 
subtype C samples by Gonzalo Yebra from southern Africa (South Africa, Botswana, 
Malawi and Zambia) obtained from LANL. 
2.2.4 Network analysis 
2.2.4.1 Network formats 
All analysis of networks was done in R using two packages: network [178] and igraph 
[179]. The two packages contain many of the same and some different functions. Both 
accept as input networks in edge list format, whereby each line in the file represents 
an edge and displays the name of the nodes linked by that edge. Each line can in 
addition contain a numerical variable describing that edge (edge weight) which can be 
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used to represent the strength of the tie for example. Alongside this, the user can input 
a data frame containing information on each of the nodes (for example age, sex and 
risk group). 
2.2.4.2 Network reconstruction 
2.2.4.2.1 Clusters as networks 
Networks in Chapter 4 were reconstructed from phylogenetically identified clusters in 
order to generate degree distributions instead of cluster size distributions. In this case, 
all individuals linked in a cluster would be linked to all other individuals in that cluster 
in the final network. An R script was written to convert each list of clustered sequences 
(output from the Cluster Picker) into an edge list (Appendix 3). 
2.2.4.2.2 Time-based reconstruction  
The method developed by the Leigh Brown group to convert phylogenies into 
networks does so based on the time to most recent common ancestor (tMRCA) for 
each pair of sequences [140]. Nodes are linked together in the network if their tMRCA 
is smaller than or equal to a user-selected cut-off. The networks returned from this 
method can be considered multifurcating trees with no time in which nodes are labelled 
by host (as well as epidemiological information and date of diagnosis). The eventual 
aim of the method is to produce transmission networks that resemble transmission 
chains, in which nodes represent hosts and links represent timed transmission events. 
The advantages of this method are discussed in section 3.2. R code was obtained from 
Samantha Lycett in order to perform this task, and was modified to return the tMRCA 
and pairwise genetic distance for each pair of nodes in addition to whether they were 
linked or not. This information was used to inform thinning algorithms implemented 
in Chapter 6 to eliminate unlikely links within reconstructed networks. 
2.2.5 Statistical analyses 
2.2.5.1 Bootstrapping 
Bootstrapping is a statistical resampling technique used to generate a distribution from 
a single sample of data (because no additional data is available) [180]. The original 
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data are resampled with replacement, each time re-estimating the variable of interest 
to test its accuracy. 
Within a sample (for example the sample of diagnosed HIV patients) it is impossible 
to know the sample statistics for the full population. By resampling sampled data, it is 
possible to make inferences about the true population statistics. This technique is used 
throughout the thesis. Bootstrapping allows us to determine whether our observed data 
diverges significantly from an effect that could be observed by chance. 
In the case of phylogenetic analysis, bootstrapping is commonly used to assess the 
support of bifurcations within phylogenetic tree [181]. The tree is initially constructed 
with the true data. Sites in the sequence alignment and then resampled with 
replacement to produce bootstrap replicates of the alignment in which some sites will 
be present more than once and others will not be present at all. The phylogeny is 
constructed for each bootstrap replicate. Support to nodes in the original tree are given 
based on the proportion of bootstrap replicates which identified the same bifurcation 
as in the original tree [181]. 
2.2.5.2 Fisher’s test/ chi-squared test 
Fisher’s exact test and the Chi squares test are both statistical significance tests used 
in the analysis of contingency tables. In both cases, these tests presume a categorical 
distribution of a variable and compare the observed distribution to the expected. 
Within large samples, a chi-squared test can be used instead of Fisher’s test because 
the sampling distribution approximates the theoretical chi-squared distribution. 
2.2.5.3 Comparing distributions 
The Kolmogorov-Smirnov (KS) test is a very general non-parametric method for 
comparing distributions [182]. A distance is calculated between the cumulative 
distributions of the two compared samples under the null hypothesis that the two 
samples are drawn from the same distribution (the KS statistic). It is sensitive to 
differences in both location and shape between the two distributions, and has the huge 
advantage of being broadly applicable to any sets of data without knowing much about 
their distribution beforehand. However, in the case of comparing network degree 
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distributions, as we do in Chapter 6, the KS test is too sensitive to differences in size 
between networks. In addition, it does not provide any measure of the distance between 
two networks. 
The recently developed Degree Distribution Quantification and Comparison (DDQC) 
[183] algorithm to compares network degree distributions and corrects for differences 
in population size. The range of node degrees of each distribution is divided into eight 
regions based on its minimum, maximum, mean and standard deviation. The 
probability of the degree of any node being contained within each interval is 
calculated. A vector of eight feature values is then extracted from each degree 
distribution and the distance between two networks is the sum of the absolute 
differences for each of the eight features extracted. JAVA code was obtained from the 
authors of this publication. 
2.2.5.4 Fitting distributions 
A more general method to compare distributions is to fit them to a theoretical 
distribution and compare the parameters of that model distribution. In the case of real-
world network degree distributions, power laws are frequently a good fit and the 
exponent of the power law can be compared. As explained in the introduction (section 
1.5.5), the exponent of those power laws is meaningful in terms of intervention 
strategies. 
In addition, the tendency of a network to fit to some degree distributions is indicative 
of the process that led to the formation of that network. In the case of sexual contact 
networks, the process of partnership formation will have an impact on the degree 
distribution [123] (see section 1.5.5).  
The R package degreenet [126] provides function to fit and simulate from the Waring, 
Pareto and Negative Binomial distributions. 
2.2.5.5 Receiver Operating Characteristic (ROC) analysis 
Receiver Operating Characteristic (ROC) analysis is a method for testing a binary 
classifier. The discrimination threshold of the classifier (a continuous variable) is 
varied, and each time, the agreement between the classifier and the true state is 
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measured. The number of cases correctly classified as positive (true positives or TP) 
and negative (true negative or TN) and those incorrectly classified as positive (false 
positive or FP) and negative (false negative or FN) are counted. 
Based on these numbers, the sensitivity, specificity and precision of the classifier at 
that threshold can be calculated: 
𝑺𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 = 𝑇𝑃/(𝑇𝑃 + 𝐹𝑁)  (7) 
 
𝑺𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 = 𝑇𝑁/(𝑇𝑁 + 𝐹𝑃)  (8) 
 
𝑷𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 = 𝑇𝑃/(𝑇𝑃 + 𝐹𝑃)  (9) 
 
The sensitivity is a measure of how well the classifier is at capturing positives, 
specificity measures how well negatives are excluded and precision tell us what 
proportion of the positives elected by the classifier were in fact positive. Depending 
on the aim of the classifier, sensitivity, specificity or precision can be optimised. For 
example, in the case of an HIV test, a high sensitivity test which captures all positives 
at the expense of specificity might be preferred in a first instance. Some positives will 
in fact be negative but this would become apparent in a second round of testing with a 
high specificity test. 
 
  Classifier 
  Positive Negative 
 
True state 
Positive True Positive False Negative 
Negative False Positive True Negative 
Figure 2.1: Agreement between classifier and true state during ROC analysis 
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ROC curves plot the sensitivity of the classifier against the inverse of its specificity 
for all thresholds, in order to estimate the overall performance of the classifier as the 
area under the curve (AUC). A reliable classifier has high sensitivity and high 
specificity and so the ROC curve increases very rapidly to yield an AUC close to 1. 
In Chapter 7, I use ROC analysis to select a threshold for reconstructed tMRCA of two 
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3 AUTOMATED ANALYSIS OF 
PHYLOGENETIC CLUSTERS 
3.1 Abstract 
As sequence data sets used for the investigation of pathogen transmission patterns 
increase in size, automated tools and standardized methods for cluster analysis have 
become necessary. The Cluster Picker identifies monophyletic clades meeting user-
input criteria for bootstrap support and maximum genetic distance within large 
phylogenetic trees. A second tool, the Cluster Matcher, automates the process of 
linking genetic data to epidemiological or clinical data, and matches clusters between 
runs of the Cluster Picker. I explore the effect of different bootstrap and genetic 
distance thresholds on clusters identified in a data set of publicly available HIV 
sequences, and compare these results to those of a previously published tool for cluster 
identification. To demonstrate their utility, I then use the Cluster Picker and Cluster 
Matcher together to investigate how clusters in the data set changed over time. I find 
that clusters containing sequences from more than one UK location at the first time 
point (multiple origin) were significantly more likely to grow than those representing 
only a single location. The Cluster Picker and Cluster Matcher can rapidly process 
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phylogenetic trees containing tens of thousands of sequences. Together these tools will 
facilitate comparisons of pathogen transmission dynamics between studies and 
countries. 
3.2 Introduction: clustering methods 
If all individuals within a transmission chain were sampled, it should in theory be 
possible to reconstruct the true sequence of transmission events from their genetic 
sequences [160]. However genetic diversity within the donor combined with a 
bottleneck at transmission [184], a delay between infection of the recipient and 
sampling and molecular evolution within patients mean that even with full coverage 
of a transmission chain, the evolution history may not be fully compatible with the 
transmission history [185]. In addition, directionality would not be resolved unless 
additional information (such as time since infection) were available. Thus 
phylogenetics does not reconstruct the true transmission chain but nevertheless enables 
inferences to be made about the epidemic that are useful to public health [186]. The 
aim of phylogenetic clustering analyses is to identify groupings within a phylogenetic 
tree that are epidemiologically meaningful. 
Sequences within the tree that are more related to each other than to the rest of the tree 
are more likely to be epidemiologically linked. Closely linked infections reflect short 
durations of time between transmissions and thus clusters represent the leading edge 
of the epidemic. They are relevant for identifying transmission correlates or designing 
and evaluating prevention strategies. High levels of clustering in an incompletely 
sampled population indicates an explosive epidemic pattern and rapid transmission.  
Cluster definition varies widely in the literature, based on genetic distance, time to 
most recent common ancestor and support for the bifurcation (the separation of the 
cluster from the rest of the tree indicated by bootstrap or posterior probability; Figure 
3.1). The specific cut-offs will also vary from gene region to gene region because of 
the different rates of substitution across the HIV genome, but as this thesis uses only 
pol, I will focus on pol here.  
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At its simplest, it has been suggested that patients should be considered linked if their 
sequences cluster as closely as two sequences isolated from the same patient [144]. In 
practice, this has meant a cluster supported by a bootstrap equal or greater to 99% and 
a genetic distance lower or equal to 0.015 nucleotide substitutions per site (or 1.5%). 
This definition is used by the San Diego Primary Infection Cohort [187], where 
patients are diagnosed early in infection, theoretically before mutations have 
accumulated within patient. All samples have been collected within the same city. 
Sequences phylogenetically linked at such tight thresholds are highly likely to 
represent direct transmission events.  
However, a large proportion of the UK HIV RDB is made up of patients who were 
either diagnosed late in infection or who were sequenced a long time after diagnosis 
(see section 2.1.2). In both cases, we expect direct transmission partners not to group 
so closely in the tree, as their sequences will have diverged since the transmission 
event. In addition, because sampling is incomplete, we may prefer to capture patients 
who whilst not directly linked themselves are nonetheless part of the same 
transmission chain (separated by 1 or 2 transmissions). If many sequences were 
contained within such a cluster, this cluster would be important for understanding 
transmission dynamics, even if some transmission links were missing.  
 
 
Figure 3.1: Diagram of a cluster of sequences in a phylogenetic tree defined by 
high confidence in the grouping (bootstrap) and low within cluster genetic 
distance. Sequences within a cluster are most likely epidemiologically related.  
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Two sequences taken from the population are on average 10% different within a 
subtype [188], but only 5% within a cohort of recently infected patients in San Diego 
[187]. Plotting the distribution of pairwise genetic distances among all UK sampled 
HIV sequences reveals two major peaks and one minor peak [108]. The two major 
peaks represent inter and intra-subtype genetic distances. The smallest peak represents 
comparisons between significantly more closely related sequences and is situated 
around 4.8%. Based on these findings, analyses of the UK HIV RDB have used genetic 
distance cut-offs of 1.5% to define infections that are likely to be direct links (strict 
definition) and 4.5% to capture transmission chains (relaxed definition). Those two 
cut-offs are used throughout this thesis. Bootstrap cut-offs are less important, as they 
are heavily influenced by the background of sequences in the tree. In this Chapter, I 
test a number of bootstrap cut-offs as sensitivity analyses to evaluate the robustness of 
the conclusions. 
Evidently, clusters complying to a strict cluster definition are more likely to reflect 
true linkages (high specificity) but strict definitions risk missing true linkages (low 
sensitivity); while more relaxed definitions will incorrectly group sequences into 
clusters (low specificity) but are more likely to capture all true linkages (high 
sensitivity). In Chapter 6, I evaluate the sensitivity and specificity of cluster definitions 
on simulated data for the first time.  
A combination of genetic distance and bootstrap is standard, but other cluster 
definitions have been developed and used by other groups. The Swiss HIV Cohort 
Study classifies as clusters monophyletic groups of at least ten sequences, of which 
≥80% are Swiss [105]. This definition is appropriate for the data because the number 
of Swiss sequences is so small compared to the number of background sequences used 
(despite coverage being so high in Switzerland). They are interested in Swiss-based 
transmission and by enforcing a minimum size, clusters with ≥80% Swiss sequences 
are very unlikely to have occurred by chance. Prosperi et al. developed an algorithm 
which bases the cluster cut-off on the distance contained within the tree as a whole 
[174]. The user selects a t-percentile threshold and sequences are grouped into clusters 
if the median of their genetic distances falls below the t-percentile threshold of the full 
Chapter 3: Automated Analysis of phylogenetic clusters 
 
Manon Ragonnet-Cronin - October 2015   69 
 
distribution. One huge advantage of this algorithm is that it has been implemented as 
a user-friendly program (PhyloPart) that processes large trees containing 100,000s of 
sequences. Indeed another problem with cluster identification methods until this point 
was that no automated software could deal with the number of sequences available. In 
this Chapter, I discuss a program developed with colleagues to process 100,000s of 
sequences based on the more widely used genetic distance and bootstrap cut-offs. 
It is noteworthy that all the definitions delineated above require clusters to be 
monophyletic. There are instances where this prerequisite will lead to 
epidemiologically linked infections not clustering. For example if sampling coverage 
of a large population were 100%, all sequences should realistically be linked to at least 
one other but the mean genetic distance would probably exceed 4.5% (and so the full 
tree would not be classed as a cluster). As an alternative, Wertheim et al.’s single 
linkage approach links sequences to each based solely on their pairwise genetic 
distance, without the need for a tree at all [99]. Another linkage method developed by 
the Leigh Brown group takes advantage of both the distances between sequences and 
the information in the tree, by linking sequences together based on their tMRCA in 
time resolved phylogenies [140]. As well as circumventing enforced monophyly, both 
the Wertheim and Leigh Brown methods allow for the connections between sequences 
to be visualised in a network. The Leigh Brown method is developed further in Chapter 
6.With sequence data sets used for the reconstruction of phylogenies now containing 
tens of thousands of sequences, identifying clusters manually is infeasible. Using in-
house pipe lines for detecting clusters is possible, but in order to compare results 
between studies, freely available software tools would be advantageous. Based on the 
support and genetic distance criteria commonly used, the Cluster Picker (CP) tool 
identifies clusters in phylogenetic trees. The Cluster Matcher (CM) describes 
identified clusters epidemiologically as well matches clusters between phylogenetic 
trees. I use the tools to examine subtype B cluster dynamics in the UK and compare 
CP performance to that of other available software.  
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3.3 Methods 
The Cluster Picker (CP) and the Cluster Matcher (CM). The CP and CM were 
developed in Java 1.6 and are platform-independent. Both programs were released 
publicly as freely available software with accompanying tutorials, manuals and test 
files. Source code is available on Google code (http://code.google.com/p/cluster-
picker-and-cluster-matcher/) under GNU GPLv3. 
3.3.1 The Cluster Picker (S.J. Lycett) 
3.3.1.1 Objective 
The CP is a JAVA program that identifies clusters of sequences in a phylogenetic tree 
based on support for the node (bootstrap or posterior probability) and the maximum 
pairwise genetic distance within the cluster.  
3.3.1.2 Input 
The CP takes as input a set of aligned sequences in fasta format and a Newick tree 
built from those same sequences, with support values on the nodes. The user inputs 
the desired node support threshold and maximum genetic distance for clusters, as well 
as an initial support threshold for splitting the tree prior to analysis.  
3.3.1.3 Algorithm 
The CP utilizes a depth-first algorithm to explore the tree: starting at the root and 
working its way along each branch before backtracking when a leaf is reached. In order 
to minimize the number of pairwise distances computed (thus reducing running time), 
the tree is initially split. The user inputs an initial node support threshold, and starting 
from the root, the tree is divided into subtrees supported at this threshold. Further 
analyses will take place only within these subtrees; therefore, the initial support 
threshold must necessarily be smaller than or equal to the cluster support threshold. 
Starting from the root of the subtree, the CP proceeds to the first node exceeding the 
bootstrap support threshold. All sequences within the group are identified and their 
pairwise genetic distances are calculated. If the largest of these is smaller than or equal 
to the user-input maximum genetic distance threshold, the group of sequences is 
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identified as a cluster. If the maximum pairwise distance is larger than the threshold, 
the cluster is rejected and the algorithm proceeds to the next supported node and 
repeats the same analysis. When a leaf is reached, the CP backtracks to the last node 
whose children have not been fully analysed. When the algorithm has analysed the 
entire tree, a list of clusters matching the user-input criteria is generated. Note that 
because the algorithm proceeds from the root towards the tips, nested clusters are not 
identified and do not appear in the final list. For pseudocode, see Appendix 6. 
3.3.1.4 Output 
The CP outputs a log file listing for each cluster: cluster number, cluster size, 
maximum genetic distance within the cluster, support value and tip names. Also output 
are a fasta file in which sequence names are preceded by their cluster number and two 
trees, one in newick format and one in FigTree format 
(http://tree.bio.ed.ac.uk/software/figtree/). In both trees sequence names are preceded 
by cluster name, and in the FigTree file, sequence names are coloured by cluster.  
3.3.2 The Cluster Matcher (E. Hodcroft) 
3.3.2.1 Objective 
The CM is a JAVA program which links sequences in clusters to epidemiological data. 
An automated tool for performing this task is necessary because of the size of the 
datasets analysed.  
3.3.2.2 Input 
The CM takes as input the newick files output by the CP and corresponding annotation 
files. The annotation file allows the user to select clusters based on those annotations. 
For example, if the annotation file contains risk group data, the CM could output only 
clusters containing at least 50% of sequences from MSM. The user can also choose to 
output clusters based on whether they contain a specified minimum number of 
sequences.  
Transmission networks inferred from HIV sequence data 
 
72  Manon Ragonnet-Cronin - October 2015 
 
3.3.2.3 Algorithm 
Traversing from root-to-tip, the CM first identifies all clusters present in each dataset, 
linking every sequence in a cluster to any epidemiological information provided. For 
each cluster, information is retrieved including its size, number of matching sequences, 
and the distribution of epidemiological traits attached to its sequences. This allows the 
clusters to be easily filtered when the user specifies cluster selection criteria, and is 
used to generate summary information for each cluster.  
3.3.2.4 Output 
The CM outputs a FigTree file for each cluster, as well as a log file detailing settings 
and summarizing results. The FigTree file contains two trees: the full tree with the 
cluster of interest highlighted and a zoom into each of those clusters, allowing for the 
visualization of single clusters within large phylogenies. In addition, the CM generates 
a spreadsheet containing the composition for each cluster identified by the CP; for 
example, the number of individual from each risk group, of each sex. 
3.4 Analysis  
3.4.1 Data 
Publicly available HIV pol sequences from the UK HIV RDB (see Methods 2.1.2) 
were used to evaluate the CP and CM (Genbank IDs: EU236439 – EU236538 [3], 
GQ462027 - GQ462532 [18], JN100661 – JN101948 [23]). Sequences were subtyped 
in SCUEAL (see Methods 2.2.1.2), and drug resistance sites were stripped (Methods 
2.2.1.3). In parallel, all unique subtype B pol sequences were downloaded from LANL 
(section 2.1.3) to perform a speed comparison between the CP and PhyloPart. 
3.4.2 Effect of cluster thresholds on cluster distribution 
Using the CP, I evaluated the effect of different cluster thresholds for genetic distance 
and cluster support on cluster identification among the UK subtype B sequences 
downloaded. One hundred replicate alignments were generated and a maximum 
likelihood tree with bootstraps was reconstructed in FastTree v2.1.4 [163] with a 
subtype C reference sequence (GenBank accession number: AY772699). I varied 
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genetic distance threshold between 1.5% and 7.5% and bootstrap between 70% and 
99%, each time outputting the clusters. From the list of clusters I generated cluster 
distributions (the number of clusters of each size). 
3.4.3 Automated analysis of cluster dynamics 
Using both the CP and the CM I reconstructed cluster dynamics over time, analysing 
409 non-B UK sequences as well as the 1381 subtype B sequences. Sequences were 
linked to sampling date and location information in the UK HIV RDB. An initial 
phylogenetic tree was constructed containing 1212 sequences of all subtypes collected 
up to 2005. Clusters supported by a bootstrap ≥90% and maximum genetic distance 
≤4.5% were identified. The CM was used to sort clusters in 2005 based on whether 
they contained sequences from a single sample location (“single” origin) or more 
(“multiple” origin). A second tree was built from the entire dataset of 1790 sequences 
and clusters matched between the early and late trees. Cluster growth was then 
calculated for each cluster as the number of new sequences per initial sequence [26]. 
Patterns of change of single origin versus multiple origin clusters were compared (see 
Appendix 3) [30]. 
3.4.4 Comparison with PhyloPart 
The CP was compared to PhyloPart, a recently released software tool for the 
identification of clusters [19]. PhyloPart generates the pairwise distance distribution 
for a tree and identifies a group of sequences as a cluster if the median of their genetic 
distances is below a user-input t-percentile threshold of the whole-tree distance 
distribution. The rooted subtype B tree containing 1381 sequences was analysed in 
PhyloPart, varying the t-percentile threshold for cluster identification from 1% to 30%. 
I compared cluster distributions to those produced by the CP.  
In order to evaluate the performance of the two tools, I ran them both on 18 data sets 
sized 1000 to 18,000. 18,436 subtype B sequences were downloaded from the LANL 
database and a random sample of 18,000 sequences was selected to construct a 
maximum likelihood bootstrapped tree in FastTree. Then, sets of 1000 tips were 
dropped sequentially from the tree to generate trees with variable number of tips (see 
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Appendix 3). As PhyloPart does not print time to completion, it was launched from 
within a python script with an additional function to calculate running time. 
3.5 Results 
3.5.1 Clusters are robust to changes in genetic distance thresholds 
Of 1831 downloaded sequences, 1381 unique subtype B sequences were used to 
examine the effect of cluster definition on cluster distribution using the CP. Although 
the phylogenetic tree contained a reference subtype C sequence, this outgroup was 
removed prior to analysis with the CP using the APE package v.3.0-8 in R [154, 189]. 
Initially, I fixed the bootstrap threshold in the CP at 90% and varied within-cluster 
maximum genetic distance between 1.5% and 7.5%. Between 4.5% and 7.5%, I found 
that for the most part, the same clusters were identified (Figure 3.2A). Within this 
range, the number of clusters stabilized around 128 (ranging from 126 to 131), with 
2/3 containing only two sequences. At a genetic distance of 1.5%, only 63 clusters 
were identified. The proportion of sequences in clusters and average cluster size both 
increased as the genetic distance threshold was increased (Figure 3.3A). At a 
maximum genetic distance of 4.5%, 25% of sequences clustered, identical to the 
proportion found after a time-resolved analysis of the same sequences [108]. Beyond 
4.5%, the ratio of these two measures became constant, indicating that as the genetic 
distance cut-off was relaxed sequences were being added equally to all clusters.  
The effect of varying the cluster bootstrap threshold was different; fixing the genetic 
distance at 4.5%, the proportion of sequences in clusters decreased gradually as 
bootstrap thresholds were increased from 70% to 99% (Figure 3.2B and Figure 3.3B). 
3.5.2 Automated analysis of cluster dynamics 
The cluster dynamics of 1381 subtype B and 409 non-B sequences between 2005 and 
2007 were analysed. These included 63 A subtypes, 219 C and 127 other non-B. In the 
phylogenetic tree constructed from sequences collected up to 2005, 148 clusters 
containing 431 sequences (35.6%) were identified. One hundred and eight of these 
clusters were pairs, with the largest containing seventeen sequences. A second tree was 
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built from the entire dataset of 1790 sequences and clusters were matched between the 
early and late trees so that cluster changes could be described. In support of the initial 
cluster definition, the genetic distance of the new clusters increased above 4.5% only 
in two clusters despite the addition of 578 sequences, while bootstrap dropped below 
0.90 only for six clusters. 
 
Figure 3.2: Cluster distributions. 1381 subtype B UK sequences from NCBI were 
processed (A) through the Cluster Picker, with bootstrap support threshold fixed 
at 90% and maximum genetic distance threshold varied between 1.5% and 7.5%, 
(B) through the Cluster Picker with maximum genetic distance threshold fixed at 
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4.5% and bootstrap support threshold varied between 70% and 99%, and (C) 
through PhyloPart, with the t-percentile threshold varied between 1% and 30%.  
 
Figure 3.3: Clustering patterns. 1381 subtype B UK sequences from NCBI were 
processed (A) through the Cluster Picker, with bootstrap support threshold fixed 
at 90% and maximum genetic distance threshold varied between 1.5% and 7.5%, 
(B) through the Cluster Picker with maximum genetic distance threshold fixed at 
4.5% and bootstrap support threshold varied between 70% and 99%, and (C) 
through PhyloPart, with the t-percentile threshold varied between 1% and 
Chapter 3: Automated Analysis of phylogenetic clusters 
 
Manon Ragonnet-Cronin - October 2015   77 
 
30%.distribution for varying bootstrap thresholds. For each threshold, we 
plotted the percentage of total sequences in clusters (grey line) and average 
cluster size (dashed line).  
Sample location information was used to sort clusters in 2005 based on whether they 
contained sequences from a single sample location (“single” origin) or more 
(“multiple” origin). The UK HIV RDB categorizes geographical origin into 17 areas, 
all of which were represented in this dataset. A large proportion of sequences originate 
from the London area (one centre). Of 148 clusters, 63 were thus classified as multiple 
origin and 85 as single origin. Mean cluster growth differed significantly between 
single and multiple origin clusters (0.155 vs. 0. 302, respectively, Kruskal-Wallis test: 
p=0.0016). 
3.5.3 Comparison with PhyloPart 
The subtype B tree was analysed in PhyloPart, varying the t-percentile threshold for 
cluster identification from 1% to 30%. Upon examination of the output, it appeared 
that this range reflected median genetic distances within clusters from 4.5% to 9% in 
the data. Once again, cluster distribution was not very much affected by the cut-off 
(Figure 3.2C), but the proportion of sequences in clusters and average cluster size 
increased as cluster definition was relaxed (Figure 3.3C). As a t-percentile threshold 
of 0.01 and 0.05 corresponded to genetic distance cut-offs of 4.5%, and 6.5%, 
respectively, the CP and PhyloPart output were compared in more depth at each of 
these two matched thresholds. Each time, the number of clusters and the cluster 
distributions were near identical (KS test, p=0.9998 and p=1 for 4.5% and 6.5% 
respectively). However, as expected, individual cluster sizes were significantly 
reduced when maximum within cluster genetic distance was used instead of median 
(Figure 3.5; one-sample sign test, p=6.1*10-5 and p=0.03 for genetic distances of 4.5% 
and 6.5%, respectively). At 4.5%, the CP and PhyloPart agreed on the cluster 
membership status of 94.5% of sequences and at 6.5% of 97.2% of sequences.  
We ran both programs on datasets up to 18,000 sequences to compare performance. 
Both programs were able to process trees with up to 17,000 sequences in less than an 
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hour on a desktop (Table 3.1), although PhyloPart did not terminate on the largest 
dataset (n=18,000 sequences). The CP completed on average three times faster than 
PhyloPart. 
 
Figure 3.4: Dynamics of a single cluster 2005-2007. In this example, the cluster 
identified in 2007 no longer matches the initial cluster definition as bootstrap 
support has dropped from 93% to 89%. Sequences A to G are those already in 
the cluster in 2005, starred sequences (H to K) have been added to the cluster in 
the intervening years.  
3.6 Discussion 
The tools that presented here can be used to investigate the dynamics of pathogen 
transmission. The CP is able to rapidly identify clusters in an automated way in large 
datasets, based on criteria demonstrated previously to accurately delineate 
epidemiologically relevant clusters [144]. Because in many cases cluster studies seek 
to combine genetic with epidemiological or clinical data (such as risk group or stage 
of infection), we have also made available the CM, which links clusters between runs 
and to epidemiological data. In contrast to other tools available for the analysis of trait-
annotated phylogenies [190, 191], the CM does not require any assumptions to be 
made about the heritability of the traits examined. As an example, I used the tools 
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together to investigate the dynamics of single vs. multiple origin HIV clusters in the 
UK. 
 
Figure 3.5: Average cluster size according to clustering method. At thresholds of 
4.5% and 6.5%, PhyloPart (in grey, median GD) and the Cluster Picker (dashed, 
maximum GD) identified nearly exactly the same number of clusters (numbers 
above the columns) but PhyloPart clusters were on average larger. GD genetic 
distance.  
There was remarkable consistency in the clusters identified at maximum genetic 
distances between 4.5% and 7.5%, as has been previously observed [108]. We 
conclude that these clusters represent well-delineated epidemiological units in the UK 
HIV epidemic. In contrast, when the maximum genetic distance threshold was 
decreased to 1.5%, only half of the clusters were identified. These clusters defined by 
such a short distance will reflect recent transmissions and frequent samplings [192]. In 
contrast, the UK HIV RDB contains mostly sequences from chronically infected 
patients, many of whom were first sequenced long after infection, and so in order to 
identify relevant clusters, a threshold of 4.5%, as we have used before [108, 109], is 
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more appropriate. The effect of the bootstrap threshold was less evident, and so I 
conclude that genetic distance is the key parameter for epidemiologically relevant 
clustering. I stress however that the present analysis alone is not sufficient to yield a 
reusable definition of cluster threshold parameters, as the data set of publicly available 
sequences was too small for extensive testing.  
Table 3.1: Time to completion (in seconds) of the Cluster Picker and PhyloPart 







1000 13.098 8.913 
2000 36.137 44.151 
3000 68.772 112.729 
4000 115.618 672.085 
5000 173.584 1447.047 
6000 244.290 1713.749 
7000 328.651 2190.336 
8000 419.369 1081.785 
9000 526.070 1043.838 
10000 658.607 2321.955 
11000 769.469 2343.197 
12000 911.086 3061.134 
13000 1059.509 2851.417 
14000 1228.151 2078.609 
15000 1383.366 2625.491 
16000 1581.351 2797.329 
17000 1775.639 3047.713 
18000 1990.372 NA 
Notes: Both programs were run on a Windows desktop computer with an Intel Core i5-2400 
3.10GHz with 4 processors, reserving 1.5G of heap space. PhyloPart did not complete on the 
desktop computer with n=18,000 sequences as heap space could not be increased. Settings 
were left as default in the Cluster Picker and set at t=0.05 in PhyloPart. For 10,000 sequences, 
program specific RAM usage was 265,000K for PhyloPart and 100,000K for the CP. 
Computational complexity for this data set approximates O (n2). 
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The CP uses maximum within cluster genetic distance, while PhyloPart, another 
recently released sequence clustering tool, uses the median. In previous studies, the 
Leigh Brown group has identified clusters in trees based on mean within cluster 
distance [109, 140]. However, it was decided to use maximum genetic distance in the 
CP for three reasons. First, maximum genetic distance (as well as median genetic 
distance) is less affected by the number of sequences within a cluster (which can be 
the result of more or less intensive population sampling and contact tracing). When 
the mean is used, the distance is normalized by the total number of sequences in the 
cluster, potentially leading to clusters in which most of the sequences are very close 
together but one sequence is only distantly related to the group. In agreement with this 
prediction, in a longitudinal analysis the genetic distance threshold did not have to be 
increased in 2007 to capture most 2005 clusters despite the additional of a large 
number of sequences. Second, maximum genetic distance is a metric more comparable 
to the time depth used to identify clusters in BEAST [140]. Third, maximum genetic 
distance is faster to compute, improving program efficiency. Another difference 
between the programs is that distances are calculated de-novo from the sequences in 
the CP, while in PhyloPart, the patristic distances are used. The use of patristic 
distances is probably preferable (because distances but the CP calculates distances 
from sequences to do automatically do what was previously done manually by our 
group. In this way its results are consistent with previously established thresholds  and 
results [108]. Cluster definition in PhyloPart is a function of the whole tree: a subtree 
is classified as a cluster if its median genetic distance is smaller than a percentage of 
the whole tree. However, the user-specified genetic distance threshold in the CP allows 
external information to be incorporated into the definition, such as the average 
observed distance within transmission pairs if that is available. This strategy was 
chosen because it is the most widely used definition; in fact, previous studies have 
demonstrated epidemiologically related viral sequences had less than 4.8% nucleotide 
substitutions between them [108]. Similarly, because studies vary in the bootstraps 
they use for support of clusters, we left this as a flexible option for the user to choose. 
For data sets containing up to 17,000 sequences, both PhyloPart and CP yield results 
on a desktop in reasonable time. Theoretically, PhyloPart will slow down in large 
Transmission networks inferred from HIV sequence data 
 
82  Manon Ragonnet-Cronin - October 2015 
 
datasets, as it calculates all pairwise distances then stores them, so they can be accessed 
each time they are needed. This is an advantage for smaller datasets and speeds up 
processing, but for large trees, the time to generate matrices of all pairwise distances 
increases as a polynomial function of the number of sequences n (n (n-1)/2 
computations). The CP calculates pairwise genetic distances within a potential cluster 
as required even if those distances were already calculated when the parent node was 
tested (and rejected). Nevertheless, the CP was not slower than PhyloPart on small 
datasets and in fact completed on average three times more rapidly. On large trees, it 
becomes faster to calculate subsets of pairwise genetic distances only within potential 
clusters, even if this must be repeated several times. Another alternative, not explored 
here, is the single-linkage approach proposed by Wertheim et al. [99], which does not 
require a phylogenetic tree and calculates pairwise distances only once. The absence 
of a requirement for building a tree means that the single-linkage method will perform 
much more rapidly than either Cluster Picker or PhyloPart on large datasets. With 
expanding sizes of HIV-1 data sets and other fast evolving pathogens, there is 
increasing need for new and faster algorithms. 
Our longitudinal cluster analysis demonstrated differences in cluster growth between 
clusters that were confined to single UK locations in 2005, and those that already 
contained sequences from several locations across the UK. If confirmed, these results 
suggest that targeting interventions on individuals within multiple origin clusters to 
prevent onward transmission would yield disproportionate results. Such real-time 
analyses are made possible by the CP and CM. As the purpose of this Chapter was to 
demonstrate the functionality of the CP and CM, a simple example was used. We hope 
that others will use the tools in more elaborate ways to truly provide insight into the 
dynamics of HIV transmission, as well as other infectious diseases. Concerning cluster 
dynamics, we note that new sequences added to clusters do not necessarily reflect new 
infections: they could reflect new diagnoses within the time frame, and one potential 
explanation of the observed cluster growth may indeed be referral-based testing. 
The automation of cluster picking and matching with epidemiological information is 
a necessary advance as pathogen sequence databases have become too large to analyse 
Chapter 3: Automated Analysis of phylogenetic clusters 
 
Manon Ragonnet-Cronin - October 2015   83 
 
manually. The pol region of HIV is routinely sequenced for clinical purposes, and 
several European countries have created central repositories for the sequences. These 
data, combined with the tools we have made available, offer opportunities for the real-
time surveillance of the HIV epidemic. I hope that by providing strategies for cluster 
identification and description, these user-friendly tools will facilitate comparisons of 
epidemics between studies and countries. In Chapter 1, I use these tools and automated 
pipeline to compare the UK and Swiss epidemics, without the two countries having to 
share data.
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4 A DIRECT COMPARISON OF 
TWO DENSELY SAMPLED 
HIV EPIDEMICS: THE UK 
AND SWITZERLAND 
4.1 Abstract 
The UK and Swiss HIV epidemics have both historically been driven by transmission 
of subtype B among MSM. The Swiss population is 1/8 the size of the UK and HIV 
prevalence in Switzerland is nearly double. Both epidemics are densely sampled, by 
the UK HIV RDB and the Swiss HIV Cohort Study respectively. Previous independent 
analyses have suggested dramatically different epidemic dynamics.  
Coordinated analyses using a common bioinformatics pipeline to compare HIV 
transmission patterns were performed. Sequence clusters were identified in maximum 
likelihood phylogenetic trees of subtype A1, B and C pol sequences against a 
background of global sequences at a range of bootstrap (70%-95%) and genetic 
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distance (1.5% and 4.5%) thresholds. Degree distributions were generated for each 
risk group and I compared distributions between countries using KS tests, DDQC and 
bootstrapping. Univariate and multivariate logistic regression was used to predict 
cluster membership based on country, sampling date, risk group, ethnicity and sex.  
Over 8000 subtype B sequences from Switzerland and >30000 from the UK were 
analysed. A genetic distance of 1.5% yielded mainly pairs in both. After adjusting for 
sample dates, the Swiss epidemic was more clustered at 1.5%, but degree distributions 
did not differ significantly between the two countries. At 4.5%, the UK was more 
clustered and the degree distributions for MSM, heterosexuals and the population as 
whole differed significantly by the KS test. Only the heterosexual distributions varied 
based on the DDQC test, and dropping high degree heterosexuals clustered exclusively 
with MSM eliminated this difference. Because the KS test is sensitive to variation in 
scale between networks compared, I tested whether the differences were due to 
different epidemic sizes by jackknifing the UK epidemic and showed the underlying 
degree distributions were the same.  
Despite differences in risk group composition, Swiss and UK clustering patterns are 
similar. Differences observed are largely explainable by the distinct sizes of two 
epidemics. The underlying epidemic dynamics driving new infections are thus likely 
to be similar.  
4.2 Introduction: The UK and Swiss epidemics 
The UK and Swiss epidemics share a similar history. HIV was introduced into UK 
MSM around 1980 [89], probably from the USA [90]. Until the early 1990s the UK 
epidemic was dominated by the transmission of subtype B among MSM and PWID 
(see Introduction 1.1.2 and 1.4.2). In the 1990s, cases among heterosexuals became 
more common [93] and these were often linked to immigration [90]. Between 2002 
and 2010, 48% of HIV diagnoses were among heterosexuals [93]. Since the 1990s, 
non-B subtypes have been increasing within the UK [94, 95]. For some time the UK 
epidemic was compartmentalised by subtype and risk group, with B circulating among 
MSM and non-B among heterosexuals. Yet recently a small but significant proportion 
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of non-B subtypes have been acquired through sex between men [93] (see Chapter 5). 
100,000 people are estimated to be living with HIV in the UK (0.15% prevalence), a 
quarter of whom are unaware of their infection [6]. HAART became available to UK 
residents in 1996 and universally available (regardless of citizenship or immigration 
status) in 2012. HIV positive people on successful treatment in the UK have a normal 
life expectancy [45].  
Switzerland was the European country with the highest HIV prevalence at the 
beginning of the HIV epidemic in the 1980s [193]. Initially HIV was spread through 
MSM and PWID [194] with heterosexual transmission only starting to play a role after 
the mid-1980s. The number of new diagnoses steadily declined in the nineties, mainly 
owing to the introduction of needle exchange programs in PWID, heightened 
awareness, wide scale HIV testing, and the introduction of HAART. The number of 
new HIV diagnoses in Switzerland has fluctuated since 2000 with no clear time trends. 
The epidemic is currently thought to be fuelled through MSM transmission with fewer 
heterosexuals and almost no PWID cases [97, 105] (less than 3 per year in the last 5 
years [195]).  
The two countries also have two of the largest and most extensive HIV sequence 
databases in the world: the UK HIV RDB (see Methods 2.1.2) and the Swiss HIV 
Cohort Study (SHCS; http://www.shcs.ch/; see Methods 2.1.4), which contain pol 
sequences from at least 60% of diagnosed patients within each country. In the early 
2000s, less than half of diagnoses entered the databases, while since 2008, this has 
reached 80-90%. Based on estimates of total numbers of infected people (including 
undiagnosed), the databases currently contain around 50% of sequences from all alive 
infected individuals within each country. These databases have allowed Switzerland 
and the UK to lead the way in the field of population-level HIV research, including 
HIV phylogenetics. 
One important focus of phylogenetic analyses is on clusters: groups of sequences 
within the tree that are more related to each other than to the rest of the tree (see section 
3.2). Clustered sequences are likely to be represent epidemiologically linked infections 
with short durations of time between transmissions and thus clusters represent the 
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leading edge of the epidemic. High levels of clustering indicate rapid transmission and 
that transmission partners are being captured.  
However, these analyses have suggested these two countries’ epidemics have different 
structures (see section 1.4.3 for details), including different proportions of sequences 
in clusters. In the UK, 24%, 40% and 22% of patients infected with HIV-1 subtypes B 
[108], A1 and C [109] respectively, have been found in clusters whereas the 
corresponding numbers for Switzerland are 55%, 21% and 16% [97, 105]. Clearly 
these different results arise, at least in part, due to the different cluster definitions (see 
section 3.2) used by the two teams: the Swiss cohort defines a cluster as a group of 
≥10 sequences supported by a bootstrap-value >80% [105], while the UK looks at 
clusters containing at least three sequences with a within cluster genetic distance 
≤4.5% and supported by bootstraps ≥90% [108]. Another reason for the disparity 
between the two countries could be differences in sampling procedures. However it is 
also possible that the contact and transmission processes between Switzerland and the 
UK differ because of the difference in size between the two countries and their 
geography. 
Access to the data from these national cohorts is subject to restrictions. Even though it 
is possible to submit proposals to carry out analyses, one limitation is that national data 
must not leave the country. UK data must be analysed in the UK and Swiss data must 
be analysed in Switzerland. Because analyses have been conducted according to in-
house bioinformatics pipelines, the differences between the two epidemics have never 
been elucidated. Here, I present an analysis of the two epidemics conducted using a 
bioinformatics pipeline applied in parallel in the two countries. In brief, phylogenies 
were reconstructed in each country independently (using the same LANL background 
sequences) and processed using the CP and CM. I wrote python and R scripts to merge 
and modify the files output by the CP and CM (see Appendix 3). The final output was 
a spreadsheet containing a cluster on each line with details on number of sequences 
(national and LANL), risk group, ethnic group and gender composition. These files 
were exchanged and data from both countries were analysed independently in each 
country. I generated degree distributions and compared those across countries 
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(including KS tests, DDQC and bootstrapping), while Mohaned Shilaih constructed 
the linear regression model. I wrote the manuscript and created all the figures. 
4.3 Methods 
4.3.1 Data 
4.3.1.1 Switzerland (CH) 
9232 HIV pol sequences were retrieved from the Swiss HIV Cohort Study resistance 
database (SHCS RDB, 2014).The SHCS RDB aggregates all HIV resistance tests 
performed across Switzerland by all laboratories involved in HIV resistance testing in 
Switzerland. SmartGene is responsible for sequences and meta-data storage and 
management (http://www.smartgene.com). The RDB is part of the SHCS, which is an 
ongoing national clinical cohort of HIV patients of age 16 and above with biannual 
follow up (http://www.shcs.ch). The sequences were assigned subtypes using the 
REGA algorithm [152, 196]: subtype B (8390 sequences, ~91%), A1 (435 sequences, 
~5%), and C (419 sequences, ~5%). The earliest available sequence for each individual 
was used in the present analysis.  
4.3.1.2 UK 
63,065 HIV pol sequences were obtained from the UK HIV RDB 2014 download (see 
Methods 2.1.2). Subtypes B (31,649 sequences, 48.6%), C (15,864, 24.4%), and A1 
(2512, 4.0%) were analysed here. 
4.3.1.3 Background sequences 
LANL background sequences were selected as described previously (see Methods 
2.1.3). For this step, UK sequences were removed from LANL alignments before the 
UK Viroblast run, and Swiss LANL sequences were removed before the Swiss run. 
4.3.2 Tree Building and Cluster Picking 
Duplicate sequences were removed from all datasets. Maximum likelihood 
phylogenetic trees were constructed for each country and subtype separately (six trees 
in total) using FastTree version 2.0 [163] with 100 bootstrap replicates. A range of 
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cluster definitions were used. Clusters were picked if they were supported by bootstrap 
thresholds of 70%, 80%, 90% and 95% and maximum genetic distance (GD) of 1.5% 
or 4.5% (8 thresholds total) [197]. In addition, clusters in the Swiss tree were selected 
to contain at least 80% SHCS sequences, and clusters in the UK trees at least 80% UK 
sequences. In a separate analysis, the 80% criterion was removed (i.e. all clusters with 
least one UK or Swiss sequence were examined) to investigate mixing between 
national and foreign sequences. The automated pipeline included analysis with the CP 
and CM as well as processing through python and R scripts (see Appendix 3). The CP 
was modified to recognise IUPAC nucleotide ambiguity codes as matches, increasing 
clustering by around 15% in both datasets. From this output file, I generated degree 
distributions (the number of links for each node). As output files contained the risk 
group composition for each cluster, it was possible to break down the degree 
distribution by risk group. Statistical frameworks exist to formally compare degree 
distributions but not cluster size distributions. In addition degree distributions can be 
bootstrapped to test the robustness of conclusions. Bootstrapping was performed to 
simulate the effect of the sampling process. Nodes were sampled with replacement 
from the network with information on their cluster membership. Nodes sampled with 
the same cluster membership were linked together in each bootstrapped network, so 
that clusters sometimes increased in size, sometimes decreased in size or otherwise 
disappeared, and degree distribution was re-estimated each time. Jack-knife 
resampling where the number of nodes sampled was smaller than the full network size 
was also performed. 
4.3.3 Statistical analysis 
The number of sequences clustering at different thresholds between the two epidemics 
was compared using Fisher’s exact test with Bonferroni correction for the number of 
tests. Degree distributions were compared using KS tests [182] and the DDQC 
algorithm [183] (see Methods 2.2.5.4). The DDCQ corrects for differences in 
population size when comparing degree distributions while the KS test does not.  
The UK subtype B dataset as a whole was 3.75 times larger than the Swiss dataset 
(Table 4.1). The UK MSM dataset was 5.7 times larger and the UK HET dataset was 
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1.3 times larger. To investigate the effect of this difference in size (the pool of possible 
infectors), the UK degree distribution was jack-knife sampled to match the size of the 
Swiss epidemic. One hundred jack-knife replicates were generated, and in each 
replicate the degree distribution was re-estimated based on the links present in the 
sample.  
Mohaned Shilaih used a logistic regression model to characterise the factors 
influencing clustering in the two countries. The model was applied with cluster 
membership as the outcome variable and with the country of origin (UK or 
Switzerland) as the main exposure variable. Sampling dates, risk group, sex, and 
ethnicity were adjusted for. 
All statistical analyses were conducted in R [154]. 
Table 4.1: Baseline demographics of the two datasets 
  UK CH 
  A1 B C A1 B C 










































































Total  2507 31450 15815 435 8390 419 
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4.4 Results  
4.4.1 Comparison of the two HIV+ populations (Baseline demographics) 
In the final analyses, the Swiss datasets contained 1374 subtype A1 sequences (435 
Swiss, 939 LANL), 15043 B (8390 Swiss, 6653 LANL) and 1571 C (419 Swiss, 1152 
LANL). The UK datasets comprised 4421 A1 (2507 UK, 1914 LANL), 38863 B 
(31450 UK, 7413 LANL) and 22027 C (15815 UK, 6212 LANL). The Swiss epidemic 
comprised more PWID, fewer self-identified heterosexuals and more patients of White 
ethnicity (Table 4.1). These differences were in part a result of the different subtype 
composition across the two countries, but even within subtype B there were notable 
differences (Table 4.1). The subsequent analysis mainly focused on subtype B.  
 
Figure 4.1: Proportion of UK (pink) and Swiss (blue) sequences in clusters. At 
different genetic distance (1.5% and 4.5%) and bootstrap (70%, 80%, 90%, 95%) 
thresholds. CH Switzerland. 
In the UK, a partial pol sequence was available for at least 30% of HIV diagnoses from 
2003 and for over 80% of diagnoses from 2007 onwards. In the SHCS, >60% of the 
HIV+ population has an HIV sequence available. Sequence dates go back to 1995 
owing to retrospective sequencing of samples from the SHCS Bio-bank. Accordingly, 
sequences are available for 79% of patients in the SHCS diagnosed with HIV after 
1995. In both Switzerland and the UK individuals for whom a sequence and 
epidemiological data were available broadly matched the characteristics of the HIV 
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diagnosed population as a whole, in terms of risk group, sex, ethnicity and age 
distribution [148, 198].  
Table 4.2: Proportion of sequences clustering at different cluster thresholds for 
the UK and Switzerland (CH) subtypes A1, B and C. 









A1 0.7 0.015 0.17 0.13 0.53 
A1 0.8 0.015 0.16 0.12 0.55 
A1 0.9 0.015 0.14 0.11 1 
A1 0.95 0.015 0.12 0.1 1 
A1 0.7 0.045 0.24 0.37 <0.0001 
A1 0.8 0.045 0.22 0.33 <0.0001 
A1 0.9 0.045 0.18 0.3 <0.0001 
A1 0.95 0.045 0.17 0.27 <0.0001 
B 0.7 0.015 0.22 0.26 <0.0001 
B 0.8 0.015 0.19 0.24 <0.0001 
B 0.9 0.015 0.15 0.19 <0.0001 
B 0.95 0.015 0.12 0.16 <0.0001 
B 0.7 0.045 0.29 0.6 <0.0001 
B 0.8 0.045 0.26 0.53 <0.0001 
B 0.9 0.045 0.2 0.46 <0.0001 
B 0.95 0.045 0.16 0.36 <0.0001 
C 0.7 0.015 0.14 0.14 1 
C 0.8 0.015 0.13 0.13 1 
C 0.9 0.015 0.12 0.11 1 
C 0.95 0.015 0.11 0.09 1 
C 0.7 0.045 0.2 0.42 <0.0001 
C 0.8 0.045 0.19 0.37 <0.0001 
C 0.9 0.045 0.16 0.29 <0.0001 
C 0.95 0.045 0.15 0.22 <0.001 
Note: p-values shown are from Fisher’s exact test, Bonferroni- corrected for multiple 
comparisons. 
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4.4.2 Difference in clustering 
A larger proportion of subtype B sequences were clustered in the UK than in 
Switzerland and this difference was statistically significant at all thresholds in the 
uncorrected analysis (Table 4.2, Figure 4.1). Concordantly, the UK was more clustered 
in the univariate analysis (Table 4.3) with odds for being in a cluster 4 times higher at 
4.5%. At a threshold of 4.5%, subtypes C and A1 were also more clustered in the UK, 
but there was no significant difference at 1.5%. The proportion of sequences clustering 
was much higher in the UK than in Switzerland at 4.5% (averaged across bootstrap 
thresholds) for subtypes B (49% vs 23%) and C (32% vs 17%). 
Because of the difference in sampling time distributions and demographics between 
the two subtype-B datasets, we considered the logistic regression adjusting for those 
variables. More recent samples were much more likely to cluster than older samples 
(Table 4.4) and when the model was adjusted for sample date, the Swiss epidemic was 
more clustered than the UK epidemic at 1.5% (and all bootstrap cut-offs). At 4.5%, 
clustering remained higher for the UK than for Switzerland but the strength of the 
association was halved compared with the univariate model.  
Table 4.3: Unadjusted logistic regression predicting cluster membership for the 
UK and Switzerland (Subtype B). 
Bootstrap  Genetic 
Distance 
Covariates OR 2.5% 97.5% 
0.7 0.015 UK 1.316 1.243 1.394 
0.8 0.015 UK 1.335 1.258 1.418 
0.9 0.015 UK 1.396 1.308 1.492 
0.95 0.015 UK 1.444 1.345 1.551 
0.7 0.045 UK 5.001 4.745 5.272 
0.8 0.045 UK 4.119 3.904 4.347 
0.9 0.045 UK 3.942 3.722 4.176 
0.95 0.045 UK 3.176 2.986 3.381 
OR: odds-ratio 
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Table 4.4: Logistic regression predicting cluster membership in the UK and 
Switzerland, corrected for sample year (Subtype B). 
Bootstrap Genetic Distance Covariates OR 2.5% 97.5% 
0.7 0.015 UK 0.66 0.617 0.705 
  Sample year 1.138 1.131 1.145 
0.8 0.015 UK 0.665 0.621 0.713 
  Sample year 1.142 1.134 1.149 
0.9 0.015 UK 0.694 0.645 0.749 
  Sample year 1.146 1.138 1.154 
0.95 0.015 UK 0.706 0.651 0.765 
  Sample year 1.153 1.144 1.162 
0.7 0.045 UK 2.692 2.538 2.856 
  Sample year 1.134 1.128 1.14 
0.8 0.045 UK 2.12 1.996 2.252 
  Sample year 1.145 1.139 1.151 
0.9 0.045 UK 1.968 1.846 2.099 
  Sample year 1.156 1.15 1.163 
0.95 0.045 UK 1.551 1.448 1.662 
  Sample year 1.161 1.154 1.168 
OR: odds-ratio 
4.4.3 Degree distributions 
Degree distributions for each country and risk group were generated based on cluster 
size distributions and compositions. For example a cluster containing 3 heterosexuals 
is equivalent to 3 heterosexuals each with degree 2. Degree distributions for the 
populations as a whole and for each risk group were then compared between the two 
countries using the KS and DDQC tests. Based on the KS test, there was no difference 
between the two countries at 1.5%. At 4.5%, distributions differed significantly for 
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HET, MSM and the population taken as a whole but not for PWID (Table 4.5). The 
difference appeared to be driven by the longer tail of the UK distributions (Figure 4.2), 
indicating the existence of larger clusters in the UK.  
Table 4.5: Results of the KS test for comparing degree distributions between the 
UK and Switzerland (Bonferroni-corrected). 





0.9 0.045 all 0 
0.9 0.045 MSM 0 
0.9 0.045 HET <0.0001 
0.9 0.045 PWID 1 
 Note: p values are shown only for bootstrap=0.9 but significance was consistent 
across bootstraps. 
 
Figure 4.2: Degree distributions of the UK (pink) and Swiss (blue) subtype B 
epidemics CH Switzerland, MSM men who have sex with men, HET 
heterosexuals. Cluster definition was: genetic distance = 4.5% and bootstrap = 
90%. Note that the proportion of individuals of each degree is shown rather than 
the absolute number of individuals of each degree. The number of clustered 
individuals was much larger in the UK than in Switzerland.  
Because the KS test is sensitive to differences in scale between networks, we then 
applied the DDQC. The DDQC measures the distance between networks based on 
features extracted from their degree distribution. This metric has been devised 
deliberately to be robust to differences in scale between networks. However, it does 
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not indicate whether distances calculated are significant or not. In order to generate a 
null distribution for the DDQC, the UK and Swiss degree distributions were compared 
to themselves through bootstrapping. The UK and Swiss degree distributions were 
each bootstrapped 100 times (see Methods) and the DDQC distance calculated 
between the true data and each bootstrap replicate (Figure 4.3). Between country 
DDQC values were considered significant if they exceeded the 95% percentile of the 
within country DDQC values (one-sided test). The DDQC distance was higher than 
expected only for HET (95th percentile DDQC=0.97, observed HET DDQC=1.22). 
 
Figure 4.3: DDQC distances within and between countries. CH Switzerland, 
MSM men who have sex with men, HET heterosexuals. Cluster definition was: 
genetic distance =4.5% and bootstrap=90%. In order to generate null 
distributions of the expected values for the DDQC, we bootstrapped the Swiss 
and UK distributions and calculated DDQC values comparing the original 
datasets to their bootstrap samples (in blue and pink). The top of the coloured 
bars represent the mean distance of within country comparisons and the whiskers 
represent the 95% percentiles. The DDQC distance was then calculated between 
the UK and Swiss degree distributions (black triangles). The distance between 
countries was considered significant if it exceeded the 95% percentile from the 
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simulated values, which was the case only for HET at 4.5% (indicated by *). 
When we removed heterosexuals who were likely to have been infected through 
sex with men from the UK degree distributions, the DDQC distance between the 
UK and Swiss HET degree distribution fell within the simulated null distribution 
(orange triangle).  
We hypothesised that the difference highlighted by the KS test at 4.5% might be the 
result of a difference in scale between the two epidemics. Although HIV prevalence is 
lower overall in the UK, the UK population (and the HIV+ population) is much larger 
than that of Switzerland and so the pool of partners available within the population is 
bigger. Thus the UK subtype B dataset (n=31450) used here was 3.75 times larger than 
the Swiss dataset (n=8390), the UK MSM dataset was 5.7 times larger and the UK 
heterosexual dataset was 1.3 times larger (Table 4.1). To examine the effect of 
epidemic size on clustering and degree distribution, we down-sampled the UK subtype 
B datasets to match the size of the Swiss datasets. In parallel, the Swiss dataset was 
bootstrap sampled with replacement. This was repeated 100 times for the population 
as a whole and for MSM and HET. In each replicate, we re-estimated the degree 
distribution based on the links remaining in the sample. When these equal-sized 
resampled datasets were compared, the UK and Swiss degree distributions overlapped 
for the population as a whole and for the MSM population, but not for HET (Figure 
4).  
In the true and the jackknife sampled UK HET population, individuals with high 
degree (>20) were present, who were not observed in the Swiss data (Figure 4.4). The 
largest exclusively heterosexual risk group in the UK comprised 27 individuals 
(bootstrap=0.9, GD=4.5%), all HETs with higher degree were in clusters that were 
dominated by MSM. When we dropped HETs with degree >26 from the UK HET 
distribution, the DDQC distance between the two networks was below the 95% 
percentile of the within country DDQC values (DDQC = 0.17, Figure 4.3).  
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4.4.4 Cross border transmission 
We investigated intermingling between national and foreign sequences by removing 
the 80% national criterion. We used a tight genetic distance threshold (1.5%, 70% 
bootstrap) to be more likely to capture close transmission partners. At this threshold, 
Swiss sequences clustered with 162 non-Swiss sequences and UK sequences clustered 
with 353 non-UK sequences. For Switzerland, Western European countries provided 
over 75% of the links. For the UK, 50% of close links were with other European 
countries and 20% originated from other Anglophone countries: Australia, Canada and 
the USA (Figure 4.5). 
 
Figure 4.4: Jack-knife and bootstrap sampled degree distributions of the UK 
(pink) and Swiss (blue) epidemics. UK subtype B degree distributions for men 
who have sex with men (MSM), heterosexuals (HET) and the population as whole 
(all) were jack-knife sampled 100 times to match the size of the Swiss epidemics 
(in light pink). The Swiss epidemic was bootstrapped 100 times to its full size (in 
light blue). Degree distributions are shown on a double-logged scale. Samples 
overlapped for MSM and the dataset as a whole, but not for HET. Where Swiss 
replicates cannot be seen they are covered by the UK replicates.  
4.5 Discussion 
The aim of this study was to compare clustering patterns between the two most densely 
sampled HIV epidemics, the UK and Switzerland, while adhering to data governance 
procedures. Because a statistical framework for comparing cluster distributions is 
lacking, we generated degree distributions based on cluster sizes and composition and 
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compared them through formal statistical tests: the KS test, the DDQC and 
bootstrapping. Based on the KS test, there were differences between the UK and Swiss 
subtype B degree distributions at 4.5%. However, downsampling the UK dataset to the 
size of the Swiss dataset rectified this difference in all risk groups except for 
heterosexuals. In parallel, only heterosexuals showed a significant difference based on 
the DDQC test, which corrects for network size.  
 
Figure 4.5: Origin of close linkages for Switzerland (left) and the UK (right). 
Swiss sequences clustered closely (1.5% genetic distance, 70% bootstrap) with 
162 non-Swiss sequences and UK sequences clustered with 353.  
The degree distribution of UK heterosexuals had a long tail representing male 
heterosexuals clustered exclusively with MSM. Previous analyses of the UK HIV 
RDB have demonstrated that a proportion of self-reported male heterosexuals are 
likely to have been infected through sex with men [106] and it is likely to be the case 
for the heterosexuals identified here. This result highlights the limitations of our 
approach in which self-reported heterosexuals are identified as heterosexuals even 
though they cluster only with MSM. Another way of classifying patients could be to 
do so based on the characteristics of the other individuals they cluster with [199]. In 
this example, these self-reported heterosexuals would instead be classified as MSM. 
When those high degree heterosexuals were removed from the UK HET dataset, the 
UK and Swiss degree distributions no longer differed. Male heterosexuals who have 
sex with men are likely to also have sex with women and provide a bridge between 
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MSM and heterosexual epidemics. This is a likely route for the spread of non-B 
subtypes among MSM in the UK (Chapter 1). More detailed analyses of the Swiss 
epidemic have found little overlap between the MSM and HET epidemics [105]; 
however, the Swiss heterosexual with the highest degree was similarly part of a 
HET/MSM cluster comprising 36 individuals, while the largest exclusively 
heterosexual cluster contained only 9. In fact, 47% of UK and 38% of Swiss 
heterosexuals were in HET/MSM clusters.  
A more obvious difference was that 23% of Swiss heterosexuals clustered with PWID, 
as opposed to 12% of UK heterosexuals. However, PWID degree distributions showed 
no difference between countries, although this could be due to sample size. More 
importantly, the stemming of the heterosexual epidemic through PWID in Switzerland 
is likely to be an old process [105] while the potential bridging between HET and 
MSM in the UK is likely to be ongoing [106] (Chapter 1). 
All our findings were consistent across bootstrap thresholds, and so bootstrap cut-off 
is not as useful in delineating clusters as genetic distance. At 1.5%, we found no 
difference between the degree distributions of the Swiss and UK epidemics. At such a 
tight threshold, mostly pairs and recently infected patients are likely to be captured and 
these groupings are similar across the two countries. At 1.5%, the UK epidemic 
initially appeared more highly clustered than the Swiss epidemic, but when sample 
date was taken into account, the Swiss epidemic became more clustered than the UK 
epidemic, indicating that close partners were more likely to be captured by the SHCS. 
The time between a new diagnosis and that patient’s sequence being included in the 
database is shorter in the SCHS, and it is possible that Swiss coverage is slightly 
higher.  
At 4.5%, the UK was more clustered and so the UK HIV RDB is more likely to capture 
larger transmission chains. However, the downsampled UK epidemic degree 
distributions overlapped with the Swiss degree distributions. While this does not 
change the fact that the proportion of individuals in clusters in the UK is higher, it 
means that the difference is seemingly due to its greater epidemic size rather than 
because of differences in the contact or transmission processes between the two 
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countries. The UK HIV epidemic is not particular insular but because the UK HIV 
RDB is so large the impact of foreign sequences in phylogenies is less dramatic. Both 
countries are integrated into global unsampled epidemics, and this study underlines the 
importance of HIV public health interventions at the European and global scales.  
Transmission between European countries has been analysed in more depth elsewhere 
[98]. In agreement with that analysis, we found Spain to be a major mixing partner for 
both Switzerland and the UK. Germany and the Czech Republic were also identified 
as important. In their phylogeographic analysis, Paraskevis et al. noted significant 
migration of HIV from the UK to Germany [98] and this may be what we are capturing 
here. We did not conduct a phylogeographic analysis to determine the direction of 
these transmission events, but our use of a tight genetic distance threshold increases 
the likelihood that links captured are direct. We also found increased linkage between 
the UK and other Anglophone countries. In Switzerland strong segregation has been 
observed between German and French-speaking regions [105] and this language-
dependency of HIV transmission warrants investigation at the global scale.  
Both countries have noted the subtype diversification of their respective epidemics 
[93, 200], yet the difference in size between the UK and Swiss subtype A1 and C 
datasets (18,000 vs 900, respectively) meant that a detailed analysis was not 
worthwhile. In Switzerland the most recent analysis concluded that fewer than 25% of 
non-B infections were acquired in the country [97] whereas in the UK over 50% of 
infections in individuals born abroad are thought to have occurred in the UK [95]. 
Local non-B non-heterosexual transmission appears far more extensive in the UK 
(Chapter 5). 
Although degree distributions are a blunt tool for elucidating the dynamics of an 
epidemic [123], they allowed us to apply statistically robust methods (which are not 
affected by our degree distribution definition) to compare the two epidemics without 
the need for exchanging sensitive data. The data being bootstrapped are not fully 
independent because a) sequences are sampled from clusters and cluster membership 
of sequences depends on other sequences in the cluster and b) sequences in the tree are 
all related to each other through the phylogeny. However, the aim of bootstrapping 
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and jackknifing tests was to determine whether sampling and population size might 
explain the differences in degree distributions observed between the two countries. 
The non-independence of the data would cause bootstrap and jackknife samples to 
look more similar to each other and to the original data, meaning that the difference 
between the UK and Swiss degree distributions would not be minimised. Thus the 
finding that the difference was no longer significant after jackknife sampling and this 
finding should not be affected by the non-independence of the data. A second issue, 
the distributions of sample dates differing between the two cohorts, arose because of 
extensive retrospective sequencing by the SHCS of patients diagnosed early on in the 
epidemic and for whom samples had been stored. The SHCS bias towards older 
samples explains in part the lower clustering observed in Switzerland. However, 
clustering remained significantly higher in the UK at 4.5% after sample date was 
adjusted for. While our aim was that the analysis conducted be as similar as possible 
across the two countries, subtypes were assigned using REGA in Switzerland and 
SCUEAL in the UK. The impact of this should be limited as the analysis focused on 
pure subtypes and mostly on subtype B. Next, our analysis is limited by the fact that 
we were unable to directly use each other’s data and analysed only meta-data generated 
from each other’s cluster analyses. We were not able to build trees containing 
sequences from both the SHCS and the UK HIV RDB, but the epidemics are likely to 
be highly intertwined. This can be concluded from the cross-border analysis as the UK 
was an important mixing partner for Swiss sequences. The reverse was not seen (i.e. 
Switzerland appearing as a major mixing partner for the UK), likely to be due to the 
ratio of LANL UK sequences available to SHCS sequences in comparison to the ratio 
of Swiss LANL sequences to UK HIV RDB sequences. A future study might be 
facilitated by the same person conducting both sets of analyses. This would allow them 
to get a better feel for each set of data, even if data were not amalgamated. Finally, 
international linkages are biased in favour of countries that have deposited sequences 
in public databases. We suggest the apparently important contribution of the Czech 
Republic to both epidemics may arise from recent submission of large numbers of 
sequences from that country.  
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In conclusion, by using a highly coordinated approach we showed that apparent major 
differences in clustering patterns between the UK and Switzerland subtype B 
epidemics can be explained by differences in size. This is the first study leveraging the 
vast amounts of data available in more than one national HIV database. We have 
shown how to make use of such data without breaching data governance procedures. 
Current transmission of subtype B in the UK and Switzerland is likely to be driven by 
similar underlying factors. 
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5 TRANSMISSION OF NON-B 




In the UK HIV subtypes continue to be characterised by risk group composition. MSM 
represent over 85% of subtype B infections, while over 85% of non-B subtype 
infections occur among self-identified heterosexuals. However, between 2002 and 
2010 the proportion of non-B diagnoses among MSM increased from 5.4% to 17%, 
which may indicate that the transmission dynamics of non-B subtypes are changing. 
Over 14,000 subtype A1, C, D and G sequences from the UK HIV RDB were analysed. 
Transmission clusters were defined by a maximum genetic distance of 4.5% and 90% 
bootstrap support, and I investigated relative patterns of growth by risk group between 
2007 and 2009.  
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Of 1148 clusters of these 4 subtypes which contained at least two sequences in 2007, 
>75% were pairs and >90% were heterosexual. Most clusters (71.4%) did not grow 
during the study period, and pairs were significantly less likely to grow than larger 
clusters (75.5%, p<0.0001). In comparison with simulated trees for the same time 
period, cluster growth was lower than expected for small clusters, and higher than 
expected for clusters larger than 6. Growth was higher than expected for clusters 
comprising sequences from MSM and PWID and lower than expected for all other risk 
groups. The number of new diagnoses in clusters containing both heterosexuals and 
MSM was much higher than expected for subtype C. Both risk group (p<0.0001) and 
original cluster size (p<0.0001) were predictive of cluster growth in a generalized 
linear model. 
These results show that despite the increase in non-B subtypes historically associated 
with heterosexual transmission, MSM and PWID continue to be most at risk of 
ongoing transmission. Crossover of subtype C from heterosexuals to MSM has led to 
the expansion of this subtype within the UK.  
5.2 Introduction: non-B subtype transmission in the UK 
The global HIV-1 epidemic is characterised by extremely high genetic diversity: nine 
subtypes (A-D, F-H, J and K) circulate along with numerous recombinant forms. 
While globally subtype C predominates, accounting for 50% of infections [11], non-B 
subtypes were rare in the USA and Europe until recently. In the UK from the 1980s to 
around 1995, the epidemic was dominated by the transmission of subtype B among 
MSM [107]. Subtype B remains individually the most prevalent subtype in Europe 
(>80% of infections) [201] and in the UK (~40% of diagnoses) [93]. However, non-B 
subtypes increased in prevalence in the UK from <25% of diagnoses in the early 1990s 
[202] to 60% in 2010 [93] (Figure 1.3). Rises have been seen in other European 
countries [97, 203, 204]. In the USA, only 3% of samples sent to the national 
laboratory between 2004 and 2010 were non-B subtypes, but the portion increased 
from 0% to 4% during that period [205]. 
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Generalised HIV epidemics (HIV prevalence > 1% in the general population [206]) 
are characterised by non-B subtypes transmitted among heterosexuals [201, 207]. The 
increase in non-B subtypes in Western countries between 1990 and 2003 corresponds 
to the rise in new HIV diagnoses among heterosexuals born abroad. However, the 
number of new HIV diagnoses among heterosexuals born abroad decreased from 4426 
in 2005 to 2,688 in 2013 due to changing patterns of migration [6]. In 2010, 
heterosexually acquired infections represented around half of all UK diagnoses [6] and 
85% were classed as non-B subtypes [93]. This association between subtype and risk 
group has led to the frequent use of subtype as a proxy for transmission route in 
phylogenetic analyses of HIV [108, 109]. However, by 2007, the prevalence of non-B 
subtype HIV infections among UK-born MSM was 5.4% [208] and by 2010, this 
proportion had risen to 17% (415 infections) [93].  
Several studies have set out to measure the relative contribution of migration and 
domestic HIV transmission to the increase in non-B subtype prevalence. In the UK, 
significant clustering of subtypes A1 and C has been observed [109] including among 
MSM [209] indicating some local transmission. However, clustering alone doesn’t 
reveal the proportion of non-B subtype infections being acquired within the country. 
In Switzerland, von Wyl et al. (2011) estimated the proportion of new infections 
arising within Swiss-specific non-B subtype clusters (subtrees including ≥80% Swiss 
sequences) to be fewer than 25% [97]. Brand et al. (2014) examined clustering of 
sequences sampled from recently acquired infections (based on the results of the BED 
enzyme immunoassay [210]) concluding that at least 20% of non-B subtype infections 
had been acquired in France. The authors noted that while most non-B subtype 
diagnoses in France are made among heterosexuals, MSM were involved in the 
majority of clusters (defined as >90% bootstrap and <1.5% average genetic distance) 
[100].  
In the UK, Aggarwal et al. investigated medical record and laboratory diagnostics for 
a small cohort to determine for each patient whether they had been infected before or 
after arrival into the UK [94] but such an intensive approach is infeasible at the national 
level. Rice et al. explored the origin of infections among heterosexuals born abroad by 
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calculating their estimated year of infection based on a detailed analysis of CD4+ 
decline [95]. In combination with their date of entry in the country, this was used to 
determine whether each patient was more likely to have been infected before or after 
arrival into the UK. These authors estimated that 73% of HIV+ heterosexuals born 
abroad diagnosed in 2002 were infected outside the UK , but by 2011 over 50% had 
acquired HIV within the UK [95]. This analysis was performed at the national level; 
however, it does not discriminate the sub-epidemics associated with different 
subtypes, and neither Aggarwal [94] nor Rice [95] can distinguish infections acquired 
through travel following domicile in the UK. 
In order to analyse the recent transmission dynamics among non-B HIV subtypes in 
the UK, I used tools recently developed by our group (Chapter 0) [197] which facilitate 
the analysis of large pathogen sequence datasets and link them to epidemiological data. 
I applied these approaches to the analysis of sequences from the UK HIV RDB. As in 
previous work international databases were used to eliminate clustering that does not 
reflect UK-based transmission [109]. Taking this approach I have quantified the 
transmission dynamics of non-B subtypes across risk groups in the UK. 
5.3 Methods 
5.3.1 Data 
43,002 partial HIV pol sequences were obtained from the UK HIV RDB 2010 
download (see section 2.1.2). Subtypes C (10872, 25.3%), A1 (2083, 4.9%), G (965, 
2.2%) and D (815, 1.9%) were the most common after subtype B and are analysed 
here.  
5.3.2 HIV cluster dynamics 
5.3.2.1 Cluster identification 
The CP and CM (Chapter 0) [197] were used to analyse transmission dynamics. 
Phylogenetic trees were built in RaxML [162] for each subtype separately against a 
background of global sequences from LANL (see section 2.1.3). In all four trees, 
clusters were picked for analysis if they contained at least 2 sequences, 80% or more 
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of sequences were from the UK, bootstrap support exceeded 90% and maximum 
pairwise genetic distance was below 4.5% [108].  
5.3.2.2 Cluster dynamics 
Clusters were sorted into risk groups based on the self-identified risk group 
information associated with each sequence in the cluster. Proportions were calculated 
based on all sequences in a cluster, including those for which risk group was 
unavailable. I used the following hierarchical rules to classify clusters: 
- If >25% of the sequences in a cluster came from PWID, the cluster was classified 
as PWID; 
- If both HET and MSM each accounted for >10% of sequences, the cluster was 
classified as “crossover”; 
- If MSM accounted for >50% of sequences the cluster was classified as MSM, and; 
- If HET accounted for >50% of sequences, the cluster was classed as HET. 
- Otherwise, the cluster was classified as unknown (not available, NA). 
Two other sets of rules tested the extremes of this risk group classification. According 
to the majority risk group definition, the risk group of the cluster was that of the 
majority of the sequences in the cluster. If two risk groups each accounted for 50% of 
sequences, both risk groups were used and growth was divided proportionally between 
them (or attributed to the crossover risk group in the case of HET-MSM clusters). 
According to the minority cluster definition, the risk group of any sequence in the 
cluster entered the risk group classification and growth rate was split between risk 
groups as for the majority definition. In both cases, clusters containing 50% or more 
sequences with unknown risk group were classified as NA. For clusters that contained 
at least one UK sequence collected up to December 2007, I counted the number of UK 
sequences in the cluster collected prior to December 2007 (old sequences) and the 
number of UK sequences added to the cluster after 2007 (new sequences). Cluster 
growth was calculated as the number of “new” sequences divided by the number of 
“old” sequences, and expressed as a percentage increment based on initial cluster size 
[211]. Cluster growth between clusters of different starting sizes and of different risk 
groups were compared using the Kruskal-Wallis test. 
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5.3.3 Simulations 
Expected distributions for cluster growth were simulated according to a model in 
which all tips in the tree are equally likely to transmit. The distribution of bootstrap 
support values and branch lengths were obtained from the full trees (excluding global 
background sequences), following which sequences collected after 2007 were 
stripped. Removed sequences were then added to a random branch in the tree to 
simulate new infections. The probability of any branch being selected was proportional 
to its length. The branch length and bootstrap support for the new bifurcation were 
drawn at random from the branch length and bootstrap distributions of the full tree 
containing all sequences up to end of 2009 (see Appendix 3). For pseudocode, see 
Appendix 6. Sequences were simulated along the resulting phylogenies under a GTR 
substitution model with nucleotide frequencies from the original data using SeqGen 
[212], ensuring that mean genetic distance among simulated sequences was equivalent 
to that of the true sequences. This was repeated 1000 times for each tree. Clusters 
(≥90% bootstrap and ≤4.5% genetic distance) were picked in the simulated trees, and 
cluster growth calculated as in the original trees, in order to generate expected cluster 
growth distributions for each subtype. Cluster growth was compared between clusters 
of different starting sizes and different risk groups.  
In parallel, we conducted a permutation test, permuting the risk groups across the tips 
of the trees. Each time risk group was re-estimated according to the rules in section 
5.3.2.2, and we compared cluster growth according to risk group. 
5.3.4 Generalised linear model 
A generalised linear model (GLM) was constructed to express the number of new 
sequences as a variable dependent on the number of old sequences, risk group and 
subtype. The distribution of the dependent variable was tested against Poisson, 
negative binomial and gamma distributions to verify that a GLM would be appropriate. 
The distribution of the number of new sequences was adequately fitted by a negative 
binomial distribution (Χ2 test, p=0.1) with no other model offering a better fit, and so 
the Negative Binomial GLM available in R [154] was used. 
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Figure 5.1: Risk group classification of clusters (2009). 2327 clusters (304 A1, 
1785 C, 113 D, 125 G) contained at least two sequences: 1630 clusters were pairs 
and 681 comprised more than two sequences. MSM men who have sex with men, 
HET heterosexual, PWID people who inject drugs, NA not available.  
I investigated the dynamics of transmission clusters of non-B subtype HIV sequences 
between January 2007 and December 2009 to determine the drivers of new diagnoses 
during this time period. After exclusion of any duplicates, the 2010 UK HIV RDB 
subtype A1 dataset contained 2083 sequences, of which 630 were collected after 
December 2006 and the subtype C dataset contained 10830 sequences, including 4852 
collected after 2006. Of 815 subtype D sequences, 279 were collected after 2006; and 
of 965 subtype G sequences, 472 were collected after 2006. Thus while the UK HIV 
RDB subtype A1 and D datasets grew by ~50% during the study period, the subtype 
C and G datasets grew by over 80%. To these were added over 7000 non-UK 
sequences selected by Viroblast to distinguish between UK and non-UK transmission. 
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Phylogenetic trees were reconstructed separately for the four subtypes and clusters 
were identified. 
A total of 2327 clusters (304 A1, 1827 C, 112 D and 125 G) meeting the above criteria 
were identified in the four trees. 101 clusters were excluded because they comprised 
<80% UK sequences, of which only 26 contained more than one UK sequence. 5999 
UK sequences (41%) clustered with at least one other UK sequence used in the 
phylogenetic analysis. Over half of linked sequences were linked to only one other 
(“pairs”; 3260 of 5999 sequences and 1630 of 2327 clusters). Of 2327 clusters, 969 
(42%) could not be assigned a risk group. Of the clusters that could be classified, the 
great majority were HET (1231/1358; 91%). A further 31 clusters were classed as 
MSM (2.3%), 23 as PWID (1.7%) and 73 as crossover clusters containing sequences 
from MSM and HET (5.4%; Figure 5.1).  
 
Figure 5.2: Risk group composition of each cluster. Clusters were sorted by 
proportion of heterosexuals (HET), men who have sex with men (MSM) and 
people who inject drugs (PWID). Sequences which did not have risk group 
information are not shown and clusters which were not assigned a risk group are 
not shown. 
Risk group cluster classifications were mostly “clean” (Figure 5.2) with 82.4% of 
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of heterosexuals, MSM and PWID. Crossover clusters were clear mixes of MSM and 
heterosexual sequences. 
5.4.1 Cluster growth depends on initial cluster size 
Of the 1148 clusters that existed (pairs or larger clusters) in January 2007, only a 
minority changed during the study period (328/1148, 28.6%; Table 5.1). This effect 
was more pronounced in subtypes A1, D and G where fewer than 20% of clusters 
changed, compared to 33.5% in C (Table 5.1, Fisher’s exact test p<0.0001). Pairs were 
significantly less likely to grow than larger clusters (p<0.0001). Among pairs only 
215/879 (24.5%) changed during the study period. Overall, of 6233 new non-B 
subtype sequences added to the database after January 2007, 1457 (23.4%) linked to 
sequences already in the database before that date. This proportion was higher among 
subtypes A1 (24.6%) and C (25.0%) than among D (11.1%) and G (12.7%; p<0.0001). 
Table 5.1: Proportion of clusters showing growth between 2007 and 2009. 
Subtype  Total Growth 
A1, C, D, G all clusters* 1148 328 (28.6%) 
A1, C, D, G Pairs 879 (76.6%)# 215 (24.5%) 
A1 all clusters* 190 37 (19.5%) 
A1 Pairs 147 (77.4%)# 24 (16.3%) 
C all clusters* 792 265 (33.5%) 
C Pairs 614 (77.5%)# 175 (28.5%) 
D all clusters* 87 12 (13.8%) 
D Pairs 63 (72.4%)# 8 (12.7%) 
G all clusters* 79 14 (17.7%) 
G Pairs 55 (69.6%)# 832 (14.5%) 
Notes: *containing at least one sequence collected before December 2006; # pairs 
as a percentage of all clusters 
For clusters containing at least one sequence collected prior to January 2007, 
growth was calculated as the number of sequences collected after this date divided 
by the number of sequences already clustered. In the UK data, growth varied 
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significantly between clusters of different starting sizes (Kruskal-Wallis test, df=4, 
p<0.0001). 
 
Figure 5.3: Cluster growth according to initial cluster size (2007). For each cluster 
in 2009 containing at least one sequence collected before 2007, cluster growth was 
calculated as the number of new sequences over the number of old sequences (in 
pink). In parallel, expected cluster growth was simulated according to initial 
cluster size (in blue, 1000 simulations, mean and distribution shown).  
Cluster growth increasing with cluster size in 2007 for subtypes A1 and C (Figure 5.3, 
in pink), and this trend was significant only for subtype C (r=0.95, p<0.05). Single 
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sequences collected prior to 2007 that formed clusters after 2007 (670 in total) were 
not included.  
A simulation-based approach was adopted to test whether observed cluster growth 
differed significantly from that expected if sequences were added to trees at random. 
If all individuals in a population are equally likely to transmit, the probability of a new 
infection linking to any specific infection from the original population is equal to one 
over the total size of the population. Although the entire population is not sampled, the 
full genetic diversity of the population is captured by the tree and a new infection 
unlinked to those previously sampled will fall on a branch distant to the tree’s terminal 
nodes. The longer the length of a single branch, the more likely it is that individuals 
have been missed along that branch and that a newly identified infection could occur 
along that branch. The probability of a new infection being linked to any given cluster 
is proportional to the size of that cluster.  
Table 5.2: Cluster growth by cluster size (2007), mean observed and expected. 












A1 2 147 0.094 0.097 0.196 
C 7+ 8 0.990 0.000 0.857 
D 2 63 0.071 0.075 0.256 
G 2 55 0.100 0.145 0.439 
Notes: Clusters are only shown if their observed growth did not fall within the 95% 
expected growth quantiles (p<0.05). Subtype C clusters sized 7 and above 
exceeded their expected growth while subtype A, D and G clusters sized 2 grew 
less than expected. 
Sequences collected after January 2007 were stripped from the tree and added back 
with the probability of attachment based on the length of each branch and on the 
genetic distance and bootstrap distributions from the original tree (see Methods 5.3.3). 
In each simulated tree, clusters were picked as described previously and average 
cluster growth was calculated for clusters of each starting size and each risk group.  
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In the simulated data, average expected growth values were normally distributed 
(Figure 5.3, in blue). For clusters of each size, I evaluated whether the observed value 
of cluster growth fell within the 95% quantile estimates of the simulations (Table 5.2). 
For subtypes A1, D and G, growth of pairs was below the 2.5% quantile (p<0.05) of 
growth in the simulations. In 2007, there were a small number (8/792) of larger clusters 
(≥ 7) in subtype C, and none in the other subtypes. For this group, growth was higher 
than the 97.5% quantile (p<0.05) of simulated clusters. All other values for cluster 
growth fell within the 95% quantiles of the simulations.  
Table 5.3: Mean observed cluster growth and expected growth by risk group. 








A1 MSM# 9 0.421 0 0.417 
A1 PWID# 2 0.833 0 0.750 
C MSM# 10 0.640 0.050 0.550 
C PWID# 5 1.015 0 0.875 
C crossover# 36 0.550 0.073 0.500 
D NA 31 0.075 0.358 1 
G non-HET 6 0.056 0.130 0.462 
Notes: *containing at least two sequences collected before January 2007. Clusters 
are only shown if their observed growth did not fall within the 95% expected growth 
quantiles (p<0.05). Clusters which grew more than expected are indicated by #. 
MSM men who have sex with men; PWID people who inject drugs; NA not available; 
non-HET non-heterosexual. 
5.4.2 Cluster growth is higher for non-heterosexual risk groups 
Analysis by risk group was performed on clusters containing at least 2 sequences in 
2007 (n=1148). Growth differed significantly between risk groups when all subtypes 
were analysed together (Kruskal-Wallis, p<0.005, df=4). Although MSM (mean 
growth=0.54), PWID (mean growth=0.64) and crossover (mean growth=0.44) clusters 
grew significantly more than HET clusters (mean growth=0.18), this was also 
observed in the simulated data (p<0.0001, df=4) due to the differing initial cluster size 
between risk groups (p<0.0001, df=4). For subtypes A and C, cluster growth was 
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higher in the observed data than in the simulations for PWID, MSM and crossover 
clusters (Table 5.3, Figure 5.4), indicating initial cluster size was not responsible on 
its own. 
In the permutation test (Figure 5.5), growth followed the same patterns as in the 
simulation except for subtype A1 and C clusters where crossover clusters where 
growth was higher than in the observed data. This can be explained by the fact that the 
majority of MSM clusters became crossover clusters after the permutations because of 
the over-representation of heterosexuals among the new tips,  
Changing the rules of cluster risk group classification changed the risk group of only 
11/1148 clusters for the minority definition and 43/1148 clusters for the majority 
definition (of which 29 were crossover clusters which became either HET or MSM). 
Differences in growth rates between risk groups were unchanged other than crossover 
growth rate dropping in the majority definition because most crossovers clusters were 
relabelled as either MSM or HET (Figure 5.6). 
5.4.3 Cluster size and risk group act independently on cluster growth 
To determine whether the effect of cluster size remained significant when risk group 
was accounted for, I constructed a generalized linear model (GLM) expressing the 
number of new sequences as a variable dependent on the number of old sequences, 
risk group and subtype. Risk group and number of old sequences were added to the 
model sequentially, with risk group highly predictive (p<0.0001) and the addition of 
cluster size significantly improving the fit of the model (ANOVA likelihood ratio test, 
p<0.0001). The difference in effect between subtypes was highly significant 
(p<0.0001). There was no significant interaction between risk group and cluster size 
(p=0.108). In terms of effect, the model explained 24.75% of the variance in growth: 
risk group accounted for 12.31%, initial cluster size for 9.32% and subtype for 3.12%. 
Cluster growth was higher for crossover (p<0.0001), PWID (p<0.05) and MSM 
(p<0.01) clusters, for subtype C clusters (p<0.01) and increased with initial cluster size 
(p<0.0001). 
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Figure 5.4: Cluster growth according to risk group (simulation). Observed cluster 
growth is shown in pink and mean expected growth and distributions from 1000 
simulations are shown in blue. For subtypes D and G, numbers of non-
heterosexual clusters were small and so these were amalgamated for analysis. 
MSM men who have sex with men; HET heterosexual; PWID people who inject 
drugs; NA not available; non-HET non-heterosexual.  
Because the data contained a large number of clusters which did not increase in size at 
all (dependent variable=0), I also ran a zero-inflated model which estimated 
coefficients separately for growth and non-growth (pscl library in R [213]). Initial 
cluster size was included as an offset because we expect larger clusters to grow more.  
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Figure 5.5: Cluster growth according to risk group (permutation). Observed 
cluster growth is shown in pink and mean expected growth and distributions 
from 100 permutations are shown in blue. For subtypes D and G, numbers of 
non-heterosexual clusters were small and so these were amalgamated for analysis. 
MSM men who have sex with men; HET heterosexual; PWID people who inject 
drugs; NA not available; non-HET non-heterosexual.  
None of the zero-inflation model coefficients (risk group and subtype) were significant 
(all p>0.6). The effect of risk group and subtype followed the same trend as in the 
original glm, but the effects were not all significant. Heterosexual clusters grew 
significantly less than crossover clusters (p <0.05) and subtype C clusters grew more 
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than other subtypes (p <0.01), but the effect of PWID, MSM and subtypes D and G 
were not significant. 
 
Figure 5.6: Growth rate according to risk group under three definitions. Two risk 
group classification procedures (minority and majority definition) were tested in 
addition to the classification used in the paper. Cluster growth rates are 
according to risk group did not change significantly as shown by the overlap in 
standard error bars, except for among crossover clusters as most of these 
disappeared based on the majority definition. MSM: men who have sex with men, 
HET: heterosexual, PWID: people who inject drugs; NA not available.  
5.4.4 C is increasingly acquired in the UK while D and G are imported.  
An increase in the ratio of clustering to non-clustering sequences in the database over 
time would indicate a rise in the proportion of local transmissions. When all subtypes 
were analysed together, this ratio did increase (Figure 5.7) but the change was not 
significant (Cochran-Armitage test across years [214, 215], p=0.5). Broken down by 
subtype, the subtype C clustering ratio rose from 0.69 to 0.75 (p=0.01), indicating an 
increasing proportion of infections acquired within the UK over time. In contrast, the 
clustering ratio decreased for D (from 0.41 to 0.33; p<0.01) and G (from 0.46 to 0.33; 
p<0.0001), signifying that most new sequences were unlinked to those already in the 
UK and are more likely to be the result of migration. However, overall numbers were 
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small, with only 279 subtype D and 965 subtype G diagnoses after 2006. The change 
was not significant for A1 (p=0.7).  
For all clusters in 2009 containing at least one sequence in 2007, I counted the number 
of new sequences clustering in crossover and MSM clusters (Table 5.4). When I 
looked at the proportion of new diagnoses linking to crossover and MSM clusters (2-
3% of new diagnoses) as opposed to HET clusters, proportions were not different 
across subtypes (Fisher’s exact test, p=0.38), although numbers were small for 
subtypes D and G, with only 90 new diagnoses linking to subtype D and G clusters.  
 
Figure 5.7: Change in clustering ratio between 2007 and 2009. The ratio of 
clustered to non-clustered sequences increased for subtype C (p=0.01), decreased 
for D (p<0.01) and G (p<0.0001) and did not change for A1 (p=0.7) or when all 
clusters were analysed together (p=0.5).  
5.5 Discussion 
The interpretation of cluster distributions and cluster change has proved difficult in the 
past because of the lack of a meaningful statistical framework to compare observed 
and null distributions. Here, I developed a novel approach to generate null patterns of 
cluster growth with which to compare observed growth. Sequences were added to the 
tree according to the branch length and bootstrap distributions of the observed 
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phylogenetic tree, but on branches chosen at random. This simulation method has the 
added benefit of not requiring all the infections to be sampled because the full genetic 
diversity of the population is still captured by the phylogenetic tree.  
Table 5.4: Number of sequences added to clusters between 2007 and 2009 
Initial 
cluster size 
crossover HET PWID MSM NA Grand 
Total 










1 2 41 2 2 44 91 













1 15 362 5 7 320 709 
2+ 66 258 33 33 112 502 










1 0 8 1 1 7 17 
2+ 2 6 0 0 6 14 








1 9 14 2 0 15 40 















1 26 425 10 10 386 857 
2+ 73 315 39 45 128 600 
Notes: According to risk group (crossover; HET heterosexual, PWID people who 
inject drugs, MSM men who have sex with men, NA not available) and cluster size in 
2007 (single sequence = 1, or cluster ≥ 2). Percentages are calculated as the 
number of sequences joining clusters of each risk group out of the total number of 
new sequences for each subtype (A1 = 630, C=4852, D=279, G=472). 
At least 25% of non-B subtype infections diagnosed between 2007 and 2009 were 
linked to previously diagnosed infections and are likely to have been acquired within 
the UK. Among pre-existing clusters, cluster size and non-heterosexual risk group 
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each independently predicted higher cluster growth. The main conclusion of this 
analysis is that crossover to non-heterosexual risk groups has resulted in increased UK-
based transmission of subtype C in particular, as has been observed in France [100]. 
However, the majority of clusters did not grow and there were important differences 
between the subtypes analysed. 
Subtypes C, A1, D and G have established generalised heterosexual epidemics in sub-
Saharan Africa [216] and are the most common subtypes in the UK after subtype B, 
where they also circulate predominantly among heterosexuals [109]. Around half of 
diagnoses in the UK every year are now non-B subtypes, with subtype C alone 
accounting for one third and A1, D and G on the rise [93]. This distinguishes the UK 
from the rest of Europe, where subtype B still accounts for >80% of infections [201]. 
Subtype AE was excluded because although similar in frequency to D (~2%), subtype 
AE shows a different pattern of spread as it is found equally in MSM and 
heterosexuals. 
The most striking patterns observed here were the differences in cluster growth 
between risk groups. The overwhelming majority of clusters in this study were 
heterosexual, as would be expected. However, clusters classified as MSM or PWID 
were significantly more likely to link to new infections despite their numbers being 
small. Despite the success of needle exchange programs in the UK and the overall low 
incidence of HIV among PWID [217], these results confirm how rapidly HIV can 
spread in PWID and raise questions about the effectiveness of harm reduction efforts 
in these particular groups. I observed a number of crossover clusters containing 
sequences from both heterosexuals and MSM, which were also more likely to grow. 
In particular for subtype C, the number of newly clustering sequences in crossover 
clusters vastly exceeded that expected based on the simulations. Although the 
dynamics of D and G remain dominated by imports, similar patterns seem to be 
emerging. Sexual linkage between risk groups leads to the introduction of new 
subtypes. Crossover of subtype B from MSM into heterosexuals has been 
demonstrated in the UK [106], where Black-African men who clustered exclusively 
with MSM were more likely to self-identify as heterosexuals compared to other 
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ethnicities. It is likely that this same pattern is acting as a driver for spread of non-B 
subtypes among MSM. In order to reduce the spread of non-B subtypes among MSM, 
it would be important to encourage self-identified heterosexual men to disclose 
whether they are having sex with men (through publicity campaigns or during 
consultations) and if so educate them on HIV transmission. MSM could also be 
informed as to the increased prevalence of HIV among Black-African MSM who also 
have sex with women.  In contrast, the epidemic growth of non-B subtypes among 
heterosexuals in the UK appears limited, in agreement with models suggesting that the 
prevalence of HIV among heterosexuals in the Netherlands was hardly affected by 
immigration [218].  
It is important to note that most pre-existing clusters did not link to any new infections 
(>70%). Subtype A1, D and G pairs grew less than expected, with 85% not changing 
at all. The tendency of larger clusters to act as a driving force for epidemic growth has 
not been formally tested previously and is consistent with the hypothesis of preferential 
attachment [140], whereby already highly connected individuals tend to make 
proportionally more contacts over time. This was emphasised by the GLM analysis 
which showed that cluster size remained significant in the model even when risk group 
was taken into account.  
Public Health England data indicate that the UK epidemic is growing, with 6000 new 
cases diagnosed every year [6], half of which are non-B subtypes [93]. These new 
diagnoses could be imports, new infections or new diagnoses of old infections. If they 
were all imports, none of their sequences would attach to pre-existing clusters. If they 
were new diagnoses but actually old infections, they could attach to pre-existing 
clusters without reflecting new infections within that cluster. Clusters would “grow” 
by the definition implemented in the present analysis, but the epidemic would be 
unchanging. It would be possible to detect a difference between this latter scenario and 
one of true growth (new infections linked to old clusters) by looking at the distribution 
of branch lengths of new diagnoses. New infections are likely to be connected by short 
branch lengths to existing clusters while old infections will be more distantly related 
(due to the greater opportunity for within host evolution). In time-resolved trees, new 
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infections would also be more likely to converge close to the tips of clusters while old 
infections would converge deeper into the cluster. We are currently performing time-
resolved analyses of these data. 
The relative frequencies of A1, C, D and G in the UK reflect their respective global 
prevalence [11], but I observed significant differences in their patterns of growth. Even 
though, proportionally, the UK subtype G epidemic grew as much as subtype C (over 
80% during the study period), the majority of those subtype G infections did not link 
to previous UK infections. The ratio of clustering to non-clustering sequences for D 
and G decreased, so D and G appear not to be being transmitted as much as C within 
the UK. Meanwhile, subtype C cluster growth was much higher than expected. Several 
large, non-heterosexual clusters displayed cluster growth more similar to subtype B 
[108], and numerous crossing over events were observed. In parallel, I found that D 
and G have for the most part not crossed over into non-heterosexual risk groups. As 
such, I conclude that the spread of non-B subtypes appears to exhibit threshold 
behaviour, whereby rapid growth follows transmission into non-heterosexuals or 
groups of high-risk heterosexuals.  
The figure of 25% is an underestimate of the proportion of non-B strains acquired 
within the UK. Only clusters that contained at least one sequence collected prior to 
2007 were analysed because there is a better chance that subsequent infections will 
have been acquired in the UK. However some infections acquired within the UK will 
be missed, because of undiagnosed patients and because of the choice of clustering 
threshold. In the latter case, evolution in one or both patients can cause sequences to 
diverge such that either genetic distance will exceed the cut-off or bootstrap support 
will be too low [219]. It is difficult to compare these results to the published estimate 
of 50% heterosexuals born abroad having acquired their infection in the UK [95], 
because I am looking at subtype acquired rather than country of birth, and risk groups 
other than heterosexuals are included. However, non-UK born individuals are more 
likely to be infected with non-B subtypes [207] and MSM are more likely than 
heterosexuals to have acquired their infection in the UK [6] so a higher proportion of 
non-B subtype infections acquired in the UK would be expected. Lower rates of 
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diagnosis among heterosexuals (31% undiagnosed compared to 16% among MSM [6]) 
may play a part in explaining this result. Sequences from MSM are more likely to be 
captured by the UK HIV RDB. Nevertheless, as the UK HIV RDB is generated through 
population surveillance, not from a cohort, over time it will accumulate HIV positive 
patients from participating centres as they transition from undiagnosed into care, and 
linkages will increase. 
There are limitations to the analysis. Importantly, the number of diagnoses in 
heterosexuals born abroad varies in parallel to patterns of migration from HIV endemic 
countries into the UK and both have recently decreased. Therefore the rise in non-
heterosexual non-B subtype diagnoses could be interpreted as a relative rise and not 
an absolute one. However these cluster analyses focus on infections that link to 
previous diagnoses and cluster growth rates will not be impacted by changing patterns 
of migration. It is true that that the increase in the clustering ratio observed for subtype 
C could have occurred a result of decreased immigration. However, as this pattern was 
unique to subtype C and is concordant with the extensive spread of subtype C among 
MSM, these results nonetheless point toward subtype C being increasingly acquired 
within the UK. 
The cut-off of January 2007 was selected to equalise the number of sequences 
available on either side. In time-resolved trees of the UK non-B epidemic, the 
distribution of branch lengths is known to be continuous indicating that sequences 
were added to clusters linearly with time [109] and so no particular cut-off would be 
expected to affect these findings. Similarly, although a bias could be introduced by the 
risk group classification of clusters, the density plots indicated that the majority of 
clusters comprised a single risk group and the sensitivity analysis demonstrated the 
robustness of the main conclusions. 
Finally, simulations of tree growth are simplifications of the epidemiological process. 
Formal methods linking phylogenetic reconstructions and epidemiological models 
remain difficult to apply to large datasets. However, the use of simulations as a null 
model to compare data to has provided a formal test. Non-heterosexual cluster growth 
rates diverge dramatically from a null model in which all individuals in the population 
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are equally likely to transmit. In addition, modelling cluster growth based on the 
phylogenetic tree instead of using an epidemiological model has the advantage of 
implicitly accounting for new infections from unsampled sources without having to 
predetermine the population sampling coverage. 
Overall, I found multiple subgroups within the UK non-B epidemic. The majority of 
clusters did not grow and those that did were more likely to already be larger and to 
contain non-heterosexuals. There were differences between the subtypes analysed, 
with subtype C infections increasingly acquired within the UK while the dynamics of 
subtypes D and G were dominated by imports. One possible explanation for the 
difference in observed cluster growth rates could be that infections in heterosexuals 
occur in sequential chains of transmissions [109] while among MSM, infections occur 
in rapid bursts [108] within a more densely connected contact network. In Chapter 1, 
I investigate differences in transmission network structure between risk groups. 
I conclude that crossover into non-heterosexual risk groups has led to rapid non-B 
expansion within the UK recently. This study underlines the importance of continuing 
efforts to prevent HIV transmission among all risk groups despite the UK epidemic 
changing from being MSM and subtype B dominated to being more diverse in terms 
of risk group and subtypes.  
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6 CHARACTERISING UK HIV 
TRANSMISSION NETWORKS 
BY RISK GROUP 
6.1 Introduction: degree distributions of networks and targeting 
interventions 
The assumption of random mixing frequently made by standard epidemic theory is 
violated in the case of sexually transmitted infections (STIs) such as HIV. HIV can 
only be transmitted to a number of close contacts which is much smaller than the total 
population size. In addition, the number of sexual partnerships is far from being 
normally distributed. Instead, most individuals have few sexual contacts while a small 
number have many [220]. This heterogeneity in number of contacts is observed in 
many real life networks (neuronal networks, power grids, social networks [116]) and 
is thought to be central to the propagation of STIs including HIV. Without taking into 
account the variation in number of sexual partnerships in models, it is difficult to 
recreate observed HIV incidence [221]. 
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The degree distribution of sexual partnerships of a population varying in number of 
contacts has a heavy tail and frequently follows a power law [128]. The variance of 
the degree distribution is determined by the exponent of that power law. Importantly, 
for certain values of the exponent, the variance of the distribution becomes infinite and 
the epidemic threshold disappears [110] which means that untargeted interventions 
will not stop the epidemic (see section 1.5.5). Although this theoretical result only 
holds true in infinite populations, the exponent of the power law can give us an 
indication of the extent to which interventions should targeted. Appropriate 
characterisation of the degree distribution can be used to assess whether a network 
adheres to a particular probability model [127], providing information on the process 
that led to its formation. 
Studies of sexual networks have found contradicting results. Some studies have found 
power law distributions with infinite variance to fit Swedish [128], British, US and 
Zimbabwean sexual contact networks [129], but reanalysis of these same data have 
shown otherwise [123, 124, 126]. Importantly, some of the best fit models make HIV 
predictions which are inconsistent with the observed epidemic patterns [123], 
underlining our lack of understanding of the contact networks themselves and their 
effect on the spread of disease.  
In reality, it is very difficult to obtain reliable contact network information (see section 
1.5.6). It is impractical and expensive for large populations and requires personal 
information which in the case of sexual contacts (and in view of the criminalisation of 
HIV transmission see reference [145] and section 7.4), participants may not readily 
volunteer. In the case of HIV, the time lapse between infection and diagnosis also leads 
to problems of recall, and patients often do not know who infected them [139]. 
Recent years have seen the development of a new method for reconstructing HIV 
transmission networks: inference from viral sequences [140] (see section 2.2.4.2). 
Sequencing HIV for detecting drug resistance has led to the accumulation of 100,000s 
of sequences in databases globally, and so data are readily available (see section 2.1.1). 
In addition, networks reconstructed from sequences have the advantage of including 
only contacts that are relevant for understanding HIV transmission. 
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In their 2011 analysis, Leigh Brown et al. found that the Waring distribution offered 
the best fit to UK subtype B transmission networks constructed from viral sequences 
[140]. Waring is a power law distribution that results from a preferential attachment 
model.  
In this chapter, I further analyse the UK degree distributions by subtype (subtypes A1, 
B and C) and risk group (heterosexuals, MSM and PWID) and by sex. This distinction 
is important because previous studies have found different distributions to fit male 
versus female sexual contact networks [123, 124, 126, 129] as well as heterosexual 
versus MSM networks [129]. The network reconstruction method from viral sequences 
has not been extensively validated until now, so in this chapter its performance is 
evaluated against simulated epidemics. In addition, the method is known to reconstruct 
far more links between nodes than the number of transmission events so I develop and 
evaluate thinning algorithms which lead to a better estimation of the true transmission 
network.  
6.2 Methods 
6.2.1 HIV Epidemic Simulation 
An HIV epidemic was simulated for 57 years using the HIV-specific individual-based 
DSPS [175]. In the underlying SIR model the R category represented AIDS and death 
(individuals are removed from the pool of infectors). Birth and (AIDS-unrelated) death 
were set at 0.1 and 0.01, respectively, and progression to AIDS (removal) was set at 
0.8. The growth of the population was set to “stable” to ensure only two individuals 
would populate each deme at any given time point. 
The population simulated was fully heterosexual (Figure 6.1). The majority of demes 
represented households containing a heterosexual couple. One deme contained a 
cohort of sex workers. The average number of sexual contacts was set at 100 per year 
and households were classed as either low risk or high risk. For high risk individuals, 
50% of contacts were within the household, 30% were with other high risk individuals 
and 20% were with low risk individuals. For low risk individuals, 80% of contacts 
were within the household, 15% were with high risk individuals and 5% were with 
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other low risk individuals. The sex worker deme contained 600 female hosts, each with 
600 contacts per year on average. All sex worker contacts are with males and so the 
sex workers cannot infect each other. The simulation was initiated with the infection 
of a single sex worker to maximise the likelihood of the epidemic starting. 
 
Figure 6.1: Contact network used in the DSPS HIV epidemic simulation © Emma 
Hodcroft [176] 
True phylogenies were generated using the VirusTreeSimulator (see Methods 2.2.3.3). 
Full genome sequences were simulated along the true phylogenies using piBUSS [177] 
according to a General Time Reversible model. Rate of evolution was partitioned by 
gene (gag/ pol: 2.5.10-3 substitutions per site per year, env: 5.10-3).  
This model was developed by Emma Hodcroft as part of the PANGEA_HIV modelling 
initiative (http://www.pangea-hiv.org/). 
6.2.2 Network reconstruction in simulated data 
6.2.2.1 Reconstruction of time-resolved phylogenies 
Full genome HIV sequences were simulated but this analysis focused on the pol region 
for consistency with previous work and comparison with currently available patient 
data. Phylogenetic trees were reconstructed independently for each of the three sets of 
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sampled sequences (100% coverage, 60% and 20%) in RaxML with 100 bootstrap 
replicates [162]. Trees were transformed into time-scaled trees using Least Squares 
Dating (http://www.atgc-montpellier.fr/LSD) [173]. LSD runs rapidly on datasets 
containing tens of thousands of sequences (see Methods 2.2.2.2). 
6.2.2.2 Receiver Operating Characteristic (ROC) analysis (see Methods 2.2.5.5) 
True times to most recent common ancestors (tMRCA) for each pair of viruses were 
retrieved from the true phylogeny as well as information on whether the host of those 
viruses were connected by a direct transmission link. In parallel, reconstructed 
tMRCAs were retrieved from the time-scaled phylogenies. The method for 
reconstructing networks from time-scaled phylogenies has been described previously 
[140] (and see Methods 2.2.4.2). Networks were reconstructed at time depths of 1-10 
years. In brief, for each cut-off x, two nodes were linked to each other in the network 
if their tMRCA was below x. The objective was then to use ROC analysis to measure 
our ability to correctly infer whether two sequences were linked or not. 
6.2.2.3 True positives (TP) 
Ideally, the true reconstructed network should capture only the true sequence of 
transmission, which in a network containing 4662 nodes, would mean 4661 links only. 
However, our method of establishing linkage is based on tMRCA so if two sequences 
share a common ancestor within the prescribed amount of time, our method will link 
them whether or not that link is direct. Therefore, I conducted two sets of analyses 
with two different sets of true positives: 1) comparing the links reconstructed to the 
true direct links (this is the true transmission network) and 2) comparing the links 
reconstructed to those expected based on the true tMRCAs of each pair of sequences. 
6.2.2.4 True negatives (TN) 
Our network is dominated by a large number of negative instances: of >10 million 
possible links in the network, only 4661 are true transmission links (and >10 million 
are incorrect). This huge number of true negatives (negatives that will be identified 
correctly as negatives in the reconstruction) will make our method look better than it 
is (high specificity). As such, I decided to include in our count only links between pairs 
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of nodes that had a tMRCA below 15 years. This reduced the total number of links 
(including all TP, TN, false positives (FP) and false negatives (FN)) to 40657 in the 
dataset of 4662 sequences. 
6.2.2.5 Network thinning 
As stated above, the current network reconstruction method links nodes in the network 
based solely on tMRCA. The number of links in reconstructed networks by far exceeds 
the true number of transmission links. In many cases, cliques (Figure 6.2A, where all 
nodes in a cluster are linked to each other) and cycles (Figure 6.2B, where groups of 
nodes are connected through a closed walk) remain, both of which reflect the incorrect 
assignment of links between nodes. Consequently, I implemented thinning algorithms 
which selectively dropped links within cliques and cycles based on pairwise genetic 
distance and tMRCA (see Appendix 3). In brief, all cliques are identified within the 
network [222] and in each clique, the largest edge is eliminated if its length (genetic 
distance or tMRCA) is greater than the smallest edge length in the clique. Because 
cliques are not independent from each other, all cliques in the network are then re-
estimated before targeting the next edge for deletion. Once all cliques have been 
eliminated, all cycles are identified within the network and processed in the same way 
based on the distance of edges. For a more detailed explanation see Appendix 4. For 
pseudocode, see Appendix 6. I then tested whether thinning improved the precision of 
our reconstructions (in terms of identifying direct links only). 
B. 
Figure 6.2: Network cliques (A.) and cycles (B.) 
A. 
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6.2.2.6 Degree distribution 
As well as the ability to reconstruct the true transmission network, I was interested in 
the ability of our method to correctly estimate the degree distribution of the network. 
The R [154] package degreenet [126] was used to fit degree distributions (and 
confidence intervals for best fit parameters) to the Pareto distribution, the Negative 
Binomial (NB) distribution, the Yule distribution and the Waring distribution. The 
discrete Pareto is a power law distribution. The other distributions tested are indicative 
of specific processes of network formation. The NB assumes that individuals in the 
population acquire partners at a fixed but heterogeneous rate. The Yule [130] and 
Waring [131] distributions both result from preferential attachment models. They 
incorporate a probability proportional to k that a new link is made to a person of degree 
k, as well as a constant probability that a new link is made to a person of degree 0 
(previously sexually inactive). In addition, the Waring incorporates a rate for non-
preferential attachments, so that a partnership may form at random between two 
people, regardless of degree [124, 131]. Importantly, the NB always has finite 
variance, while the Yule and the Waring have infinite variance when their exponent 
value is between 2 and 3. Infinite variance of a degree distribution indicates that 
interventions targeted towards the network’s high degree nodes will be necessary (see 
section 1.5.5).  
6.2.3 True data 
In addition to the simulated data, real HIV pol sequences were obtained from the UK 
HIV RDB (2014 download; Methods 2.1.2). In order to distinguish between UK and 
non-UK transmission clusters, trees were reconstructed with a background of 
sequences from LANL, as described previously (Methods 2.1.3). 2507 UK subtype 
A1, 31450 subtype B and 15815 subtype C sequences were analysed along with 1414 
subtype A1, 7413 subtype B and 6212 subtype C LANL sequences. 
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6.2.3.1 Phylogenetic analysis 
For each of the three subtypes, phylogenetic trees were reconstructed in RaxML with 
100 bootstrap replicates. Clusters were picked if they were supported by a bootstrap 
≥90% and had a maximum genetic distance ≤4.5% [108].  
For time resolved analysis, clusters were pooled for analysis in BEAST [76] because 
of the size of the datasets. Clusters from the ML tree were sorted into pools of up to 
300 sequences so that all sequences from the same cluster were analysed together 
[140]. In the final reconstructed networks (see below), we ensured that no sequences 
from different clusters has been linked together based on the tMRCAs estimated in 
BEAST. In a subset of data, I compared the constant, exponential, lognormal, Bayesian 
skyline plot and Bayesian skyride models. The best model was selected as the skyride 
by means of its Bayes Factor, as estimated through path sampling. Chains were run for 
100,000,000 generations and sampled every 1000 with an SRD06 genetic model and 
uncorrelated lognormal clock. Chains were run in duplicate, checked for convergence 
in Tracer and combined. Maximum clade credibility trees were generated in Tree 
Annotator.  
6.2.3.2 From phylogeny to network 
In the maximum clade credibility trees, networks were generated as above by linking 
nodes if their estimated tMRCA was below 5 years. Networks for subtypes A1, B and 
C were amalgamated for analysis. Thinning was performed as explained above based 
on pairwise tMRCA and genetic distances within cliques and cycles. Nodes were 
linked to epidemiological information available (sex and risk group) and degree 
distributions were generated for the network as whole and for each sex, each risk group 
and each subtype. Degree distributions were fitted using degreenet [126].  
6.3 Results from simulated data 
6.3.1 Epidemic dynamics 
Sampling was set to begin in year 43 of the simulation (by which time the epidemic 
had stabilised) to last until the end of the simulation (year 57; Figure 6.3). Based on 
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the timed series of transmission events (or transmission tree), the true phylogeny of all 
viruses in hosts alive and infected during the sampling period (4662 in total) was 
generated. The dataset was down sampled to 60% (2798 nodes) and 20% (933 nodes).  
 
 
Figure 6.3: Simulation epidemic dynamics 
6.3.2 The true and reconstructed tMRCAs are highly correlated 
Trees were reconstructed at all three sampling depths independently. These trees were 
then processed using LSD (see Methods 2.2.2.2) in order to convert branch lengths 
into calendar time. For each pair of nodes, I then extracted the tMRCA from these 
reconstructed phylogenies, and in parallel extracted their true tMRCA from the 
transmission trees. The true tMRCA and reconstructed tMRCA were highly correlated 
(r-=0.96, p<0.0001), with reconstructed tMRCAs estimates slightly above true values 
(Figure 6.4). The correlation stayed significant and did not drop at lower sampling 
depths. Based on the true transmission network, I was able to distinguish between pairs 
of nodes that had directly transmitted to each other (direct links) and those who hadn’t. 
The correlation and its significance were not affected by whether direct links only were 
analysed as opposed to all links. 
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6.3.3 Sensitivity and specificity of the network reconstruction method 
are high 
 
Figure 6.4: Correlation between true tMRCA and reconstructed tMRCA (r=0.96 
and p<0.0001 for all sampling depths). Correlation coefficients were estimated 
between the true tMRCA and the tMRCA for each pair of sequences in 
reconstructed trees with 100% sampling, 60% sampling and 20% sampling; and 
between true tMRCAs of all sequence pairs in the tree (all links) and only those 
pairs linked by direct transmission (direct links).  
For a cut-off of 5 years, for example, two sequences would be considered linked (true 
state = positive) if their true tMRCA ≤ 5 years (Figure 6.5). If their tMRCA> 5 years, 
the sequences would be unlinked (true state = negative). The true state of the edge is 
thus categorical. The predictor variable (reconstructed tMRCA), meanwhile, is 
continuous. ROC analysis tests all the different cut-offs for the predictor variable, and 
each time calculates the number of TP, FP, TN and FN (Figure 6.5). Based on these 
numbers, the sensitivity and specificity are calculated (Methods 2.2.5.5). ROC curves 
plot sensitivity against 1- specificity for every cut-off (Appendix 5, left hand column). 
Both measures can also be plotted against the cut-off used (Appendix 5, right hand 
column) in order to identify the cut-off which maximises sensitivity and specificity 
(best cut-off). 
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  Reconstruction (all cut-offs tested) 
  Linked Unlinked 
 
True state (e.g. at  
5 years) 
Linked (true 
TMRCA ≤ 5 years) 
True Positive False Negative 
Unlinked (true 
TMRCA > 5 years) 
False Positive True Negative 
Figure 6.5: ROC analysis: comparing the reconstructed and true state of edges. 
 
 
Figure 6.6: Best cut-offs for each network year based on sampling proportion 
(100%, 60%, and 20%) and whether links were direct or indirect. 
The area under the curve (AUC) of ROC curves measures how well the method as a 
whole is doing at predicting the true state of each edge. For a perfect predictor, the 
AUC would be equal to 1. In the analyses, the AUC never fell below 0.9, in any of the 
sample fractions or whether I looked at all links or at direct links only. The 
performance of the classifier as a whole decreased as network years increased, but 
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classed as true, or direct links only. When classifying only direct links as true, the AUC 
decreased, as did the best cut-off (Appendix 5). 
Table 6.1: Accuracy of reconstruction of (direct and time-based) links at three 
sampling depths. True links are nodes with a true tMRCA ≤ 5 years and a 
reconstructed tMRCA of 5.38 was used for all 
Sampling  positives TP FP TN FN sensitivity specificity precision 
100% All Links 3260 1031 36173 19
3 
0.94 0.97 0.76 
100% Direct 
Links 
1473 2818 36292 74 0.95 0.93 0.34 
60% All Links 1117 406 12944 72 0.94 0.97 0.73 
60% Direct 
Links 
493 1030 12983 33 0.94 0.93 0.32 
20% All Links 136 47 1631 9 0.94 0.97 0.74 
20% Direct 
Links 
68 115 1636 4 0.94 0.93 0.37 
For a true network depth of 5 years, the best selected cut-off remained stable (5.26-
5.71, mean=5.45) at all sampling depths (100%, 60%, 20%) and whether I classified 
all links as true or only direct links (Figure 6.6). The best cut-off for identifying direct 
links ranged from 5.26 to 5.55 (mean = 5.38). Networks were analysed at a true depth 
of 5 years in all subsequent analyses with a reconstructed tMRCA of 5.38 years. 
At a network depth of 5 years and using a cut-off 5.38 years, the sensitivity and 
specificity were above 90% (Table 6.1). When all links with a tMRCA ≤ 5 years were 
considered positive, precision however was ~74%, meaning that of the reconstructed 
links, ¾ were correct. When only direct links with a tMRCA ≤ 5 years were considered 
positives, precision was only ~34%, meaning that only 1/3 of reconstructed links were 
in fact true links. Of note, precision did not drop at lower sampling depth as compared 
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Table 6.2: Accuracy of reconstruction of direct links after thinning at three 
sampling depths. Thinning was performed by dropping links within cliques and 
cycles based on genetic distance and tMRCA. True links are nodes with a true 
tMRCA ≤ 5 years and a reconstructed tMRCA of 5.38 was used for all. 
Sampling  positives thinning TP FP TN FN sensitivity specificity precision 
100% direct Distance, 
no 
cliques 
1249 925 38185 298 0.81 0.98 0.57 




1246 830 38280 301 0.81 0.98 0.6 
100% direct tMRCA, 
no 
cliques 
1237 990 38120 310 0.8 0.97 0.56 




1231 845 38265 316 0.8 0.98 0.59 
60% direct Distance, 
no 
cliques 
447 489 13524 79 0.85 0.97 0.48 




446 465 13548 80 0.85 0.97 0.49 
60% direct tMRCA, 
no 
cliques 
450 507 13506 76 0.86 0.96 0.47 




449 462 13551 77 0.85 0.97 0.49 
20% direct Distance, 
no 
cliques 
64 82 1669 8 0.89 0.95 0.44 




64 82 1669 8 0.89 0.95 0.44 
20% direct tMRCA, 
no 
cliques 
65 82 1669 7 0.9 0.95 0.44 




65 81 1670 7 0.9 0.95 0.45 
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6.3.4 Thinning improves precision with little cost to sensitivity and 
specificity 
The aim of the thinning algorithms was to eliminate FP links to improve the precision 
of the network reconstruction method as the number of FP called was so high. In this 
case the reconstructed links were counted only against the true direct links in the 
network. Thinning improved the precision of the reconstruction method, but with some 
costs to its sensitivity (Table 6.2). At high sample fractions, precision improved the 
most, but at low sample fraction thinning had the smallest impact on sensitivity. 
Removing links from cliques and cycles was slightly better than cliques only. There 
was no difference between distance-based thinning and tMRCA-based thinning. 
Overall, around 10% of TP links and 52% of FP links were removed by thinning 
(Figure 6.7). 
 
Figure 6.7 Change in the number of true positives (TP) and false positives (FP) 
after thinning (tMRCA-based with both cliques and cycles thinned).  
Thinning removed 37/183 links at 20% sampling (20%), 612/1523 links at 60% (40%) 
and 2215/4291 links at 100% (52%). We compared the thinning algorithm to an 
approach where the same proportion of links were dropped at random from the 
network, (Figure 6.8). We repeated the random thinning 100 times at each sampling 
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generated. Precision was significantly higher in the networks with targeted thinning, 
as was sensitivity at 60% and 100% sampling depth.   
 
Figure 6.8: Sensitivity, specificity and precision in randomly thinned networks 
compared to targeted thinning. Coloured distributions show results from 100 
replicates, black triangles represent the results for targeted thinning.  
6.3.5 Degree distributions 
At 100%, mean degree in the thinned networks was closer to that in the true network 
than mean degree in the unthinned network, but the difference was not significant 
(overlapping error bars, Figure 6.10). Maximum degree was much higher in the 
unthinned 100% network than in the true data (23 vs 14). 
The true transmission network was best fit by a Waring distribution with an exponent 
α=28.91. I reconstructed the degree distribution for networks at all three sampling 
depths, unthinned and with four kinds of thinning (distance-thinning with no cliques, 
distance-based thinning with no cliques or cycles, tMRCA-thinning with no cliques, 
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tMRCA-based thinning with no cliques or cycles; Figure 6.9). Each time I evaluated 
whether the best fit distribution matched that of the true transmission network. Waring 
was the best fit distribution at 100% sampling and 60% sampling for the unthinned 
networks and for the distance-based thinned networks (Figure 6.11). The tMRCA-
thinned distributions were best fit by NB distributions. The 20% sampled unthinned 
network and tMRCA-thinned networks were best fit by the NB and the distance-
thinned networks were best fit by a Yule distribution. In all cases, the exponent α was 
above 3. The 95% confidence intervals for α overlapped with the 95% confidence 
intervals in the true network in all reconstructions except for the unthinned networks 
at 100% and 60% (Figure 6.11). In all networks analysed α was within the range of 
finite variance, as was the case in the true transmission network. 
 
 
Figure 6.9: Degree distributions of the true network and the unthinned and 
thinned reconstructed networks (distance-based, no clique, no cycle).  
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Figure 6.10: Mean and maximum degree in the simulated networks. 
 
 
Figure 6.11: Exponent α (Waring distribution) in the true transmission network 
and according to sampling proportion and thinning method. Triangles represent 
datasets where Waring was selected as the best fit. Bars represent 95% 
confidence intervals and were estimated through bootstrapping. 
6.4 Degree distributions of the UK HIV epidemic 
Network membership for sequences from the UK HIV RDB was established in two 
stages. Initially, clusters were picked in a ML tree based on genetic distance (≤4.5%) 
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and bootstrap support (≥90%) for the cluster. All clusters containing at least two UK 
HIV RDB sequences were selected for analysis in BEAST (Table 6.3). Maximum 
clade credibility trees generated from BEAST runs were processed using an R script 
(see Appendix 3) to return the tMRCA and genetic distance for pairs of sequences with 
tMRCA ≤5 years. The returned tables are network edge lists where each line contains 
the names of the two linked nodes as well as their genetic distance and tMRCA. 
Networks for all subtypes and pools were combined for analysis. The breakdown by 
subtype, risk group and sex for the population as whole is shown in Methods 2.1.2. 
The breakdown for sequences which stayed linked to at least one other in the final 
network is shown in Table 6.4. 30% of subtype B sequences remained linked to at least 
one other compared to only 10.5% of subtype A1 sequences and 12.3% of subtype C 
sequences (Table 6.3). 
Networks were thinned, as described previously. For unthinned and thinned networks, 
degree distributions were generated for each subtype, risk group and sex, totalling nine 
categories: females (F), males (M), MSM, PWID, heterosexuals (HET), heterosexual 
females (HET F), heterosexual males (HET M), subtype B, and subtypes A1 and C.  
Table 6.3: Number of sequences and clusters analysed at each stage 
 A1 B C 
Total number of  
sequences 
4421 (2507 UK, 
1414 LANL) 
38863 (31450 
UK, 7413 LANL) 
22027 (15815 
UK, 6212 LANL) 
Clustered sequences  
(% of total)* 
993 (22.5%) 16544 (42.6%) 4827 (21.9%) 
Number of clusters 315 3519 1731 
Sequences linked at 5 
years 
(% of total)* 
462 (10.5%) 11750 (30.2%) 2712 (12.3%) 
Number of clusters 191 3547 1184 
*these numbers include LANL sequences 
In the unthinned network, Waring was the best fit distribution for all categories of 
nodes other than HET F and subtype A1 and C nodes. Subtype B nodes were best fit 
by a Waring distribution with 2 < α < 3, as shown previously [140] (Table 6.5, Figure 
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6.12). This effect was particularly driven by PWID (α=2.73), while for MSM, α was 
slightly above 3. However, in the thinned networks, only subtype B nodes, PWID and 
MSM were still best fit by the Waring, and in all cases α exceeded 3 (Table 6.5, Figure 
6.12).  
Table 6.4 Sex and risk group of patients whose sequences linked to at least one 
another in a network with a cut-off of 5 years.  
  A1 B C 
Sex F 168 (41.5%) 589 (5.2%) 1124 (42%) 
 M 164 (40.5%) 9165 (80.9%) 976 (36.5%) 
 NA 73 (18%) 1572 (13.9%) 574 (21.5%) 
Risk group HET 242 (59.8%) 1083 (9.6%) 1759 (65.8%) 
 PWID 19 (4.7%) 186 (1.6%) 38 (1.4%) 
 MSM 58 (14.3%) 8153 (72%) 241 (9%) 
 Other/NA 86 (21.2%) 1904 (16.8%) 636 (23.8%) 
Total* 14925 405 11326 2674 
*These numbers represent only UK HIV RDB sequences. Females (F), males (M), 
men who have sex with men (MSM), people who inject drugs (PWID), heterosexuals 
(HET). 
6.5 Discussion 
The aim of this study was to evaluate and improve the performance of the published 
network reconstruction method [140]. Because the method infers far more links than 
those which could have existed in the true transmission network. I tested thinning 
algorithms which eliminate links based on pairwise tMRCAs and genetic distance. I 
then reconstructed thinned UK HIV networks to estimate whether their variance was 
finite, given the implications of degree variance on intervention strategies (see section 
1.5.5).  
As before, the unthinned subtype B network was best fit a by a Waring distribution 
with 2 < α < 3, indicating infinite variance [140]. Broken down by risk group, α for 
PWID alone remained <3, while for MSM it was actually slightly above 3. 
Heterosexuals were also best fit by a Waring but α was well above 3. When 
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heterosexual men and women were split up, Waring was the best fit for heterosexual 
men, but the NB was selected as the best model for women. Distinct distributions of 
sexual partnerships are commonly found for heterosexual men and women [123, 129]. 
In the UK HIV RDB, one possible explanation is that a proportion of heterosexuals 
may be misclassified MSM [106] (Chapters 1 and 5). After thinning, the mean and 
maximum degree for every category of nodes decreased but the change in means was 
not significant. For females, heterosexuals and heterosexual males who previously had 
been best fit by a Waring distribution, the NB was the best fit in the thinned networks. 
For subtype B, males, PWID and MSM, Waring was still the best fit but in all cases α 
exceeded 3, indicating finite variance. Nonetheless, α remained lowest for PWID. 
While α may not lie in the range indicating the necessity of targeted interventions, the 
value for α among PWID still indicates high variance, so targeted interventions may 
be more efficient. This is an impressive finding given the overall small number of 
PWIDs in the dataset: 243 only, as compared to 8452 MSM. Taken together, these 
findings are consistent with our understanding of the difference in epidemic dynamics 
between risk groups in the UK [108, 109], and with the results presented in Chapter 5.  
 
Figure 6.12: Exponent α (Waring distribution) in the thinned and unthinned UK 
networks. Triangles represent datasets where Waring was selected as the best fit. 
Bars represent 95% confidence intervals (estimated through bootstrapping). The 
pink band indicates the range of α signifying infinite variance. Results for thinned 
networks are from distance-based no clique, no cycle networks. Subtypes A1 and 
C (A1/C), subtype B (B), heterosexual females (HET F), heterosexual males (HET 
M), people who inject drugs (PWID), men who have sex with men (MSM). 
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Table 6.5: Best fit degree distribution for each category of nodes 
 Best fit degree distribution and Waring distribution 
parameter α (95% confidence intervals) 
Node type Unthinned network Thinned network 
Subtypes A1/C NB NB 
Subtype B Waring: 2.93 (2.93-3.16) Waring: 6.47 (6.3-7.4) 
F Waring: 9.65 (8.4-17.3) NB 
M Waring: 3.29 (3.28-3.5) Waring: 10.51 (10.1- 13.4) 
HET Waring: 10.21 (9.34-16.1) NB 
HET F NB NB 
HET M Waring: 7.45 (6.42-11.76) NB 
PWID Waring: 2.73 (2.7-4.1) Waring: 5.02 (4.7-14.9) 
MSM Waring: 3.09 (3.03-3.3) Waring: 7.10 (6.8-8.1) 
Note: Results for thinned networks are from distance-based no clique, no cycle 
networks. Females (F), males (M), men who have sex with men (MSM), people who 
inject drugs (PWID), heterosexuals (HET). 
In the simulated data, the unthinned networks contained numerous very high degree 
nodes (Figure 6.9), leading to an incorrectly estimated very low α. Thinning networks 
eliminated 50% of FP links, improved our recovery of mean and maximum degree, 
and generated values for α closer to its true value. However, there were high numbers 
of FP links in the thinned networks (precision never exceeded 60% even at 100% 
sampling), and 10% of true positive links were lost through thinning. Therefore while 
some kind of thinning appears necessary, the exact thinning algorithms developed here 
may not be best suited to the problem.  
I am currently examining how systematic misclassifications of links are. For example, 
as time between infection and sampling increases, direct transmission links will 
become more difficult to identify because of within patient evolution, but it would be 
possible for an algorithm to take additional information into account before deciding 
whether to link two nodes or not. Some predictors (such as the time between infection 
and sampling) will never be available in true epidemics, but others like the date of 
ART initiation or whether or not patients were sampled in early infection (inferred 
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through CD4+ counts, viral load, genetic diversity or RITA result), can help determine 
the likelihood or direction of a link.  
 
Figure 6.13: Resolution of the transmission chain from a phylogenetic cluster. 
The phylogeny is compatible with both transmission diagrams, but the 
transmission diagrams entail different interventions. 
The aim of thinning is to better resolve the true chains of transmission. Reconstruction 
of exact HIV transmission chains through phylogenetic analysis has remained elusive. 
For large clusters of closely related infections, it is not possible to determine the 
sequence of transmission events (Figure 6.13). In terms of interventions, the two 
scenarios represented would engender dramatically different responses. In the first 
case, an intervention would need to focus on individuals with many contacts. In the 
second case, meeting places or patterns should be targeted. Here, I wished to improve 
the estimation of the degree distribution of the true transmission network, because 
degree distribution is indicative of the intervention strategies suited to the population 
as whole. Other metrics that may be important in understanding the HIV spread include 
network clustering coefficients (see section 1.5.3) and assortativity (the tendency of 
linked nodes to share characteristics). It will be important to evaluate how thinning 
affects our estimates of those metrics.  
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Another aim of thinning is to identify high degree nodes that should be targeted with 
interventions (for example early initiation of treatment). In the same vein, numerous 
studies have focused on identifying correlates of transmission by identifying clustering 
on the tree of factors such as the presence or absence of co-infections, including STIs, 
stage of infection, and drug treatment and compliance [59]. In those types of analyses, 
all clustered sequences are treated as high transmitters, despite the fact that many of 
them will be recipients who have not necessarily transmitted the virus onwards. 
Because a person can only be infected once, if they are linked to many other nodes in 
a transmission network, all but one are onward transmissions. Therefore, 
characteristics associated with high degree nodes will be more pertinent to high 
transmitters than those associated with clustered individuals. We are currently in the 
process of testing whether we are able to correctly identify high transmitters in the 
simulated data. In parallel, we have been epidemiologically characterising high degree 
nodes in the UK data.  
One criticism of methods that reconstruct networks from phylogenies is that the 
phylogeny contains all the information and that some links are artefactually created 
based on tMRCA that would not be possible based on the phylogeny. However, this 
assumes that the phylogeny is correctly resolved. It is likely not possible to know the 
direction of transmission very well from phylogenies based on sequences alone. There 
are too many uncertainties due to sequence similarity, as demonstrated by the low 
observed bootstrap support values within clusters. (Full length sequences may 
however improve the resolution of branching order within clusters, see section 7.8.3). 
Networks which incorporate this uncertainty can be annotated with additional 
information (such as RITA result, date of initiation of ART etc.) to eliminate 
improbable links. Novel methods which improve the resolution of the chain of 
transmission directly from the phylogeny (section 7.7) will likely perform better than 
the methods presented here; however at this point they cannot be run on datasets as 
large as this one. In parallel, approximations such as the one presented here as still 
useful, especially on such large datasets.   
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Another limitation of the network reconstruction method is that it appears not to 
perform well at low sampling densities. In the simulated epidemic sampled at 20% the 
Waring distribution was not selected as the best fit, and α varied dramatically between 
the thinned and unthinned networks. In the UK, sampling is around 60% so this will 
not be an issue, but it will limit the applicability of these methods (in their present 
form) to low sampled epidemics, such as those of sub-Saharan Africa [223]. It is 
possible that the method is not limited directly by sampling proportion but by sample 
size, and in order to test that, I will analyse low sampling proportions (5-20%) from 
much larger simulated epidemics (50-100,000 nodes). At low sampling densities, exact 
transmission links will not be captured, however by using more relaxed tMRCA 
thresholds for linkages, it may be possible to generate degree distributions which 
approximate the degree distribution of the true transmission network. Another 
important next step will be to test how well we are able to estimate α in epidemics 
simulated with 2 < α < 3. 
In this chapter, I used LSD to reconstruct tMRCA in the simulated sequences and 
BEAST in the UK HIV RDB data. The LSD tMRCA reconstruction performed 
extremely well in the simulated data (Figure 6.4) but this underlines a problem with 
the simulated sequences: they were simulated under a GTR model and phylogenies 
were reconstructed under a GTR model, leading to over-fitting. BEAST may not have 
improved the tMRCA reconstruction any further. However in the true HIV data, within 
patient and between patient evolution combined with selection and heterogeneity in 
time between transmissions mean that a Bayesian genealogical framework will 
improve reconstructions [224]. With any simulation, there is a risk of over-fitting to 
that simulation rather than to true data. For that reason, I did not use the 5.38 year cut-
off selected in the simulations in the true as it is unlikely to be any more informative 
that using a 5 year cut-off. In the future, I will evaluate the performance of selected 
thresholds in an independently simulated epidemic.  
In conclusion, the network reconstruction performs well in simulated data at high 
sampling densities (>60%) consistent with UK coverage, but many non-existent links 
are inferred. Thinning improves the precision of the reconstruction. The best fit degree 
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distributions in thinned networks vary by risk group, with heterosexuals displaying 
much less variation in onward transmissions than MSM and PWID. Among MSM and 
PWID, the Waring distribution was selected as the best fit but parameters remained 
within those indicating finite variance. Nonetheless, α was very low among PWID 
suggesting that interventions targeted towards high degree nodes may be more 
efficient to curve HIV spread in this group.  
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7 DISCUSSION 
7.1 Summary of findings 
In this thesis, I have presented automated tools for the analysis of large sequence 
databases and used them to compare what are currently the two most densely sampled 
national epidemics, the UK and Switzerland. This analysis revealed similarities 
between the two countries’ epidemics despite clear variation in risk group composition 
and distinct proportions of sequences in clusters [97, 105, 108, 109]. I conclude that 
the current underlying subtype B transmission dynamics in the UK and Switzerland 
are likely to be similar, including the integration of both countries’ epidemics into the 
European and global epidemics. For this analysis, I focused on subtype B because 
numbers of non-B subtypes were so low in Switzerland. In contrast, non-B subtypes 
now represent >50% of diagnoses in the UK [93]. In Chapter 5, I examined the 
transmission of non-B subtypes within the UK. An increasing proportion of non-B 
subtypes have previously been shown to have been acquired within the UK [95]. I 
found that spread was most rapid when non-B subtypes have been introduced into high 
risk groups (MSM and PWID). This pattern is consistent with observations in France 
[100] and appears to be to be emerging in Switzerland [97]. Two initially distinct 
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epidemics, the MSM subtype B, and heterosexual non-B have become connected. Men 
self-reporting as heterosexuals who have been infected through sex with men are likely 
to drive the crossing over of subtypes between risk groups [106] (Chapters 4 and 5). 
In Chapter 6, I estimated the degree distribution for different risk groups in the UK. 
Differences in fit were in agreement with findings from previous chapters. 
Importantly, the best fit of the Waring distribution for MSM and PWID networks 
underlines the importance of identifying the most highly connected individuals within 
these groups. 
7.2 HIV in the UK 
Recent years have seen a surge in the number of HIV infections acquired through 
heterosexual sex, heterosexuals accounted 45% of diagnoses in 2012 [198]. However, 
as immigration from sub-Saharan Africa has declined, so have diagnoses among 
heterosexuals [6]. I found that for the most part, onward transmission from this group 
is very limited (Chapter 5). Heterosexual transmission network structure is consistent 
with a small number of transmissions per person, indicating that random interventions 
can be successful in curbing the heterosexual epidemic. The UK epidemic continues 
to be concentrated within high risk groups. However, heterosexuals, especially men, 
tend to be diagnosed much later, underlining the need for better testing and increased 
awareness in this group. Another issue highlighted in this thesis is the possible 
importance of male heterosexuals being infected through sex with men [106] (Chapters 
4 and 5). Sexual questionnaires should be rephrased to recognise such men to 
accurately estimate their risk factors. These men may play a role in bridging previously 
disconnected epidemics, and future network analysis will focus on further 
characterising such nodes. Previous work has already shown that they are more likely 
to be black African [106]. Similar overlap has been observed in Switzerland [97] and 
in the USA [225] although to a lesser extent, and bridging may be even more extensive 
in countries where homosexuality is illegal or more stigmatised than in the UK. MSM 
are much less likely to openly identify as MSM and are likely to also have female 
sexual partners [226, 227].  
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Another finding of Hué et al. was the high proportion (42%) of heterosexual clusters 
containing only women [106]. Female only transmission clusters are likely to represent 
a bias against sampling heterosexual men, because heterosexual men tend to present 
later. This issue of “missing men” is widespread in databases from the USA (Joel 
Wertheim, personal communication) and African countries, where proportionately 
more women are recruited to many HIV studies (Marcia Kalish, personal 
communication). Methods to estimate the likelihood of unsampled transmitters within 
clusters are not yet applicable to datasets of the size of the UK HIV RDB [228]. 
However, representation in the database has increased over time and if this 
interpretation is correct, analyses should start to capture these “missing men” 
retrospectively. Future work will include reconstructing UK HIV RDB clusters 
through time to investigate whether men appear in clusters (or in their genetic 
neighbourhood) over time.  
In Chapter 5, I found evidence of recent rapid transmission of HIV among PWID 
despite excellent harm reduction in this group in the UK. This result has instigated a 
reanalysis of PWID sequence data at the national level to quantify transmission 
dynamics within this group as such an analysis has never been carried out in the UK. 
In parallel, the Leigh Brown group is collaborating with local health authorities (who 
have additional data associated with each sequence) affected to elucidate the cause of 
these recent outbreaks. One possibility is that some PWID infections could have taken 
place in prisons, where clean needles are not provided. Another is that infections may 
be among Eastern Europeans not accessing health services. 
This analysis underlines that the UK HIV epidemic continues to be led by MSM, but 
that even within this group there is high variability in the number of onward 
transmissions. A recent modelling study found undiagnosed and asymptomatic high 
sexual activity aged below 35 years to be the key group sustaining the HIV epidemic 
[229]. The Leigh Brown group are working on characterising highly connected nodes 
in these networks. If nodes they are connected to represent individuals diagnosed 
before them, this will confirm that they were transmitting before being diagnosed. 
Together, these results highlight the importance of better testing among MSM and 
Transmission networks inferred from HIV sequence data 
 
158  Manon Ragonnet-Cronin - October 2015 
 
suggest there may be a place for PreP in the UK as well. The next few years will 
demonstrate whether deployment of PreP in the USA has succeeded in reducing HIV 
incidence. It will be particularly interesting to estimate the effects of PreP at the 
population level, i.e. how many MSM not taking PreP have been protected by those 
that do. Uninfected MSM sharing the characteristics of highly connected nodes would 
be the prime targets for PreP. 
7.3 Integration of molecular epidemiology into public health 
Taken together, these results demonstrate the insights offered by integrating molecular 
epidemiology into public health. Some studies have gone even further. In San Diego, 
phylogenetic analysis was combined with contact tracing, hugely increasing the 
proportion of sequences clustering [187]. Such a deliberate (and non-anonymised) 
quest for transmission partners can offer clear opportunities for selecting individuals 
for interventions, for example if they are part of large active transmission clusters, or 
have only recently become infected (and are highly infectious). The San Diego group 
then reconstructed networks through time from HIV sequences and estimated a 
network connectivity metric for each individual [230]. They found that network 
connectivity was more predictive of increase in degree (or the number of onward 
transmissions) than any epidemiological or clinical factors associated with each node. 
In a follow up study they demonstrated that targeting highly connected nodes with an 
early intervention (for example early initiation of ART) outperformed any baseline 
demographics in reducing further transmissions [231]. Similarly in Beijing, targeting 
nodes based on network connectivity worked better than based on CD4+ counts or 
viral loads [232]. In Chapter 6, I discussed the possibility of identifying node 
characteristics associated with high degree. These characteristics could then be used 
either to select HIV negative individuals with those characteristics for prevention 
(PreP or behavioural) or to select HIV positive individuals for interventions (early 
initiation of ART or behavioural). In contrast, the interventions delineated above 
require reconstruction of an individual’s (non-anonymised) network at diagnosis to 
determine connectivity. 
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Information on partners in addition to sequence data would make it possible to 
determine whether transmission occurred between individuals. The collection of 
behaviour data, such as testing frequency, last negative HIV test, change of behaviour 
after diagnosis, date of ART initiation and PreP usage, could further bound the timings 
of transmission events. 
7.4 Risk to privacy and stigma 
In view of the criminalisation of HIV transmission [145], the use of non-anonymised 
sequences combined with contact tracing raises concerns over the legal repercussions 
to source partners that are identified. As coverage in the UK HIV RDB increases, direct 
transmission links are found more and more frequently. As additional information is 
incorporated into models (such as dates of ART initiation or recency of infection) it 
will become possible to identify direction of transmission. The use of additional 
information can greatly improve the accuracy of reconstructions, and can enable the 
detailed identification of correlates of transmission [59]. Yet it is also possible that 
specifically identifying detailed correlates of transmission could increase the 
stigmatisation of individuals subsequently considered high-risk (both infected and 
uninfected).  
Nonetheless, one can envisage a public health model which makes use of advances in 
molecular epidemiology methods without compromising the rights of the individual 
[233]. For example, public health providers could submit the sequence from a new 
diagnosis (potentially alongside those obtained through contact tracing) anonymously 
to a third party who would reconstruct phylogenies and networks with a background 
of fully anonymised sequences to estimate the connectivity of that individual. New 
diagnoses could be added to the database through a separate procedure. 
As discussed in section 2.1.2, the database is anonymised and aggregated so as to 
prevent deductive disclosure. To some extent, genetic sequences are a form of 
identifiable information as they are distinct for each patient sampled. The UK HIV 
RDB comprises sequences from upwards of 60% of the HIV positive population, and 
releasing sequences into public databases could enable others to fish through those 
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databases to find sequences linked to their own. The Swiss and UK HIV databases 
have addressed this concern by making available only 10% of sequences analysed with 
each publication [105, 140]. 
7.5 Clustering methods 
As explained in Chapter 3, the aim of clustering is to identify subtrees that are 
epidemiologically meaningful. When trees are large, this may be done for 
computational reasons, in order to reduce a large dataset into smaller ones. For 
example in Chapter 6, I preselected sequences within the large phylogenies through 
clustering before analysis in BEAST, which is computationally demanding. 
Elucidating the behaviour of clusters may the aim of the analysis in itself, because 
clusters represent sites of active or recent transmission. As such, the characteristics of 
clustered individuals are important in terms of focusing interventions. Clusters 
frequently stratify into risk groups [105], with some overlap between risk groups, 
revealing the structure of the population and the importance of crossing over between 
risk groups. For example the Swiss heterosexual epidemic was driven by PWID [105] 
early in the epidemic, and this continues to be the case in Eastern European countries 
such as Latvia (Denise Kuhnert, unpublished results). Currently both the Swiss and 
UK epidemics are more likely to be driven by crossing over from MSM into 
heterosexuals (Chapters 4 and 5).  
However, clustering approaches have severe limitations. Firstly, a lot of information 
is lost from the tree. Results from the clusters, even though they represent active 
transmission, are not necessary generalizable to the whole of the study region’s 
epidemic. Secondly, clustering methods rely on relatively dense sampling, or at least 
sampling biased towards related infections. If sampled infections are distantly related 
to each other, they are highly unlikely to be part of the same transmission chain and 
clustering is meaningless. This means that clustering analyses may not be very useful 
analysing low sampled epidemics in low-resource settings (see section 7.8.1). Thirdly, 
the choice of clustering thresholds is problematic. In my analysis (Chapter 3), clusters 
identified were overall consistent at a range of genetic distance thresholds (4.5% to 
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7.5%), indicating that clusters represented delineated epidemiological units. However 
there was still some change even when distance threshold was changed only a little, 
and there is a huge difference between clusters identified at 1.5% and at 4.5% [192]. 
Standard practise is to perform sensitivity analyses to evaluate the robustness of 
epidemiological conclusions at a range of clustering thresholds. Furthermore, 
clustering thresholds meaningful in one epidemic cannot necessarily be extended to 
another. A (quite relaxed) cut-off of 4.5% was found to delineate clusters in the UK 
epidemic [108], but this is in part because such a high proportion of sequences are 
from chronically infected individuals. Appropriate thresholds are affected by sampling 
fraction, the evolutionary rate within the population, the time between infection and 
sampling. Nearly all clustering analyses have been performed on pol, and cut-offs 
developed for pol are not suited to analyses of other parts of the genome.  
Finally, clustering does not reveal the true genealogical relationships between 
sequences (see section 7.7) and do not fit into traditional epidemiological modelling 
(see section 7.6). 
7.6 Network methods 
The main advantage of reconstructing networks as well as (or instead of) phylogenies 
is that networks fit within a body of work on epidemiological modelling, allowing for 
testing of hypotheses within a rigorous statistical framework. In this thesis, I focused 
on estimating the degree distribution from the transmission network because of its 
impact on the success of different kinds of interventions. Previous analyses of sexual 
contact network data are limited by the fact that they are likely to miss high degree 
individuals. One suggestion to increase the likelihood of sampling high degree nodes 
has been to sample people with STIs [129]. The present method includes data only 
from HIV positive individuals, and so is much more likely to capture high degree 
nodes and to better estimate the behaviour of the tail of the distribution.  
However, all individuals captured are infected and so transmission networks are being 
reconstructed rather than contact networks. While on one hand, there may be 
advantages to capturing only contacts that have led to transmissions, existing 
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frameworks have been developed based on the sexual contact network and it is at 
present unclear how the two can be reconciled. The transmission network is a result of 
the pathogen’s behaviour on the contact network and depends on many factors 
including its period of infectivity and how knowledge of a person’s infection status 
will affect their behaviour [234]. Therefore while contact networks can be used to 
model the transmission of a number of diseases, transmission networks inferred from 
pathogen phylogenies will tell us only about the pathogen under study. As sequence 
databases for other infectious agents grow, it will be possible to compare and contrast 
networks reconstructed from different pathogens.  
 
Figure 7.1: Number of distinct clusters in the network increasing as nodes are 
removed either at random (in grey, 5 replicates) or according to four different 
centrality measures.  
Information on the contacts that didn’t lead to transmission can be equally important 
for understanding disease dynamics [133]. The HIV-DSPS offers clear opportunities 
to reconcile transmission and sexual contact networks. One next step would be to build 
sexual contact networks using data from NATSAL, simulate HIV transmission and 
evolution along those networks and compare simulated phylogenies and transmission 
networks to those reconstructed from the UK HIV RDB. Another question is whether 
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transmission networks inferred from sequence data can be used to better calibrate 
sexual contact networks. Social network data, such as Twitter and Facebook, also offer 
new opportunities for constructing social and sexual network data, sometimes in 
parallel with subjects’ sexual and drug using behaviours.  
 
Figure 7.2: Size of the largest cluster in the network (giant component) decreasing 
as nodes are removed either at random (in grey, 5 replicates) or according to four 
different centrality measures. 
As explained above, representing relationships between sequences in a network 
enables the isolation of individual nodes within clusters for characterisation; for 
example high degree nodes and bridging nodes. Many additional metrics are available 
to describe networks which were not investigated in this thesis. For example centrality 
measures quantify how important a node is in keeping a network connected. In Chapter 
6, I found that targeted interventions may not be necessary in the UK, however 
preliminary analyses have shown that removing nodes based on centrality measures 
breaks up the network much more rapidly than doing so at random (Figure 7.1 and 
Figure 7.2). As targeted interventions are much more difficult to carry out, further 
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modelling should quantify optimal proportions of targeted and random interventions 
to maximise impact. Currently, nodes targeted in these networks represent only already 
infected individuals (who could be targeted with early initiation of ART) but models 
will eventually include uninfected individuals who could be targeted with PreP. 
7.7 Resolving the true chain of transmission 
The clustering and network methods developed in this thesis are limited by the fact 
that they do not resolve the true transmission chain and cannot detect the direction of 
the transmission. Novel methods have been developed to estimate the direction of 
transmission events on phylogenies. Overall these methods work by assuming that 
each internal node represents a transmission event and the branch before that, the virus 
in its ancestral host. Assuming complete sampling, the probability of each node in the 
phylogeny being the ancestral host/transmitter can be calculated to estimate the 
direction of each transmission event. Ancestral states can be reconstructed moving 
back through the tree from the tips to root.  
These methods require highly sampled networks (close to 100%) with little to no 
introduction of new strains. As such, datasets available usually represent outbreaks of 
diseases among farm animals, such as foot and mouth [235-237]. Despite the very high 
coverage of the UK HIV RDB, and even for subtype B which is dominated by within 
UK transmission, imports are high and the UK epidemic is well integrated in to the 
global epidemic, so sampling fraction of the full epidemic is likely to be low. 
Nonetheless, Volz and Frost estimated for pairs of nodes in HIV phylogenies the 
probability of either being the transmitter [228]. While they were able to infer direction 
as well as calculate the probability of the transmitter missing from the phylogeny, 
inferences required detailed information on incidence, prevalence, sampling fraction 
and stage of infection. 
As well as requiring high coverage, these methods are highly computationally 
intensive. Cottam et al. exhaustively mapped all possible transmission histories onto 
phylogenies for the 2001 UK foot and mouth disease outbreak, calculating for every 
node in their phylogeny the probability that it represented each host, but this would 
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not be possible for larger phylogenies or over multiple trees [237]. However, Morelli 
et al. implemented MCMC to sample from the probability distribution of transmission 
trees without having to examine every single one [236], as well as to iterate over 
multiple trees.  
In order to improve transmission history reconstruction even further, some models now 
incorporate within host diversity and evolution, as well as estimate the number of 
unsampled cases [238]. Indeed availability of multiple sequences from patients can 
reveal direction of transmission and provide detail on the timing of transmission [239]. 
Expressing mutation rate as a rate per generation can facilitate counting of unsampled 
cases [240].  
While lower sampling decreases the likelihood that transmission pairs will be sampled, 
algorithms developed to reconstruct transmission histories provide statistical 
frameworks for testing epidemiological scenarios on trees. Importantly, while results 
on direction of transmission between pairs are not generalizable, investigating wider 
epidemiological enquiries may be useful in understanding numerous epidemics. For 
example, rates of transmission between risk groups can be estimated [228, 235]. 
7.8 Remaining issues and opportunities 
7.8.1 Applicability to low-resource settings 
One important final question is whether the methods developed in this thesis can be 
useful in less densely sampled epidemics, in particular those of sub-Saharan Africa, 
where the burden of infections is greatest [223]. The network reconstruction method 
in Chapter 6 performed poorly at 20% sampling – and 20% sampling by far exceeds 
the sampling fraction currently available in sub-Saharan Africa. It remains to be tested 
whether low sample number, rather than low sample fraction is the issue and whether 
it is possible to reconstruct the properties of the true transmission networks when only 
small numbers of transmission partners are captured. It is possible that these methods 
will have to be better integrated with phylodynamic methods which use more 
information from the tree as a whole rather than focusing solely on related transmission 
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partners. Developing phylogenetic and network methods for sub-Saharan Africa is one 
of the objectives of the PANGEA-HIV Consortium [241]. 
7.8.2 Recombination 
An underlying assumption of phylogenetics is that a single tree can describe the 
evolutionary history of all the sequences. However this assumption is violated for HIV, 
as recombination occurs frequently in the HIV lifecycle (section 1.2.2). 
Recombination will cause errors in our estimation of phylogenetic relationships and 
divergence times. Common practice is to look for recombination among sequences 
before analysis and exclude recombinants. In this thesis, I did not analyse any inter-
subtype recombinants but did not eliminate intra-subtype recombinants. While 
extensive recombination will take place even within subtypes, Lemey et al. argue that 
this does not invalidate transmission trees inferred from HIV phylogenies as sequences 
analysed for transmission are sufficiently closely related to ensure phylogeny 
reliability [242]. In our case, analysis focused only on transmission clusters in which 
recombination is unlikely to have taken pace. 
Recombination is likely to become more of a problem when analysing the epidemics 
of countries with high subtype diversity and frequent co-infection, such as Uganda, 
one of the counties involved in PANGEA (section 7.8.1). Even in the UK, the 
proportion of recombination has inarguably been increasing [93] and the recombinant 
epidemic cannot be ignored altogether.  
One solution is to reconstruct the ancestry of sequences through networks in which 
sequences can have multiple ancestors [29]. To date this type of analysis has been 
carried out manually, but our group is currently automating the process by integrating 
repetitive fast single-linkage network construction [99] with a sliding-window 
approach to scan the entire genome across the whole population. 
7.8.3 Novel sequencing methods: deep sequencing and full genome 
sequencing 
For some pathogens, reconstructing transmission through phylogenetic analysis has 
only become possible because of full genome and deep sequencing. This is the case 
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for example for tuberculosis, because variability is so low between isolates [243]. HIV 
mutates so fast that pol alone is sufficient for reconstruction transmission trees [144]; 
however  full genome and deep sequences will improve the precision of 
reconstructions.  
Availability of multiple sequences from patients makes it possible to infer direction of 
transmission [239] based on tree structure, as will sequences obtained from deep 
sequencing. Estimates of timing of transmission will also be improved [238]. Deep 
sequencing will also disentangle co-infection. Full genome sequences improve the 
resolution of phylogenies and will make it easier to reconstruct the order of infections 
within clusters. In simulates data, HIV phylogenies reconstructed from full genome 
sequences more closely resemble true viral phylogenies (Gonzalo Yebra, personal 
communication).  
Models will have to be adapted to analyse multiple sequences per patient by 
accounting for within host genetic diversity (see section 7.7) [238]. Phylogenies will 
then have to be interpreted differently: nodes will no longer represent solely 
transmission evets but also divergence within hosts. Full genome availability will also 
make it necessary to develop methods that account for recombination as longer 
sequences are much more likely to have undergone recombination. It has been 
suggested that expanding sequencing may lead to subtypes disappearing altogether 
[29]. 
7.9 Conclusion 
Phylogenetic analysis can enhance traditional epidemiology by providing insights into 
HIV transmission patterns. The UK HIV RDB is an incredible resource for 
understanding the UK epidemic and the quality of the data collected is improving all 
the time. Better data will enable increasingly detailed analyses but come at a risk for 
the privacy of the individual. Researchers should be aware of these risks and in parallel 
have a responsibility to fight against the criminalisation of HIV transmission. While 
the methods developed in this thesis are useful to tailoring prevention programs in the 
UK, more efforts are need to develop standardised phylogenetic epidemiology 
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methods that can be applied as public health tools to prevent new infections in sub-
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APPENDIX 1: CENTRES CONTRIBUTING DATA TO UK HIV 
RDB 
 
 Addenbrooke’s Hospital, Cambridge (Jane Greatorex) 
 Chelsea and Westminster Hospital, London (Adrian Wildfire) 
 Guy’s and St. Thomas’ NHS Foundation Trust, London (Siobhan O’Shea, Jane 
Mullen) 
 PHE Birmingham Public Health Laboratory (Erasmus Smit) 
 PHE London (Tamyo Mbisa) 
 Imperial College Health NHS Trust, London (Alison Cox) 
 King's College Hospital, London (Richard Tandy) 
 Leeds Teaching Hospitals NHS Trust (Tony Hale, Tracy Fawcett) 
 Liverpool Specialist Virology Centre, Royal Liverpool University Hospital 
(Mark Hopkins, Lynne Ashton) 
 Manchester Specialist Virology Centre, Central Manchester Foundation 
Trust (Peter Tilston) 
 Royal Free Hospital, London (Claire Booth, Ana Garcia-Diaz) 
 Royal Infirmary of Edinburgh (Jill Shepherd) 
 Royal Victoria Infirmary, Newcastle (Matthias Schmid, Brendan Payne) 
 South Tees Hospitals NHS Trust, Middlesbrough (David Chadwick) 
 St George's Hospital, London (Phillip Hay, Phillip Rice, Mary Paynter) 
 St Bartholomew’s and The London NHS Trust (Duncan Clark, David Bibby) 
 St Mary's Hospital, London (Steve Kaye) 
 University College London Hospitals (Stuart Kirk) 
 West of Scotland Specialist Virology Centre, Gartnavel General Hospital, 
Glasgow (Alasdair MacLean, Celia Aitken, Rory Gunson) 
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APPENDIX 2: FAST TREE VS RAXML CLUSTERS 
Subtype C sequences from the 2010 UK HIV RDB release (see section 2.1.2) were 
analysed, totaling 10830 sequences. Trees were reconstructed in parallel using  
FastTree [163] and RaxML [162] each with 100 bootstraps. Bootstrap distributions 
were mostly overlapping, with RaxML showing a slight tendency towards assigning 
higher bootstraps (Figure 8.1). Clusters were picked in the resulting phylogenies using 
the Cluster Picker [197] at 90% bootstrap and 4.5% genetic distance. 1805 clusters 
were identified in the RaxML tree and 1565 in the FastTree phylogeny. 1547 clusters 
(84%) were identical across the two methods (Figure 8.2). 
 
Figure 8.1: Bootstrap distributions from RaxML and FastTree phylogenies 
 
Figure 8.2: Overlap between RaxML and FastTree clusters 
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APPENDIX 3: CODE AVAILABLE ON CD-ROM 
 
Chapter Language Code details 
2 R Remove drug resistant sites in alignments based on 
International AIDS Society List 
3 R Sort clusters into single origin and multiple origin, do stats, drop 
tips from trees (all in one script) 
4 Python Launch Cluster Picker in a loop 
 Python Process and merge CPCM output 
 R Process and merge CPCM output 
 R Cluster spreadsheets into degree distributions 
 R Jackknifing degree distributions 
5 R Simulations tree growth/cluster growth 
 R GLM 
6 R Get tMRCA from tree 
 R Thinning algorithms 
 R Fit degree distributions to networks 
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APPENDIX 4: THINNING ALGORITHMS 
The thinning algorithm consists of two steps: thinning of cliques (fully connected 
clusters), then thinning of cycles (nodes connected through a closed path). Clique and 
cycle identification are both functions available in the sna package [222] in R. 
First all cliques in the unthinned network are identified and sorted by size. The clique 
with the most nodes is examined first. When more than one clique contains the same 
maximum number of nodes, all edge lengths (genetic distances or tMRCA) from all 
those cliques are examined. The algorithm starts with the clique with the highest single 
edge length (edgeMax), sorts the edges by length and eliminates the edgeMax edge if 
it is higher than the minimum length edge (edgeMin). The ratio between the two can 
be altered, so that the edgeMax edge will only be eliminated if it is x times larger than 
edgeMin, but in this thesis we eliminated the edgeMax edge if edgeMax>edgeMin (x 
=1). 
It is important to recognise that many cliques and cycles are not independent, and each 
time a link is removed, many other cliques in the list will be affected. Therefore, every 
time a link is removed, all cliques are identified again in the network as a whole before 
another link is selected for elimination.  
If edgeMax is not greater than edgeMin in a clique examined, that clique is skipped 
and the next clique of the same size is examined next. If there are no more cliques of 
that size, the algorithm proceeds to cliques of the next size down.  
Once all cliques (where edgeMax>edgeMin) have been eliminated (the smallest being 
triangles), the algorithm returns the clique-thinned network for cycle thinning.  
Cycle thinning proceeds in the same way, first identifying all cycles, looking at the 
cycle containing the most nodes first, identifying edgeMax within that cycle and 
eliminating the edge if edgeMax>edgeMin. 
The number of nodes in the network and the number of clusters are not affected by 
thinning. All nodes remain in the same clusters as in the unthinned network, but those 
clusters have fewer links after thinning.  
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APPENDIX 5: ROC CURVES 
100% - all links 
 
100% - direct links only 
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60% - all links 
 
60% - direct links only 
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20% - all links 
 
20% - direct links only 
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APPENDIX 6: PSEUDOCODE 
CLUSTER PICKER (CHAPTER 3) 
Initial set-up 
- SET initial threshold (IT), support threshold (ST), genetic threshold (GT) 
- READ sequences and tree  from files 
- CHECK there is a sequence for every tip (and vice versa) 
Recurse through tree and LIST all subtrees with support ≥IT 
For each subtree [ 
 Calculate all pairwise genetic distances (from sequences) 
 Get support from subtree root? node 
 If (max of pairwise distances ≤ GT) and (support ≤ ST) [ Subtree is marked 
as a cluster ] 
 else [ Get all children nodes and add these to the subtree list to be analysed as 
above ] 
] 
RANDOM ADD TIPS (CHAPTER 5) 
READ tree (tip names contain dates) 
Get a list of all branch lengths and store in ‘BranchLen’ 
Get a list of all bootstraps and store in ‘Bootstraps’ 
Count number of tips with tip date >2007 (nberTips). Drop all tips with tip date >2007 
For the length of nberTips [ 
 Select a branch on the tree (the likelihood of any branch being selected can 
be proportional to its length or just 1 over the total number of branches) 
 Select a position along that branch 
 Sample a bootstrap from Bootstraps and a branch length from branchLen 
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 Create a split in the tree at chosen location, supported by selected Bootstrap 
and add tip with selected branch length 
] 
THINNING (CHAPTER 6) 
 
 READ network (network contains node names and pairwise distances 
between each pair of nodes) 
 ‘x’ is set by the user as the multiplier for how much bigger the maximum edge 
distance has to be compared to the minimum edge distance before you delete 
that edge (thinning the clique). x=1 was used in this thesis.  
 
1. Clique thinning 
 Identify all cliques (nodes in a cluster all connected to each other) in network 
and store in ‘allCliq’ – they are all initially marked as ‘unthinned’ 
 This is an inbuilt function in the sna library in R 
 While ‘unthinned’ cliques remain in allCliq [ 
  Identify all cliques in network and store in ‘allCliq’  
  Sort cliques by size 
  Select the ‘unthinned’ clique with the largest number of nodes 
(If more than one clique has the same largest number of nodes, 
look at all pairwise distances within those cliques and select the 
one with the single largest pairwise distance) 
Sort pairwise distances of the clique. Identify the max (edgeMax) and 
min (edgeMin) 
If edgeMax < (x times edgeMin), mark clique as ‘thinned’ (it will not 
be inspected again) 
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  Else: eliminate the clique’s edgeMax and repeat loop 
 ] 
 
2. Cycle thinning 
Identify all cycles (nodes in a cluster linked up in a loop) in network and store 
in ‘allCycl’ – they are all initially marked as ‘unthinned’ 
  This is an inbuilt function in the sna library in R 
 While ‘unthinned’ cycles remain in allCycl [ 
  Identify all cycles in network and store in ‘allCycl’  
  Sort cycles by size 
  Select the ‘unthinned’ cycle with the largest number of nodes 
(If more than one cycle has the same largest number of nodes, 
look at all pairwise distances within those cycles and select the 
one with the single largest pairwise distance) 
Sort pairwise distances of the cycle. Identify the max (edgeMax) and 
min (edgeMin) 
If edgeMax < (x times edgeMin), mark cycle as ‘thinned’ (it will not be 
inspected again) 
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